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Abstract 
Enlargement of the cerebral ventricles is relatively common among extremely preterm 
neonates born before 28 weeks’ gestational age. One common cause of ventricle dilatation is 
post hemorrhagic ventricle dilatation (PHVD) following a bleed in the cerebral ventricles. 
While many neonates with PHVD will have spontaneous resolution of the condition, severe, 
persistent PHVD is associated with a greater risk of brain injury and morbidity later in life 
and left untreated can cause death. The current clinical management strategy consists of daily 
measurements of head circumference and qualitative interpretation of two-dimensional US 
images to detect ventricular enlargement and monitoring vital signs for indications of 
increased intracranial pressure (i.e. apnea, bradycardia). Despite the widespread clinical use 
of these indicators, they do not have the specificity to reliably indicate when an intervention 
to remove some CSF is required to prevent brain damage. Early recognition of interventional 
necessity using quantitative measurements could help with the management of the disease, 
and could lead to better care in the future. Our objective was to develop and validate a three-
dimensional ultrasound system for use within an incubator of neonates with PHVD in order 
to accurately measure the cerebral ventricle volume. This system was validated against 
known geometric phantoms as well as a custom ventricle mimicking phantom. Once 
validated, the system was used in a clinical study of 70 neonates with PHVD to measure the 
ventricle size. In addition to three-dimensional ultrasound, clinical ultrasound images, and 
MRIs were acquired. Clinical measurements of the ventricles and three-dimensional 
ultrasound ventricle volumes were used to determine thresholds between neonates with 
PHVD who did and did not receive interventions based on current clinical management. We 
determined image based thresholds for intervention for both neonates who will receive an 
initial intervention, as well as those who will receive multiple interventions. Three-
dimensional ultrasound based ventricle volume measurements had high sensitivity and 
specificity as patients with persistent PHVD have ventricles that increase in size faster than 
those who undergo resolution. This allowed for delineation between interventional and non-
interventional patients within the first week of life. While this is still a small sample size 
study, these results can give rise to larger studies that would be able to determine if earlier 
intervention can result in better neurodevelopmental outcomes later in life. 
Keywords 
Hydrocephalus, three-dimensional ultrasound, preterm neonate, intraventricular hemorrhage, 
post hemorrhagic ventricle dilatation, evidence based medicine, classification 
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Chapter 1  
1 Introduction 
Post hemorrhagic ventricle dilatation in preterm born neonates has highly variable 
outcomes and management strategies. This chapter will give a brief outline of the 
disease, its outcomes, the clinical management practices, and image based monitoring. 
1.1 Overview 
Very low birth weight (VLBW) neonates (less than 1500g) represent 1.2% of all live 
births. In recent decades, due to changes in perinatal management such as increased use 
of antenatal steroids to speed up lung development, use of surfactant to improve lung 
function after birth, and delayed (umbilical) cord clamping, the rates of neonatal 
mortality have been substantially decreasing in this population.1 However, even with 
these improvements, almost half of all VLBW neonates in Canada will either die or 
survive with major neonatal morbidity including, but not limited to, severe 
intraventricular hemorrhage (IVH).2  
IVH, a bleed located inside the lateral cerebral ventricles, is a common disease found in 
VLBW neonates with occurrence around 20-30% in this population.3 The incidence and 
severity of the hemorrhage increases with the degree of prematurity of the neonate, with 
those born earliest having the highest risk.4 The clots and blood breakdown products from 
a severe hemorrhage can block the flow of the cerebral spinal fluid (CSF), leading to post 
hemorrhagic ventricle dilatation (PHVD), which is the abnormal, progressive 
enlargement of the ventricular system. This enlargement can compress the surrounding 
brain and can lead to major disability and even death. In its most severe state, PHVD is 
known as post hemorrhagic hydrocephalus (PHH). Occurrence of PHH is 9-25% of all 
patients with IVH.5,6 While the mean direct costs of initial hospitalization for VLBW 
preterm neonates with IVH is $300,000 USD, in patients with PHH the cost increases to 
$495,000 USD.6 Neonates with PHH would tend to have a more complicated care course 
than neonates without PHH, and these numbers only reflect the initial stay within the 
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neonatal intensive care unit (NICU) and not the prolonged care required for preterm 
patients after discharge, which adds considerably to the cost of care.  
Neonates with PHH tend to have poor developmental outcome and higher mortality rates, 
thought to be caused by injury to the white matter.7 While cranial ultrasound (US) has 
been used to diagnose and monitor IVH and PHVD, there is currently no consensus on 
how and when to treat neonates with this disease in a manner that optimizes neurological 
outcomes and quality of life. 
1.2 Anatomy 
1.2.1 The neonatal brain 
The preterm neonatal brain has many significant differences when compared to an adult, 
or even a term age neonate. The most apparent is the less prominent sulci and gyri 
(cortical folds) in comparison to the term age neonate, or adult (Fig. 1-1).8 In addition, 
the germinal matrix located inferior to the lateral ventricles, and superior to the caudate 
nucleus is present in the early neonatal period. This structure is a highly vascularized 
region from which neurons migrate to the cortex during brain development. Generally, 
the most active part of this cell migration occurs while the fetus is in utero for neonates 
born at term equivalent age.9 However, very preterm neonates are born during this very 
active cell proliferation and migration, and angiogenesis (creation of new blood vessels), 
and this is the primary site of hemorrhage in many IVH cases.  
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Figure 1-1 MR images of brains. a) preterm brain at 28 weeks GA with a grade III 
IVH, b) preterm born neonate at 38 weeks GA (term equivalent age) and c) and 
adult brain. Adapted with permission by Kieran Maher using Graphic Converter 
from Applied Imaging Technology 
As the germinal matrix is adjacent to the lateral ventricles, hemorrhages stemming 
from this region tend to pour into the ventricles causing IVH. (See Fig. 1-2) 
 
Figure 1-2 Approximate anatomy of ventricle and germinal matrix. Germinal 
matrix is indicated next to the lateral ventricles in the sagittal plane.  
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1.2.2 The ventricle system and flow of cerebral spinal fluid 
The ventricular system allows for the generation of CSF which is involved in the 
mechanical protection of the brain and functions to regulate the cerebral environment.10 
The cerebral ventricles themselves are four communicating chambers that house the CSF 
generating choroid plexus. Under normal conditions, CSF is generated by specialized 
cells that filter blood plasma into the ventricles and this CSF is then circulated through 
the ventricles into the subarachnoid space surrounding the brain and also within the 
spinal cord, both of which house areas that the CSF can be reabsorbed into the blood 
stream.  Visual representation of the flow of CSF can be found in Fig. 1-3. 
 
Figure 1-3 Flow of CSF. Used with permission from Textbook OpenStax Anatomy 
and Physiology as Published May 18, 2016 at: 
https://commons.wikimedia.org/wiki/File:1317_CFS_Circulation.jpg 
The lateral ventricles are the two largest chambers on either side (left and right) of the 
brain wrapping around the thalamus in a C-shape. They can be subdivided into the 
anterior, temporal (inferior), and posterior (occipital) horns and house the largest portions 
of choroid plexus. In the anterior horn region of the lateral ventricles, the Foramen of 
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Monroe communicate with the third ventricle. The third ventricle is located at the mid-
line of the brain between the two thalami. From the third ventricle CSF can drain into the 
fourth ventricle through the Aqueduct of Sylvius, which is the narrowest channel in the 
ventricular system and is highly susceptible to blockage. From the fourth ventricle, which 
is also located at mid-brain, the CSF then drains into the subarachnoid spaces through the 
lateral foramina of Luschka. Image of the ventricle anatomy can be seen in Fig. 1-4. 
 
 
Figure 1-4 Drawing of a cast of the ventricular cavities, viewed from the side. From 
Anatomy of the Human Body by Henry Gray. Image is a scan of a piece of work that is part 
of public domain. 
The choroid plexus generates CSF and is located within the lateral ventricles, the roof of 
the third and forth ventricles.  The choroid plexus can generate upwards of 500 mL of 
CSF per day in healthy adults, and therefore any blockage in the flow of the CSF from 
the choroid plexus containing ventricles to the subarachnoid space where it is reabsorbed 
can result in CSF gathering in the ventricles leading to ventricle dilatation. 
6 
 
 
1.3 Risk factors  
The major risk factor for severe IVH is very low gestational age11 and very low weight at 
birth with neonates born closest to viability at highest risk.12,13 Additional antenatal risk 
factors include no antenatal steroid treatment and/or no magnesium sulfate therapy to the 
mother and having been conceived via fertility treatment (especially in vitro 
fertilization).14,15 Perinatal risk factors include early sepsis, high fraction of ventilated 
oxygen in the first day of life, pneumothorax (air or gas between the lungs and the chest 
wall), born outside of level three NICUs, treatment for hypotension in first days of life, 
and acidosis.14-16  Neonates born after maternal substance abuse, specifically cocaine use, 
are at an increased risk of IVH, and increased severity of the disease even after 
accounting for gestational age.17-19 These risk factors can generally be considered to 
cause fluctuations in blood flow, high venous pressure, and/or abnormal blood pressure, 
and as the vasculature in the germinal matrix is particularly fragile and not able to adapt 
to rapidly changing hemodynamic environments, this can cause the vessels to burst and a 
hemorrhage to occur. 20 Although the mechanism is not totally understood, male sex is 
associated with having more severe IVH even after confounding factors are controlled.21 
1.4 Pathophysiolgy of IVH to PHVD and 
hydrocephalus 
For most very preterm patients, IVH occurs within the first 72 hours of life with the 
subsequent ventricle dilatation occurring soon after the hemorrhage. Generally, the 
hemorrhage is thought to stem from the germinal matrix, which is a site of rapid cell 
division and migration, as neuronal progenitor cells are generated and moved to their 
eventual site (the cerebral cortex). Rapid angiogenesis occurs within the germinal matrix 
during this early neonatal period to feed the cell division. These rapidly generated vessels 
are fragile, immature, and lack structural support (such as smooth muscles or collagen) of 
more developed vasculature.20 Additionally, the germinal matrix is located between 
relatively large arterials and veins. This makes it a prime site for rupture should any 
fluctuation in blood pressure or flow occur. When born preterm, the neonate has many 
major stressors as mentioned previously that cause various amounts of extra stimuli to 
their system. The poor capacity of the preterm neonate to adapt and regulate the body’s 
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cardiovascular systems to outside stimuli (autoregulation) causes surges in blood flow 
and/or pressure in the vessels of the brain instead of the body automatically tempering the 
system to a lower flow/pressure which could be accommodated by the fragile vessels. 
Following an IVH, red blood cells are destroyed (hemolysis), and hemoglobin is released 
into the ventricular space. The commonly held belief was that IVH induces 
hydrocephalus due to blockage of the flow of CSF from the ventricles into the 
subarachnoid space. Through this line of thought, blood clots can acutely block smaller 
aqueducts between the lateral ventricles and third and fourth ventricle. This would cause 
‘obstructive’ hydrocephalus, an enlargement of the ventricles as the CSF is continually 
generated by the choroid plexus, but cannot flow to where it can be reabsorbed. Over 
time, as the blood clots have been broken down, hemosiderin, an end product of 
hemoglobin breakdown, can become lodged in the subarachnoid space and reduce the 
amount of CSF that can be absorbed. If the CSF flow had been restored between the 
ventricles and the subarachnoid space, the enlargement of the ventricles from this lack of 
reabsorption could cause ‘communicating’ hydrocephalus. 
Between the acute blood clot phase, and the hemosiderin deposit phase, many pro-
inflammatory pathways are induced as the hemoglobin breaks down into different blood 
breakdown products. Over time, the visual appearance of the CSF change to reflect the 
breakdown of the hemorrhage and clearance of the breakdown products (Fig. 1-5). While 
research into the particular processes of the hemorrhage breakdown following IVH 
causing induction of inflammation in the preterm neonatal brain is ongoing, a few 
pathways and factors have been elucidated.  
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Figure 1-5 CSF from patients with PHVD. CSF colour change as a hemoglobin is 
broken down and the blood break down products are slowly removed from the CSF. 
Specifically, methemoglobin, a hemoglobin breakdown product, has been shown to form 
pro-inflammatory cytokines (tumor necrosis factor alpha, TNFα) in a rabbit model, and 
the same cytokine, TNFα, was observed to increase in concentration as the amount of 
methemoglobin increased in CSF samples of preterm neonates following IVH.22 
Additionally, the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) 
protein complex was found to be significantly more activated in barrier cells of the 
choroid plexus in a rat model of IVH with marked ventricle dilatation.23 The author’s 
posited that the activation of this complex could lead to barrier cell, and tight junction 
dysfunction leading to abnormally high transfer of proteins into CSF, and perhaps the 
increased generation of CSF.23  
Hemolysis was determined to be a factor in the increase in size of ventricles in a rat 
model, while intact red blood cells injected into the ventricles did not show a similar 
increase in ventricle dilatation.24 Iron, also released as a part of hemolysis, has also been 
implicated in the development of hydrocephalus.24,25 While specific pathways that seem 
to cause the inflammation from hemoglobin breakdown products have not been fully 
investigated, inflammation, and subsequent tissue scarring, is certainly a likely cause of 
stenosis and blockage of the smaller channels (i.e., cerebral aqueduct) that CSF must go 
through in order to become reabsorbed.  
In general, irrespective of the mechanism of action, there are three clinical courses of 
PHVD, 40% of patients spontaneously resolve, 10% rapidly progress, and 50% 
persistently but slowly progress.5  Infants who have rapidly progressing PHH and some 
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with persistent, slowly progressing PHH will require interventions to prevent further 
brain damage.26   
1.5 Treatment of PHVD 
Definitive, curative medical treatment for PHVD as of yet does not exist for routine 
clinical use. However, there have been a few prior studies investigating potential 
therapies, as well as surgical therapies that are the standard of care for neonates with 
PHVD that does not resolve. 
1.5.1 Prior medical treatments, the DRIFT trial, current stem cell 
therapies 
For many years, to minimize the production of CSF, and hopefully reduce the number of 
complications and surgical procedures, neonates with progressive hydrocephalus were 
treated with diuretics.27 Diuretics such as acetazolamide and furosemide cause a 
reduction in CSF production, and one uncontrolled study suggested that there was a 
reduction in surgical shunt placement.28 However, this drug-based therapy came with side 
effects that could increase risk of morbidity and mortality. In one multicenter 
randomized, control trial of the efficacy of the treatment, it was found that neonates with 
PHVD treated with acetazolamide and furosemide had no difference in shunt placement, 
but had an increase in neurological morbidity.29,30 This type of therapy is no longer 
standard care, or recommended.31 
As it was thought that the cause of PHVD was primarily caused by a blockage of the flow 
of CSF from the ventricles to areas of reabsorption, medication to break up the blood 
clots were administered.32 The intraventricular administration of the thrombolytic agent 
streptokinase was seemingly promising in an early, non-randomized study;32 however, 
the results of a case controlled follow up study did not find any benefit to the therapy, and 
indeed more of the treated patients required shunt surgery than those who had standard 
care.33 Following this, and with the hypothesis that both the blood clots as well as pro-
inflammatory cytokines are causing the PHVD, the drainage, irrigation, and fibrinolytic 
therapy trial (DRIFT trial) was proposed.34 The surgical insertions of two catheters into 
the lateral ventricles (one right frontal, one left posterior) was followed by fibrinolytic 
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therapy to break up blood clots, then after a period of time a constant, slow infusion of 
artificial CSF was administered until the draining fluid cleared to the appearance of 
“white wine”.34  While the randomized, controlled study was suspended due to an 
increase in secondary intraventricular bleeding within the treatment arm, among those 
patients who survived and completed the trial, a lowered rate of severe cognitive 
disability and higher mental developmental index was seen in the treatment group in 
comparison to control when the patients were followed up at 2 years of age.35 In spite of 
this, due to the significant risk of meningitis from the indwelling catheters and increased 
secondary hemorrhage, DRIFT therapy is not recommended.31,36 
Some current research into treatment of IVH include the use of umbilical cord blood 
derived mesenchymal stem cells to attenuate inflammation after a severe IVH.37 Pre -
clinical results in a rat model of PHH have shown an attenuation in development of PHH, 
brain injury, and impaired behavioral test.38 A single center clinical trial is ongoing.39 
1.5.2 Surgical Intervention 
A number of procedures exist to alleviate increased intracranial pressure (ICP) caused by 
the excess CSF from PHVD. The most commonly used temporary methods include 
lumbar puncture, external ventricle drainage, ventricular access devices (reservoirs), and 
ventriculosubgaleal shunts. In addition, our center uses ventricle taps for temporary ICP 
relief. Additional, slightly more invasive procedures include the valveless ventriculo-
peritoneal (VP) shunt and endoscopic third ventriclostomy. There is no consensus of 
evidence into which of these methods are the best for temporary CSF diversion40,41 with 
all procedures linked to poorer neurodevelopmental outcomes.42 Often the end point 
‘permanent’ surgical intervention is a VP shunt that is valve regulated and this can 
remain in the patient for their entire lifespan. Patients with VP-shunts tend to have poorer 
outcomes than those without shunts.43 Generally, the progression of treatment ranges 
from least invasive (lumbar puncture), to most invasive (VP-shunt); however, during the 
course of each type of treatment, a small subset of neonates will have spontaneous 
resolution of the symptoms from increased ICP and require no further therapy while in 
the NICU. Of those patients who are non-symptomatic after some treatment, a small 
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number will once again require treatment later in life, often once the skull sutures close. 
All mentioned techniques will be outlined briefly. 
1.5.2.1 Serial CSF tapping – Lumbar Puncture and Ventricle Tap 
Serial tapping allows for the temporary relief of increased ICP as well as analysis of CSF 
to determine the amount of protein. A needle is inserted either in the lumbar spine 
(lumbar puncture), or transfontelle into the ventricle space through the frontal lobe 
(ventricle tap, VT). Lumbar puncture had previously been shown to improve 
hydrocephalus in patients who appeared to have communicating hydrocephalus (not a full 
blockage in the flow of CSF) at least temporarily;44 however, after a systematic review of 
literature, this is no longer advised for most patients with PHH as generally, they showed 
no improvement in rates of VP shunt placement, death, or disability in comparison to 
conservative treatment.45 The ventricle tap is the first line of treatment in our center as the 
nursing care and management of the neonate post-ventricle tap is somewhat less 
complicated than in neonates with drains or access devices (there are not catheters or skin 
irritation from a constantly growing subcutaneous reservoir). This is especially important 
for those patients with extremely low birth weights who might have sensitive skin and 
require minimal handling. Ventricle taps do however result in needle cysts that can be 
seen on imaging in between serial VTs (Fig. 1-6). It should be additionally noted, that the 
neonate is experiencing periods of high ICP followed by low ICP immediately following 
the intervention and this change in pressure can be experienced multiple times a week 
when serial tapping is occurring. Certainly, this is not optimal management, though that 
has not been definitively determined through scientific study. 
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Figure 1-6 MR images of needle track cysts from serial VTs. MRI was taken prior to 
VP-shunt insertion from a neonate at term equivalent age who had PHVD following 
grade III IVH. 
1.5.2.2 External Ventricle Drainage 
An external ventricle drainage (EVD) system allows for the constant removal of CSF in 
order to keep a consistently lowered ICP. A catheter is inserted through the fontanelle 
into the anterior horn of one of the lateral ventricles and this is generally done within the 
NICU. The end of the catheter is placed within a bedside, external, closed drainage 
system which can be raised or lowered to adjust the amount of CSF drained. A neonate 
cannot go home with an EVD as even within the hospital setting the risk of infection has 
been reported to be quite high (26%).46 However, it has been reported that the use of 
EVD reduces VP shunt placement in a third of neonates with PHH.47-49 Clinical 
judgement is generally indicated to determine if an EVD is used.31 
1.5.2.3 Ventricle Access Devices and Reservoirs 
Ventricular access devices (VADs) have a catheter placed into the anterior horn of the 
lateral ventricle much like EVDs; however, instead of an external container constantly 
collecting CSF at the end, there is a subcutaneous reservoir that collects CSF. This 
reservoir can be aspirated through a needle puncture to remove CSF daily, and has the 
advantage of allowing a slower, more controlled removal of CSF in compared to VT or 
lumbar punctures. In theory, this would mediate the extreme high and low ICP 
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experienced in the latter procedures. The major risks and complications from VADs are 
peri-operative infection, skin defects, and CSF leaking.50 
1.5.2.4 Ventriculosubgaleal Shunts 
A ventriculosubgaleal shunt (VSGS), has a catheter, which shunts CSF from the lateral 
ventricles into a large ‘pocket’ made in the subgaleal potential space by the surgeon.51 
This allows for temporary continuous drainage until the pocket becomes full of fluid and 
stops draining, or the PHVD resolves. In the former case, the VSGS can be converted 
into a VP shunt. There is some evidence from a single center study that a VSGS results in 
a lesser VP shunt rate than using VAD as well as requiring less often CSF aspirations.31,50 
It should be noted that the complications that VADs have held true for VSGS; however, 
due to the less often CSF aspirations, perhaps there is a lowered infection risk. Despite 
the benefits, the unsightly cosmetic appearance of the pocket protruding from the 
patient’s head is possibly a factor in the reduced use of this type of shunt. 
1.5.2.5 Endoscopic Third Ventriculostomy 
The endoscopic third ventriculostomy (ETV) is a technique where a hole is made on the 
floor of the third ventricle through an endoscopic approach so that CSF can drain into the 
basal cistern where it can be reabsorbed by the arachnoid granulations.52 This technique 
was typically used in patients with non-communicating hydrocephalus (CSF is blocked 
from draining into the arachnoid granulations, often through aqueduct stenosis). PHH is 
thought to be both communicating (where there is an increased production of CSF) as well 
as non-communicating (having a blockage of CSF flow). Since, PHH is not easily 
categorized as either for any given patient, and indeed it can be both in the same patient, 
choroid plexus cauterization (CPC) which decreases the amount of CSF produced is often 
combined with ETV. There are ongoing trials into the use of ETV/CPC in patients with 
PHH;53,54 however, there is no data from randomized controlled trials at this time. 
1.5.2.6 Ventriculo-peritoneal Shunt 
The ventriculo-peritoneal (VP) shunt is often the definitive surgery for patients with PHH. 
In this, a catheter is placed between the ventricles and the abdominal cavity and can be 
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seen in Fig. 1-7. A valve is set to either maintain a certain pressure or flow of CSF so that 
the ventricles are not over drained when a patient sits or stands. The VP shunt is however 
prone to failure55, whether through infection, obstruction, or over drainage. Generally, 
infection and obstruction requires shunt revision surgery and patients who undergo VP 
shunts from PHH are at a high risk of complications requiring revision.55 VP shunt insertion 
is correlated with poorer outcomes, and with every additional revision increases the risk 
for morbidity. Although some criteria such as patient weight over 1500g and/or CSF 
protein count <100mg/dL has been used to determine when shunts are inserted, there is no 
evidence from randomized controlled trials to back up these criteria.31 It has previously 
been noted through laboratory experiments that blood cells impact shunt valves more than 
protein levels, though there may be a correlation between the two, this has not be 
definitively shown.56 
 
Figure 1-7 Diagram of a VP-shunt. Fair use under the Creative Commons 
attribution international license (attribution to: Cancer Research UK / Wikimedia 
Commons) 
1.5.2.7 Valveless Shunts 
A valveless shunt is much like a VP-shunt, except it lacks a valve to maintain pressure or 
flow of CSF. While this type of shunt has been shown to reduce neurosurgical 
hospitalizations in adult patients with PHH, the use in preterm neonates with PHVD 
requires either the removal or conversion to a valve regulated VP-shunt once the infant 
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become ambulatory enough to sit upright.57 As this type of shunt might allow for infants 
to go home earlier than waiting for a VP-shunt, clinical judgement is required to determine 
if a patient is well enough to leave the NICU, and if parents are able to return to the hospital 
for a revision surgery once the infant is sitting upright. Complications are similar to that of 
VP-shunts with valves; however, they hold a larger risk of over drainage. 
1.6 Current Monitoring and Management 
Neonates at risk of PHVD are screened using transfontanelle head ultrasound. The exact 
time frame for when this screening occurs varies widely from hospital to hospital. At our 
center, neonates born at less than 1500g are screened during the first week of life as well 
as the fourth week of life if no pathology is present on the first image. As most IVHs are 
evident by the third day of life58 the first week scan often detects the presence of severe 
IVH before they become obvious from the clinical status of the patient. More frequent 
ultrasound scanning occurs at the discretion of the clinical team. Once PHVD is 
diagnosed, neurological exams are routinely performed to assess for worsening signs and 
symptoms of increased ICP. In general, a full and tense fontanelle, splaying skull sutures, 
and increased in head circumference are used to determine raised ICP. Additionally, 
clinical signs and symptoms such as increased spells of apnea and bradycardia, lethargy, 
and decreased activity could be signs of increased ICP, but are non-specific as other 
common co-morbidities in this patient population could also cause these symptoms. 
Additionally, there are some preterm neonates who have no clinical signs and symptoms 
and who only are diagnosed upon screening imaging. 
1.7 Imaging Neonatal Brains 
Imaging preterm neonates is challenging for many reasons. Those born the most preterm 
(about 24-28 weeks gestational age (GA)), are those who should be screened most often; 
however, they are also the population who will more likely have spells of apnea, unstable 
heart rate (bradycardia and/or tachycardia), and who could require resuscitation and 
increased oxygen just from handling (touching, moving the neonate). Additionally, these 
patients are incubator bound, requiring outside temperature regulation, in addition to 
ventilation for their immature lungs. A large fraction of these patients will also have IVs, 
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for various different reasons, such as requiring IV nutrition as they are not able to suckle 
(total peripheral nutrition (TPN)), for antibiotics, for treatment for other co-morbidities 
(such as patent ductus arteriosus), or for blood infusions. Therefore, methods that require 
the least amount of handling, and can be done with the patient inside the incubator are 
highly preferred for this patient population. Additional factors, such as the cost of care 
and time investment, need to be weighed against the potential value of an imaging 
session. 
1.7.1 X-ray based methods 
X-ray based imaging techniques have the ability to generate 3D images of the head 
through computed tomography (CT) and are relatively cost and time efficient. The first 
images of the preterm neonatal brain were performed using CT in the late 1970s, and the 
IVH grading system still used to this day was developed using this modality.59 However, 
CT images quickly went out of favour, and are not generally done in the neonatal 
population anymore due to concerns over potential DNA damage from ionizing radiation. 
Neonates are growing at very fast rates, with many organ systems undergoing rapid cell 
division and this makes them at risk candidates for dose-related induction of cancer later 
in life. Additionally, CT would require moving the neonate into an imaging facility, 
which is often not feasible.  
1.7.2 Magnetic Resonance Imaging (MRI) Methods 
MRI methods for imaging preterm neonates is an ongoing area of research and clinical 
interest. MRI allows for better structural visualization of the brain and has high tissue 
contrast allowing for the differentiation of white and grey matter along with 
hemorrhages. Fig. 1-8 illustrates MR images from preterm neonates at term equivalent 
age. Additionally, 3D images can be acquired to determine the size of brain structures 
including the ventricles following PHVD. However, there are many challenges associated 
with MRI that are specific to the neonatal patient population. 
To image neonates who are incubator bound, they must be moved from the incubator in 
the NICU into a MRI compatible incubator. These incubators are relatively expensive 
and are generally only available in research centers. Preterm neonates are therefore only 
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imaged sparingly in these specialized centers after careful consideration to patient risk if 
imaged. The transfer to the MRI incubator and then to the MRI suite requires a dedicated 
staff member which increases costs, and increasing the amount of patient handling 
considerably. 
 
Figure 1-8 MR images of neonatal brains. From left to right: Motion artifact, 
hemorrhage and ventricle dilatation, poor image quality due to low signal to noise 
ratio 
Motion is another particularly difficult issue to overcome since breath holding and other 
immobilization techniques are not feasible. Immobilization blankets and swaddling have 
been shown to work well for patients less than three months’ age; however, this does not 
work for all neonates. Motion artifacts can be seen in Fig. 1-8a. Thermoregulation, if not 
done through an MRI-compatible incubator, is an additional challenge as MRI rooms are 
relatively cool. Neonates must be monitored closely for signs of distress from cold. 
In general, the largest problem with imaging preterm neonates is the use of medical 
equipment such as IVs, ventilation devices, infusion pumps, and resuscitation devices 
that either are not safe to use in the MRI suite, or function inappropriately during 
scanning. Changing all medical devices to MRI compatible versions is expensive and 
challenging, and often this means delaying scans until the neonate is no longer reliant on 
ventilation or certain IV pumps. 
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Specialized head coils for neonates are not widely commercially available, which limits 
the highest quality imaging to centers that can develop these coils themselves, or to use 
sub-optimal set ups that worsen image quality. As such, imaging sequences for neonates 
are often limited by the hardware, and better imaging is only possible if the technology 
was developed in house. 
1.7.3 Ultrasound Imaging Methods 
Ultrasound imaging is particularly well posed for this preterm neonatal population in that 
it allows for rapid acquisition of images while at the bedside of the patient without using 
any ionizing radiation. Additionally, the imaging is relatively cost-efficient, which allows 
for serial exams to be performed to detect changes that can occur during both the initial 
stay in the NICU and during follow up. For these reasons, historically, US has been the 
imaging of choice for first line diagnosis of cerebral pathologies in incubator bound 
neonates. 
2D US imaging is performed using mid-frequency, small footprint, curvalinar transducers 
with wide views. The small footprint allows for the use of the anterior fontanelle as an 
acoustic window as the skull would prove difficult to image through due to its high speed 
of sound (4000 m/s) and therefore high attenuation of ultrasound in comparison to soft 
tissues and bodily fluids (1480-1570 m/s). The frequency of the probes are between 5-8 
MHz which allows for adequate depth of penetration of the tissues (between 7-14 cm). 
The images are generally acquired at a temporal frame update rate of 10-15Hz depending 
on the depth setting. Due to CSF having low scatter in US, the ventricles tend to appear 
hypoechoic (black) in images, while the solid blood clot from IVH appears hyperechoic 
(white) and the surrounding brain is a grey color. PHVD then appears as an increasing 
large CSF and blood presence surrounded by the brain. 2D US images of patients with 
mild, moderate, and severe PHVD can be seen in Figure 1-9. 
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Figure 1-9 2D ultrasound images of neonatal brains. Para-coronal 2D US images of 
a) mild, b) moderate and, c) severe PHVD. Patients in b) and c) required 
interventions, and eventually had VP-shunts inserted. 
Initially, ultrasound was performed through the temporal bone which allowed for a 
measurement across the anterior horns.60 A normative curve was generated for patients 
born 25 weeks GA and older which allowed for the detection of ventricle dilatation and 
hydrocephalus in patients who were significantly above the normal range (the 97th 
centile).60 Later, the anterior fontanelle was used as an acoustic window for imaging. The 
previously used anterior horn measurement was later appropriated to this new acoustic 
window though now measured on a para-coronal plane and is now known as the ventricle 
index (VI) (Fig. 1-10a). In some patients, the ventricles do not expand laterally and the 
VI might not change much during ventricle dilation, but instead balloon out into a more 
rounded shape.61 For these patients, the anterior horn width (AHW),62 which is measured 
diagonally across the largest part of the ventricle on the same para-coronal plane as VI 
(Fig. 1-10a) might be a better indicator of progressing ventricle dilatation. Since the 
ventricles are a highly irregular 3D structure, the anterior horns are not always the portion 
of the ventricles, which undergo dilatation. In 2000, Davies et al. generated reference 
curves for both the VI and AHW as well as for the 3rd ventricle width (Fig. 1-10a) and the 
thalamo-occipital distance (TOD) (Fig. 1-10b) to better address patients who could have 
ventricles dilating in different areas. The TOD is the only measurement made on the 
oblique sagittal plane instead of the oblique coronal and could be a better measurement to 
determine the course of PHVD in a sub-set of patient with ventricle dilatation primarily 
in the posterior horn. The 3rd ventricle width could potentially determine the site of the 
blockage of the flow of CSF, as it likely only undergoes dilatation if the blockage is in 
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the cerebral aquaduct, while would be less likely to dilate if the blockage is in the 
foremen of Monroe.  
 
Figure 1-10 Ultrasound images of different linear ventricle measurements 
a) VI, AHW and 3rd b) TOD 
While these quantitative measurements are better than qualitative estimations of ventricle 
dilatation, they still are limited by the intra- and inter- variability of each measurement. 
Specifically, while there is error in performing the measurement itself, there is additional 
error in the plane selection that an ultrasound technician records. This is confounded by 
the inherent limitation of using linear measurements to quantify the 3D irregularly shaped 
ventricles.  
To address this, Brann et al. developed a cylindrical coordinate estimate of VV from 2D 
US images.63 VV was estimated assuming that the technician was able to record 2D 
planes at equal angular spacing and found good agreement to phantoms63 as well as to in 
vivo measurements of removed fluid during interventions.64 They were able to create 
guidelines from a small pool of patients (N=48) with severe IVH and then prospectively 
used these guidelines predict which infants would go on to require interventions in a 
follow up study.65 Although this work was performed in the late 1980 and early 1990s 
and was remarkably good at characterizing which patients would require treatment, it was 
never brought into clinical practice. Likely, this was due to the amount of time required 
to segment the ventricles from 2D US, and the training required to reproduce ultrasound 
planes that were spaced out at regular angular intervals.  
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1.7.4 Emerging 3DUS Imaging and Ventricle Volume Estimates 
In the late 1990s, 3D US imaging began to look more feasible in a clinical research 
setting as 3D US systems became more readily available. Imaging was accomplished 
initially using a mechanical device to rotate a conventional US transducer to generate the 
third dimension66 and this system was based on one used for cardiac imaging. Another 
group tracked a 2D US transducer during free hand scanning through electromagnetic 
tracking to generate 3D US images.67 Other groups have had success acquiring 3D US 
images of neonatal ventricles using commercial tilting transducers,68-70 which are not 
currently used as standard of care.  
Mechanically rotated transducers use a motorized device to translate, tilt, or rotate a 
transducer during image acquisition in order to capture the volume of interest. These 
captured images are recorded by a computer, and because the scanning protocol (i.e., the 
amount rotated and the speed of rotation) is already known and precisely controlled, the 
captured 2D images have a known relative position to one another.71 The computer that 
recorded the images and controlled the motor can then reconstruct the 3D volume. An 
electromagnetic tracking system in comparison is used to track the relative position of 
each image plane by tracking the location of a hand held transducer in space and relating 
that to where the recorded images would be located in relation to one another.71 Again, 
the anatomy is imaged during acquisition and manipulation of the handheld transducer 
through the region of interest, but as the tracked images are not predefined to one degree 
of freedom, reconstruction of a tracked transducer takes longer than a mechanical 
rotation.  
More recently, commercially available matrix transducers72 have been used to image the 
neonatal ventricles.  
Mclean et al. have found that 2D US measurements (the VI and AHW) can be made 
accurately on 3D US images. Salerno et al in a single center study on 30 patients, and 
Romero et al in a separate single center study on 59 patients found diagnostic agreement 
for ‘normal’ as well as diagnosis of hydrocephalus, IVH, periventricular leukomalacia, 
and subdural collection between 2D and 3D ultrasound images made on the same patient. 
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Images for both studies were taken immediate after one another. In general, the time per 
scan is reduced when a 3D US image is acquired in comparison to 2D US images (2 
minutes for 3D US vs 5-10 minutes for 2D US).70,72,73  
Some previous work has been performed acquiring ventricle volumes (VV) from 3D US 
images, including a study on ‘normal’ preterm ventricles68 and those with mild ventricle 
dilatation69 although this work has not been done in patients with PHVD.  
While the commercially available 3D US systems are high performing, their high cost 
may limit their use, especially in the developing world. The previous studies using 
conventional 2D transducers (Abdul-Khaliq et al., 2000; Nagdyman et al., 1999) 
reconstructed the 3D US images offline, well after the patient had been imaged due to the 
time involved in reconstructing the image. Offline reconstructions resulted in 
examinations not encompassing the full ventricle volume in some patients, or the images 
were otherwise not of sufficient quality to be used in the study. While all previous studies 
have found 3D US to be feasible in a clinical setting, a system that could be used in 
conjunction with a conventional clinical 2D transducer to generate full 3D images at the 
bedside (incubator) would allow centers without a 3D US capable machine to confidently 
acquire 3D ventricle volumes. 
1.8 Research Hypothesis and Objectives 
The overall objective of the thesis was to develop a 3D US system that can accurately 
measure and monitor the ventricle volume of neonates with PHVD. Once developed, the 
system could then be used in a pilot study of patients with PHVD to develop thresholds 
for treatment and help guide clinical management of at risk neonates. The specific 
objectives and hypotheses tested in each chapter are briefly outlined below.  
In Chapter 2, our objective was to develop a 3D US system and validate the system in the 
lab through various phantom experiments. We wanted to determine if the system was 
generating geometrically correct images that could provide volume measurements of 
irregular 3D structures, such as the lateral ventricles. We expected to find the system was 
able to measure linear strings in three orthogonal directions ±5% of the actual distance 
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between strings. Additionally, we made a phantom approximating the neonatal head with 
ventricles of known volume and hypothesized our 3D US system would be able to 
measure the phantom ventricle volume ±5% of the actual volume. As a proof of concept, 
three neonates were imaged and their ventricle volumes were segmented by three 
different observers to determine intra- and inter- observer variance of the measurement.  
In Chapter 3, our objective was to further validate the 3D US system through in vivo 
experiments within neonates with PHVD in the NICU. We hypothesized that ventricle 
volumes from gold standard 3D MRI and 3D US from our system if acquired within 24 
hours of each other will be highly correlated (Pearson correlation, R2 > 0.9). 
Additionally, we hypothesize the difference between the volume of CSF removed from 
the ventricles during a ventricle tap will highly correlate (R2 > 0.9) with the difference in 
VV of 3D US images taken immediately prior to and within an hour after the ventricle 
tap. 
In Chapter 4, our objective was to compare 3D US VV against previously reported 2D 
US based measurements that were made on images taken on the same day. Additionally, 
we compared between changes in VV estimates and changes in 2D US measurements 
made between serial US imaging sessions. We hypothesized that although VV is strongly 
correlated with 2D US measurements, as had been previously shown using 3D MRI VV, 
the change in 2D US measurement between imaging sessions might not be strongly 
correlated with change in VV. We hypothesized this is due to higher variability in 2D US 
measurements than 3D US VV.  
In Chapter 5, our objective was to determine thresholds for treatment based on our pilot 
study 3D US VV data. We hypothesized that neonates who require interventions will 
have both larger VV and higher change in VV when measuring the VV over time than 
neonates who have PHVD but do not require interventions. While image-based 
guidelines exist to determine when an initial intervention for PHVD exist, follow up 
interventions are often not able to be done based on quantitative imaging. Given the 
previous 2D US based work, we believe that 3D US based estimates of VV should be 
able to determine thresholds for treatment in neonates with PHVD assuming those who 
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require treatment have ventricle dilatation that occurs significantly more rapidly than 
patients who undergo spontaneous resolution of PHVD. 
In Chapter 6, our aim was to expand upon previously published work74 that had generated 
an equation to estimate ventricle volume from 2D US measurements. Our aim was to 
investigate this technique using a larger patient population and test whether the 
measurement could predict surgical interventions, which was not performed in the 
original study. We were able to corroborate their initial results showing strong 
correlations between 3D US VV and this 2D US-based estimate of VV (R2=0.74). We 
hypothesized that although strong correlations have been found between this technique 
and 3D US VV, the relatively high variance in 2D US measurements will mean 2D US-
based VV is less sensitive to predict whether a neonate received an intervention.  
In Chapter 7, an overview and summary of the important findings of Chapters 2-6 will be 
presented. The limitations of the current findings, study specific limitations, and potential 
solutions will be highlighted. Directions for future research to begin to address these 
limitations, as well as potential follow up studies that can build on the foundation of this 
knowledge will be addressed at the end.  
 
 
 
 
 
 
 
 
 
25 
 
 
 
1.9 References 
 
1. Malloy, M.H. Changes in infant mortality among extremely preterm infants: 
US vital statistics data 1990 vs 2000 vs 2010. Journal of perinatology : official 
journal of the California Perinatal Association 35, 885-890 (2015). 
2. Horbar, J.D., et al. Mortality and neonatal morbidity among infants 501 to 
1500 grams from 2000 to 2009. Pediatrics 129, 1019-1026 (2012). 
3. Synnes, A.R., Chien, L.Y., Peliowski, A., Baboolal, R. & Lee, S.K. Variations in 
intraventricular hemorrhage incidence rates among Canadian neonatal 
intensive care units. The Journal of pediatrics 138, 525-531 (2001). 
4. Szpecht, D., Szymankiewicz, M., Nowak, I. & Gadzinowski, J. Intraventricular 
hemorrhage in neonates born before 32 weeks of gestation-retrospective 
analysis of risk factors. Child's nervous system : ChNS : official journal of the 
International Society for Pediatric Neurosurgery 32, 1399-1404 (2016). 
5. Murphy, B.P., et al. Posthaemorrhagic ventricular dilatation in the premature 
infant: natural history and predictors of outcome. Arch Dis Child Fetal 
Neonatal Ed 87, F37-41 (2002). 
6. Christian, E.A., et al. Trends in hospitalization of preterm infants with 
intraventricular hemorrhage and hydrocephalus in the United States, 2000-
2010. Journal of neurosurgery. Pediatrics 17, 260-269 (2016). 
7. Bassan, H. Intracranial hemorrhage in the preterm infant: understanding it, 
preventing it. Clin Perinatol 36, 737-762, v (2009). 
8. Orasanu, E., et al. Cortical folding of the preterm brain: a longitudinal analysis 
of extremely preterm born neonates using spectral matching. Brain and 
behavior, e00488 (2016). 
9. Stiles, J. & Jernigan, T.L. The Basics of Brain Development. Neuropsychology 
Review 20, 327-348 (2010). 
10. Stratchko, L., Filatova, I., Agarwal, A. & Kanekar, S. The Ventricular System of 
the Brain: Anatomy and Normal Variations. Seminars in ultrasound, CT, and 
MR 37, 72-83 (2016). 
11. Gleissner, M., Jorch, G. & Avenarius, S. Risk factors for intraventricular 
hemorrhage in a birth cohort of 3721 premature infants. Journal of perinatal 
medicine 28, 104-110 (2000). 
12. Wells, J.T. & Ment, L.R. Prevention of intraventricular hemorrhage in preterm 
infants. Early human development 42, 209-233 (1995). 
13. Shankaran, S., Bauer, C.R., Bain, R., Wright, L.L. & Zachary, J. Prenatal and 
perinatal risk and protective factors for neonatal intracranial hemorrhage. 
National Institute of Child Health and Human Development Neonatal 
Research Network. Archives of pediatrics & adolescent medicine 150, 491-497 
(1996). 
26 
 
 
14. Linder, N., et al. Risk factors for intraventricular hemorrhage in very low 
birth weight premature infants: a retrospective case-control study. Pediatrics 
111, e590-595 (2003). 
15. Sarkar, S., Bhagat, I., Dechert, R., Schumacher, R.E. & Donn, S.M. Severe 
intraventricular hemorrhage in preterm infants: comparison of risk factors 
and short-term neonatal morbidities between grade 3 and grade 4 
intraventricular hemorrhage. American journal of perinatology 26, 419-424 
(2009). 
16. Szpecht, D., Szymankiewicz, M., Nowak, I. & Gadzinowski, J. Intraventricular 
hemorrhage in neonates born before 32 weeks of gestation-retrospective 
analysis of risk factors. Child's nervous system : ChNS : official journal of the 
International Society for Pediatric Neurosurgery (2016). 
17. Viteri, O.A., et al. Relationship between Self-Reported Maternal Substance 
Abuse and Adverse Outcomes in the Premature Newborn. American journal 
of perinatology 33, 165-171 (2016). 
18. Singer, L.T., et al. Increased incidence of intraventricular hemorrhage and 
developmental delay in cocaine-exposed, very low birth weight infants. The 
Journal of pediatrics 124, 765-771 (1994). 
19. McLenan, D.A., Ajayi, O.A., Rydman, R.J. & Pildes, R.S. Evaluation of the 
relationship between cocaine and intraventricular hemorrhage. Journal of the 
National Medical Association 86, 281-287 (1994). 
20. Whitelaw, A. Intraventricular haemorrhage and posthaemorrhagic 
hydrocephalus: pathogenesis, prevention and future interventions. Seminars 
in neonatology : SN 6, 135-146 (2001). 
21. Mohamed, M.A. & Aly, H. Male gender is associated with intraventricular 
hemorrhage. Pediatrics 125, e333-339 (2010). 
22. Gram, M., et al. Hemoglobin induces inflammation after preterm 
intraventricular hemorrhage by methemoglobin formation. Journal of 
neuroinflammation 10, 100 (2013). 
23. Simard, P.F., et al. Inflammation of the choroid plexus and ependymal layer of 
the ventricle following intraventricular hemorrhage. Translational stroke 
research 2, 227-231 (2011). 
24. Gao, C., et al. Role of red blood cell lysis and iron in hydrocephalus after 
intraventricular hemorrhage. Journal of cerebral blood flow and metabolism : 
official journal of the International Society of Cerebral Blood Flow and 
Metabolism 34, 1070-1075 (2014). 
25. Strahle, J.M., et al. Role of hemoglobin and iron in hydrocephalus after 
neonatal intraventricular hemorrhage. Neurosurgery 75, 696-705; discussion 
706 (2014). 
26. Shooman, D., Portess, H. & Sparrow, O. A review of the current treatment 
methods for posthaemorrhagic hydrocephalus of infants. Cerebrospinal Fluid 
Res 6, 1 (2009). 
27. Huttenlocher, P.R. TREATMENT OF HYDROCEPHALUS WITH 
ACETAZOLAMIDE: RESULTS IN 15 CASES. The Journal of pediatrics 66, 1023-
1030 (1965). 
27 
 
 
28. Shinnar, S., Gammon, K., Bergman, E.W., Jr., Epstein, M. & Freeman, J.M. 
Management of hydrocephalus in infancy: use of acetazolamide and 
furosemide to avoid cerebrospinal fluid shunts. The Journal of pediatrics 107, 
31-37 (1985). 
29. Group, I.P.D.T. International randomised controlled trial of acetazolamide 
and furosemide in posthaemorrhagic ventricular dilatation in infancy. 
International PHVD Drug Trial Group. Lancet (London, England) 352, 433-
440 (1998). 
30. Kennedy, C.R., et al. Randomized, controlled trial of acetazolamide and 
furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 
year. Pediatrics 108, 597-607 (2001). 
31. Mazzola, C.A., et al. Pediatric hydrocephalus: systematic literature review and 
evidence-based guidelines. Part 2: Management of posthemorrhagic 
hydrocephalus in premature infants. Journal of neurosurgery. Pediatrics 14 
Suppl 1, 8-23 (2014). 
32. Whitelaw, A., Rivers, R.P., Creighton, L. & Gaffney, P. Low dose 
intraventricular fibrinolytic treatment to prevent posthaemorrhagic 
hydrocephalus. Archives of disease in childhood 67, 12-14 (1992). 
33. Yapicioglu, H., Narli, N., Satar, M., Soyupak, S. & Altunbasak, S. 
Intraventricular streptokinase for the treatment of posthaemorrhagic 
hydrocephalus of preterm. Journal of clinical neuroscience : official journal of 
the Neurosurgical Society of Australasia 10, 297-299 (2003). 
34. Whitelaw, A., Pople, I., Cherian, S., Evans, D. & Thoresen, M. Phase 1 trial of 
prevention of hydrocephalus after intraventricular hemorrhage in newborn 
infants by drainage, irrigation, and fibrinolytic therapy. Pediatrics 111, 759-
765 (2003). 
35. Whitelaw, A., et al. Randomized trial of drainage, irrigation and fibrinolytic 
therapy for premature infants with posthemorrhagic ventricular dilatation: 
developmental outcome at 2 years. Pediatrics 125, e852-858 (2010). 
36. Whitelaw, A. & Odd, D.E. Intraventricular streptokinase after intraventricular 
hemorrhage in newborn infants. The Cochrane database of systematic reviews, 
Cd000498 (2007). 
37. Ahn, S.Y., Chang, Y.S. & Park, W.S. Mesenchymal stem cells transplantation for 
neuroprotection in preterm infants with severe intraventricular hemorrhage. 
Korean journal of pediatrics 57, 251-256 (2014). 
38. Ahn, S.Y., et al. Mesenchymal stem cells prevent hydrocephalus after severe 
intraventricular hemorrhage. Stroke; a journal of cerebral circulation 44, 497-
504 (2013). 
39. Ahn, S.Y., Chang, Y.S. & Park, W.S. Stem Cells for Neonatal Brain Disorders. 
Neonatology 109, 377-383 (2016). 
40. Zaben, M., Finnigan, A., Bhatti, M.I. & Leach, P. The initial neurosurgical 
interventions for the treatment of posthaemorrhagic hydrocephalus in 
preterm infants: A focused review. British journal of neurosurgery 30, 7-10 
(2016). 
28 
 
 
41. Badhiwala, J.H., et al. Treatment of posthemorrhagic ventricular dilation in 
preterm infants: a systematic review and meta-analysis of outcomes and 
complications. Journal of neurosurgery. Pediatrics, 1-11 (2015). 
42. Srinivasakumar, P., et al. Posthemorrhagic ventricular dilatation-impact on 
early neurodevelopmental outcome. American journal of perinatology 30, 
207-214 (2013). 
43. Lee, I.C., et al. Posthemorrhagic hydrocephalus in newborns: clinical 
characteristics and role of ventriculoperitoneal shunts. Pediatrics and 
neonatology 50, 26-32 (2009). 
44. Kreusser, K.L., et al. Serial lumbar punctures for at least temporary 
amelioration of neonatal posthemorrhagic hydrocephalus. Pediatrics 75, 
719-724 (1985). 
45. Whitelaw, A. Repeated lumbar or ventricular punctures in newborns with 
intraventricular hemorrhage. The Cochrane database of systematic reviews, 
Cd000216 (2001). 
46. Kirmani, A.R., Sarmast, A.H. & Bhat, A.R. Role of external ventricular drainage 
in the management of intraventricular hemorrhage; its complications and 
management. Surgical neurology international 6, 188 (2015). 
47. Kreusser, K.L., et al. Rapidly progressive posthemorrhagic hydrocephalus. 
Treatment with external ventricular drainage. American journal of diseases of 
children (1960) 138, 633-637 (1984). 
48. Rhodes, T.T., et al. External ventricular drainage for initial treatment of 
neonatal posthemorrhagic hydrocephalus: surgical and neurodevelopmental 
outcome. Pediatric neuroscience 13, 255-262 (1987). 
49. Berger, A., et al. Long-term experience with subcutaneously tunneled 
external ventricular drainage in preterm infants. Child's nervous system : 
ChNS : official journal of the International Society for Pediatric Neurosurgery 
16, 103-109; discussion 110 (2000). 
50. Lam, H.P. & Heilman, C.B. Ventricular access device versus 
ventriculosubgaleal shunt in post hemorrhagic hydrocephalus associated 
with prematurity. The journal of maternal-fetal & neonatal medicine : the 
official journal of the European Association of Perinatal Medicine, the 
Federation of Asia and Oceania Perinatal Societies, the International Society of 
Perinatal Obstet 22, 1097-1101 (2009). 
51. Fulmer, B.B., Grabb, P.A., Oakes, W.J. & Mapstone, T.B. Neonatal 
ventriculosubgaleal shunts. Neurosurgery 47, 80-83; discussion 83-84 
(2000). 
52. Kulkarni, A.V., et al. Endoscopic third ventriculostomy in children: 
prospective, multicenter results from the Hydrocephalus Clinical Research 
Network. Journal of neurosurgery. Pediatrics, 1-7 (2016). 
53. Warf, B.C., Campbell, J.W. & Riddle, E. Initial experience with combined 
endoscopic third ventriculostomy and choroid plexus cauterization for post-
hemorrhagic hydrocephalus of prematurity: the importance of prepontine 
cistern status and the predictive value of FIESTA MRI imaging. Child's nervous 
system : ChNS : official journal of the International Society for Pediatric 
Neurosurgery 27, 1063-1071 (2011). 
29 
 
 
54. Peretta, P., Ragazzi, P., Carlino, C.F., Gaglini, P. & Cinalli, G. The role of 
Ommaya reservoir and endoscopic third ventriculostomy in the management 
of post-hemorrhagic hydrocephalus of prematurity. Child's nervous system : 
ChNS : official journal of the International Society for Pediatric Neurosurgery 
23, 765-771 (2007). 
55. Bir, S.C., et al. Outcome of ventriculoperitoneal shunt and predictors of shunt 
revision in infants with posthemorrhagic hydrocephalus. Child's nervous 
system : ChNS : official journal of the International Society for Pediatric 
Neurosurgery (2016). 
56. Brydon, H.L., Bayston, R., Hayward, R. & Harkness, W. The effect of protein 
and blood cells on the flow-pressure characteristics of shunts. Neurosurgery 
38, 498-504; discussion 505 (1996). 
57. Vinchon, M., Lapeyre, F., Duquennoy, C. & Dhellemmes, P. Early treatment of 
posthemorrhagic hydrocephalus in low-birth-weight infants with valveless 
ventriculoperitoneal shunts. Pediatric neurosurgery 35, 299-304 (2001). 
58. Paneth, N., et al. Incidence and timing of germinal matrix/intraventricular 
hemorrhage in low birth weight infants. American journal of epidemiology 
137, 1167-1176 (1993). 
59. Papile, L.A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of 
subependymal and intraventricular hemorrhage: a study of infants with birth 
weights less than 1,500 gm. The Journal of pediatrics 92, 529-534 (1978). 
60. Levene, M.I. Measurement of the growth of the lateral ventricles in preterm 
infants with real-time ultrasound. Archives of disease in childhood 56, 900-
904 (1981). 
61. Whitelaw, A. & Aquilina, K. Management of posthaemorrhagic ventricular 
dilatation. Archives of disease in childhood. Fetal and neonatal edition 97, 
F229-223 (2012). 
62. Perry, R.N., Bowman, E.D., Murton, L.J., Roy, R.N. & de Crespigny, L.C. 
Ventricular size in newborn infants. Journal of ultrasound in medicine : official 
journal of the American Institute of Ultrasound in Medicine 4, 475-477 (1985). 
63. Brann, B.S.t., Wofsy, C., Wicks, J. & Brayer, J. Quantification of neonatal 
cerebral ventricular volume by real-time ultrasonography. Derivation and in 
vitro confirmation of a mathematical model. Journal of ultrasound in medicine 
: official journal of the American Institute of Ultrasound in Medicine 9, 1-8 
(1990). 
64. Brann, B.S.t., Wofsy, C., Papile, L.A., Angelus, P. & Backstrom, C. Quantification 
of neonatal cerebral ventricular volume by real-time ultrasonography. In 
vivo validation of the cylindrical coordinate method. Journal of ultrasound in 
medicine : official journal of the American Institute of Ultrasound in Medicine 
9, 9-15 (1990). 
65. Brann, B.S.t., Qualls, C., Papile, L., Wells, L. & Werner, S. Measurement of 
progressive cerebral ventriculomegaly in infants after grades III and IV 
intraventricular hemorrhages. The Journal of pediatrics 117, 615-621 (1990). 
66. Abdul-Khaliq, H., Lange, P.E. & Vogel, M. Feasibility of brain volumetric 
analysis and reconstruction of images by transfontanel three-dimensional 
30 
 
 
ultrasound. Journal of neuroimaging : official journal of the American Society 
of Neuroimaging 10, 147-150 (2000). 
67. Nagdyman, N., Walka, M.M., Kampmann, W., Stover, B. & Obladen, M. 3-D 
ultrasound quantification of neonatal cerebral ventricles in different head 
positions. Ultrasound in medicine & biology 25, 895-900 (1999). 
68. Haiden, N., et al. 3-D ultrasonographic imaging of the cerebral ventricular 
system in very low birth weight infants. Ultrasound in medicine & biology 31, 
7-14 (2005). 
69. Gilmore, J.H., et al. Infant cerebral ventricle volume: a comparison of 3-D 
ultrasound and magnetic resonance imaging. Ultrasound in medicine & 
biology 27, 1143-1146 (2001). 
70. Salerno, C.C., et al. Three-dimensional ultrasonographic imaging of the 
neonatal brain in high-risk neonates: preliminary study. Journal of ultrasound 
in medicine : official journal of the American Institute of Ultrasound in 
Medicine 19, 549-555 (2000). 
71. Fenster, A., Downey, D.B. & Cardinal, H.N. Three-dimensional ultrasound 
imaging. Physics in medicine and biology 46, R67-99 (2001). 
72. McLean, G., et al. Measurement of the lateral ventricles in the neonatal head: 
comparison of 2-D and 3-D techniques. Ultrasound in medicine & biology 38, 
2051-2057 (2012). 
73. Romero, J.M., et al. Time efficiency and diagnostic agreement of 2-D versus 3-
D ultrasound acquisition of the neonatal brain. Ultrasound in medicine & 
biology 40, 1804-1809 (2014). 
74. Benavente-Fernandez, I., Lubian-Gutierrez, M., Jimenez-Gomez, G., Lechuga-
Sancho, A.M. & Lubian-Lopez, S.P. Ultrasound lineal measurements predict 
ventricular volume in posthaemorrhagic ventricular dilatation in preterm 
infants. Acta paediatrica (Oslo, Norway : 1992) 106, 211-217 (2017). 
  
 
 
31 
 
 
Chapter 2  
This chapter will discuss the in vitro validation experiments and initial patient 
experiences with the three-dimensional ultrasound system. 
The contents of this chapter were previously published in the journal Physics in Medicine 
and Biology: J. Kishimoto, S. de Ribaupierre, R. Mehta, K. St. Lawrence, D.S.C. Lee, A. 
Fenster. 3D ultrasound system to investigate intraventricular hemorrhage in preterm 
neonates. Phys. Med. Biol. 58 (2013) 7513-7526. doi: 10.1088/0031-9155/58/21/7513. 
Reproduced by permission of IOP Publishing and is provided in Appendix A.1. 
2 3D Ultrasound System to Investigate Intraventricular 
Hemorrhage in Preterm Neonates 
2.1 Introduction 
Very low birth weight infants (less than 1500g) account for 1.4% of all births in the United 
States1 and, of those, 20-30% will develop intraventricular hemorrhage (IVH).2 Once 
detected, the grade of the hemorrhage is ranked clinically from I-IV (least to greatest 
severity)3 and patients with grade II or higher tend to have a period of ventriculomegaly 
(ventricle dilation).4 Patients with mild IVH (grade I) usually have good outcomes, whereas 
those with severe IVH (grades III and IV) can go on to develop hydrocephalus and cerebral 
palsy.5 Additionally, nearly one in four infants with hydrocephalus will also progress to 
develop epilepsy in later life.6  
Patients may progress to a hydrocephalic state by different mechanisms. This progression 
can be due to hemosiderin (a hemoglobin breakdown product) blocking the subarachnoid 
granulation causing a decrease in the re-absorption of cerebral spinal fluid (CSF) leading 
to communicating hydrocephalus, or from membranes within the ventricular system 
causing stenosis of the aqueduct of Sylvius leading to obstructive hydrocephalus4 The 
timing of treatment of hydrocephalus in IVH infants is not well standardized and as the 
progression of the disease is not constant, monitoring of patients with post hemorrhagic 
hydrocephalus (PHH) who might require a timely intervention is critical to patient 
outcome.7 
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2D cranial ultrasound (US) imaging is performed as standard care on preterm neonates to 
diagnose and monitor IVH and ventriculomegaly. The selection of ‘slices’ of brain imaged 
in 2D vary from technician to technician, which can lead to variability and ambiguous 
grading of IVH, as the location of the hemorrhage may not be apparent after the initial US 
exam.  In addition, clinical US lacks sensitivity to changes in ventricular volume, as 2D 
images alone cannot provide accurate quantitative measures of irregular structures such as 
the ventricular system.   
Previous work has been performed on neonates to evaluate the utility of 3D US for cranial 
imaging exams. Imaging was accomplished using a mechanical device to move a 
conventional 2D transducer to generate the third dimension8 or free hand electromagnetic 
tracked 3D US scanning.9 Other groups have had success acquiring 3D US images of 
neonatal ventricles using commercially available matrix transducers10 or commercial 
tilting transducers11-13, which are not currently used as standard of care. While these 
commercially available systems are high performing, the high cost may limit their use, 
especially in the developing world. The previous studies using conventional 2D 
transducers8,9 reconstructed the 3D US images offline, well after the patient had been 
imaged due to the time involved in reconstructing the image. Offline reconstructions 
resulted in examinations not encompassing the full ventricle volume in some patients, or 
the images were otherwise not of sufficient quality to be used in the study. All of these 
studies have found 3D US to be feasible in a clinical setting; however, a system that could 
be used in conjunction with a conventional clinical 2D transducer to generate full 3D 
images at the bedside (incubator) would allow centers without a 3D US capable machine 
to confidently acquire 3D ventricle volumes. 
We have developed a hand-held mechanical 3D US scanner system that can be coupled to 
any clinical 2D US machine with an appropriate conventional transducer used for imaging 
neonatal’ brains. This system makes use of the mechanical “tilting” scanner system for 3D 
US imaging as described in Fenster et al. (2001),14 but constructed to suit a neonatal 
cerebral scan in the confines of an incubator. Since this system acquires images using the 
same transducer used in clinical scans, we are able to make direct comparisons to clinical 
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images and the estimates from those images as to whether or not ventricular dilation is 
occurring. 
In addition to the 3D US system, we have developed a volumetric phantom using three-
dimensional rapid prototyping technology to mimic a neonatal head with both mild and 
severe ventriculomegaly.  Previously reported volume phantoms of ventricles15 did not 
have transfontanelle properties, and previous US phantoms of neonatal skulls have not been 
for volumetric measurements, and therefore did not include ventricles.16 Using geometries 
segmented from MR images of infants with IVH, we built US phantoms with ventricles of 
known volumes that allowed us to validate the volume measurements of our system.  
In this paper, we describe our new 3D US system and report on the validity of its volumetric 
measurements of phantom ventricles of known volumes. We verify the ability to image in 
vivo the ventricles of preterm neonates using this system and analyze volumetric 
measurements made from these images. 
2.2 METHODS 
2.2.1 3D US System 
Although our system can be used with any US machine and appropriate transducer, we 
tested it with a HDI 5000 (Philips, Bothel WA) and C8-5 (Philips, Bothel WA) curved 
array 5-8 MHz broadband transducer, which is used in the NICU in our hospital. The 3D 
US scanner consists of a motorized transducer housing powered by a Faulhaber IE2400 
1409 dc motor with a 2100:1 gear ratio (MicroMo Electronics, Clearwater, FL) and a 
MCDC controller for the motor. Conventional 2D US images were acquired using an 
Epiphan VGA2USB LR frame grabber (RB Computing, Nepean, ON). A diagram of the 
transducer attachment, as well as a photograph of the transducer with attachment placed on 
approximately the anterior fontanelle inside an incubator is shown in Figure 2-1.  
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Figure 2-1 The handheld motorized 3D ultrasound system. a) The handheld 
motorized transducer housing with transducer (C8-5, Philips) attached. The 
“shield” region protects user from making contact with the moving transducer and 
indicates where the probe will be at maximum scan angle allowing optimal 
positioning prior to scanning a patient who may be lying prone, or on their side. b) 
The motorized transducer at the anterior fontanelle of a mannequin illustrating a 
scan inside an incubator. 
To perform a 3D US scan, the motor controller, which is connected to the computer via 
USB, tilts the transducer, while the frame grabber acquires 2D images from the video 
output of the US machine throughout the scan. Software developed in our laboratory 
controls the motor’s movements, accepts the 2D US images as they are acquired by the 
frame grabber, and reconstructs the 2D images into a 3D image as the 2D US images are 
acquired.14 Thus, the acquired 2D US images are spaced at a regular angular interval 
arranged in a fan-like form. Bilinear interpolation is used to fill in gaps between successive 
2D images to generate a full 3D volume that can be manipulated through any plane. 
During image acquisition, the technician or physician locates the middle of the target of 
interest, and then firmly holds onto the motor encasement (see Fig. 1b) while the device 
tilts the transducer on an axis at the probe tip, which is held against the patient’s head. The 
angular spacing between images can be chosen to be between 0.2 and 0.3 degrees, and 
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images are acquired at 25 frames/second over a scan angle of 30-72 degrees making total 
image acquisition between 4-14 seconds.  Typically, for neonates in our study, we have 
used an angular spacing of 0.3 degrees and a total scan angle of 65 degrees, for a scan time 
of 8.7 s, and a 3D US image size of about 400 x 350 x 350 voxels. The voxel size for the 
most commonly used depth setting of 7.9 cm was 0.22 x 0.22 x 0.22 mm. 
Patient images used in this study were collected following protocols approved by the 
Research Ethics Board of Western University (London, ON, Canada) and informed 
parental consent.   
2.2.2 Geometric Validation of Image Reconstruction 
To ensure our reconstructed 3D US geometries are correctly calibrated, linear 
measurements in all three scanning directions (axial, lateral, and elevation) must be 
validated. To test the accuracy of these measurements, a phantom made of strings spaced 
1 cm apart in each direction was constructed and scanned in a solution of distilled water 
and 7% glycerol by weight (speed of sound 1540m/s).17 The 3D US scanner was stabilized 
and the transducer face was completely submerged in the glycerol solution during image 
acquisition. The string phantom was then scanned at every calibrated depth setting (4.9 cm 
to 16.0 cm). The distance between strings was measured manually using our visualization 
software. Specifically, we measured from one intersection of a string to the next closest 
intersection in the axial, lateral, or elevation direction four times per direction per depth. 
Ten depth settings were calibrated, for a total of 40 measurements per orthogonal direction. 
As for all data analysis, we used SPSS Statistics v. 20 (IBM) to perform t-tests between the 
measured data and the expected measurement of 10 mm. Additionally, a two-way ANOVA 
was performed between direction and depth to ensure distance measurements at all depth 
settings were the same. 
2.2.3 Ventricle Volume Validation 
2.2.3.1 Development of Ventricle Mimicking phantom 
Images from a 1.5T Signa HDxt MRI scanner (General Electric Health Care, 
Milwaukee,WI) of infants with severe IVH were collected after their parents gave consent. 
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Axial T1 weighted images (Ax FSPGR 3D) were used to design the ventricle phantoms. 
The interior surface of the skull and the lateral ventricles were manually segmented in 
parallel slices with 1 mm between slices. We generated a model of the skull after adding 
an additional 3.5–4 mm margin around the skull surface, which is approximately the 
thickness of a neonatal skull.18,19 To model a neonate of 30 weeks gestational age, an 
anterior fontanelle measuring 32 mm anterior to posterior and 30 mm left to right was 
added to the model using values from a recent study.20 STL files were generated from the 
segmented ventricle surfaces and the skull and those models were manufactured using 
rapid prototyping (A FORTUS 400mc 3D Production System, Stratasys, Eden Prairie, 
MN).  
A positive model of the lateral ventricles and the skull (Fig. 2-2) were generated in ABS-
M30i (acrylonitrile butadiene styrene). Using these, negative moulds of the ventricles were 
produced by casting the positive ventricle model in silicone SILBIONE® RTV 4420 A/B 
(Bluestar Silicone, East Brunswick, NJ) to create a two-part mould for the large ventricles 
(288 cm3) and a four-part mould for the more intricate small ventricles (51 cm3).  
 
Figure 2-2 Model of the ventricle phantom. a) a top-down view of the anterior 
fontanelle and b) profile of the skull and attached base (semi-transparent) and the 
position of the large lateral ventricle phantom (dark region) inside the model skull. 
An agar mixture of 1L distilled water, 35 g of agar powder (high strength A-6924, Sigma 
Chemicals, St Louis, MO) and 80 mL glycerol (EMD Chemicals Inc. Gibbstown, NJ) was 
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heated to 85˚C.  The ventricle was composed of 500 mL of this agar mixture combined 
with 10 g of 100 mesh tungsten powder (Alfa Aesar, Ward Hill, MA) to generate contrast 
in MR images for volume validation. The brain-like medium was prepared using the other 
500 mL of agar mixture with 15 g of SigmaCell (Sigma Chemicals, St Louis, MO) to 
generate soft-tissue mimicking scatter in US images.21 The volumes of the ventricles were 
determined by water displacement measurements prior to embedding into the brain-like 
agar. Photographs of the agar ventricles are shown in Figure 2-3. 
 
Figure 2-3 Photographs of the phantom models of the ventricles once molded in an 
agar/tungsten compound.  a) small ventricle (51 mL) and b) large ventricles (288 
mL) 
2.2.4 Imaging of the Volume Phantom 
The ventricle phantoms were scanned using a 3.0T Discovery 750MR scanner (General 
Electric Health Care, Milwaukee, WI). Sagittal T2 weighted 3D fast spin echo sequence 
was used (TR 2500ms, TE 65.6 ms, echo train 100, scanning matrix 160x160, slice 
thickness 1mm) with geometric correction to give accurate volume measurements.  The 
phantom was also scanned using our 3D US system through the fontanelle. A 60 degree 
tilting sweep was sufficient for the smaller ventricles, while a 72 degree sweep was 
required for the larger ventricles. Images were acquired with 0.3 degrees between frames, 
and at 25 frames per second.  
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Ventricles were manually segmented five times by a single observer (JK) in parallel slices 
with 1 mm between slices through the sagittal plane in both MR and 3D US images. Two-
way, repeated measures ANOVA was performed to determine if there were statistically 
significant differences between volumetric measurements in MRI, 3D US and the gold 
standard of water displacement.   
2.2.5 In vivo Imaging and Volume Measurements 
After an initial conventional 2D US clinical exam showed an IVH of at least grade II, 
parents of the neonate were asked for their consent to image their child. Following a routine 
cranial 2D US exam, the US transducer was placed into the 3D US scanner housing (Fig. 
1b) and the 3D US image was acquired. The clinical US technician or a physician located 
the midline of the lateral ventricles through the anterior fontanelle.  A 3D US image was 
then acquired while the 3D US scanner was held firmly and the transducer tip was 
monitored to ensure constant contact with the patient’s head while maintaining a low level 
of pressure applied to the fontanelle.  The 3D US system acquired 2D US sagittal slices at 
a depth of 5-15 cm (usually 7.9cm) and were reconstructed into a 3D image as the 2D 
images are acquired.  Scans were performed with a 60-72 degree scan angle, a step size of 
0.3 degrees at a frame rate of 25 frames/s. Scans were completed once a 3D US image of 
sufficient quality was acquired (one with limited movement, and the full ventricular 
volume). Generally, this was obtained in 1-4 acquisitions of 3D US images with the entire 
investigation, including routine US acquisition, lasting 10-25 minutes.  
To determine the variability of the measured ventricle volumes, an evaluation of the 
ventricles of three patients with similar grades of IVH were segmented by one physician 
examiner (SdR) and two trained observers (JK and RM). The 3D US images were randomly 
ordered and manual segmentation was done on each 3D US image 5 times (a total of 45 
image segmentations). Each manual segmentation required 20-30 minutes to complete and 
was performed at least 24 hours apart from previous segmentations to avoid memory bias.  
Two-way, repeated measures ANOVA was performed to determine if there were 
significant differences between repeated measurements of the three patient images by three 
different observers. Intra-class correlation (ICC) was performed to assess the agreement 
between observers.  
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2.2.6 Intra- and Inter-observer Variability Measurements and 
Measurement Error Analysis 
The inter- and intra-observer variability was measured as the standard error of 
measurement (SEM) from the means squared calculated from the repeated measures 
ANOVA as cited in Eliaszim et al. (1994).22 
Equation 2-1 

SEMintra  MSE          
Equation 2-2 

SEM inter  [(MSR  (n 1)MSSR  n(m 1)MSE ]/[mn]    
 
Where MSE is the mean squared error, MSR is the mean squared rater (observer), MSS is 
the mean squared for subject (patient), and MSSR is the mean squared interaction between 
the subject and the rater for n subjects segmented m times. 
The minimal detectable difference (MDD) between measurements for the same observer 
was also calculated from equation 2-3.22 The critical value is ( ) is 1.96 corresponding 
to  = 0.05. The measurement of MDD is the smallest measured volume difference 
between segmentations that can be detected with 95% confidence. Thus, if the measured 
change between two time points is greater than this value, then one can be confident (at 
95%) there has been a volume change.  
Equation 2-3 

MDDin tra,in ter  Z / 2 2SEMin tra,in ter       
As volume changes less than 1 cm3 would not be clinically relevant in this patient 
population, a MDD of less than 1 cm3 will be considered acceptable. 

Z/2


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2.3 RESULTS 
2.3.1 Geometric Validation using String Phantom Measurements 
The string phantom as well as a 3D US image of the phantom is shown in Figure 2-4. The 
measured values and t-test results are shown in Table 2-1. T-tests failed to show statistically 
significant differences between the manufactured distance of 10 mm and the mean 
measured distances from 3D US images of the string phantom. This is indicative of a 
correctly calibrated geometry in our 3D reconstruction. As the head grows due to either 
normal brain development or ventriculomegaly, US exams will require different settings 
to best visualize the ventricles, so it is important to ensure that there are no discrepancies 
between the geometric calibrations between different depth settings (4.9-16.0 cm). An 
additional two-way ANOVA to determine if there were discrepancies in measurements at 
different calibrated depth settings failed to find statistical significant differences between 
distance measurements made at different depth settings for any of the three orthogonal 
directions (p=0.603, 0.622 and 0.568 for axial, lateral and elevation respectively).  
 
Figure 2-4 The string phantom. a) Photograph of string phantom prior to imaging 
with 3D US. b) String phantom imaged in 3D US with A – axial, L – lateral and E – 
elevation directions indicated 
 
41 
 
 
Table 2-1 Results from the string phantom. Results of 40 manual measurements of 
the distances between strings in the 3 orthogonal directions along with confidence 
intervals. T-test results listed are for comparisons between measured and 
manufactured distance between the strings, which was 10 mm, and no significant 
differences were found between them (p>0.05). 
Direction 
Mean  
(mm) 
St. dev.  
(mm) 
95% CI (mm) 
p-value 
(α=0.05) 
Axial 
10.02 0.14 10.00-10.09 0.280 
Lateral 
10.01 0.04 10.00-10.02 0.269 
Elevation 
10.01 0.16 9.97-10.08 0.590 
2.3.2 Volume Validation using Ventricle-like Phantom 
Sagittal image showing the mid-lateral left ventricle and a coronal image showing anterior 
and inferior horns of the lateral ventricles at approximately the same plane in 3D US and 
MR images are shown in Figure 2-5. Ventricle volume measurements from all three 
methods (water displacement, MRI, 3D US) are shown in Table 2-2 shows the imaging 
methods of volume measurement compared to the gold standard. ANOVA performed 
between the methods of measurement and the volumes calculated for each phantom failed 
to find a statistical significant differences between them with p>>0.05 (Table 2-2). The 
coefficient of variation (COV) was 4.1% and 0.8% for the small phantom and 1.7% and 
2.1% for large phantom for segmentations in 3D US and MRI respectively.  
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Figure 2-5 3D images in 3D US and MRI of a ventricle volume phantom. The 
sagittal and coronal planes of the ‘small’ ventricle phantom in approximately the 
same slice in both MRI (a and c) and 3D US (b and d). 
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Table 2-2 Volume measurements of two ventricle-like phantoms. Water 
displacement (WD) and manual segmentation in MRI and 3D US images. ANOVA 
between the manual segmentations and water displacement found no significant 
differences (p>0.05). Measurement ± standard deviation 
Phantom 
WD 
(cm3) 
MRI 
(cm3) 
3D US 
(cm3) 
p-value (α=0.05) 
Large 287.9 ± 2.0 289.8 ± 6.2 286.5 ± 4.9 0.71 
Small 51.2 ± 1.0 49.9 ± 0.4 49.4 ± 2.0 0.31 
2.3.3 In vivo Volume Measurements 
Figure 2-6 shows 3D US images of a neonate with bilateral grade II IVH along with the 
segmented ventricle model from that image with a mean volume of 35.2 cm3. Figure 2-6d 
shows the ‘cube view’, which is immediately available to view at the bedside manipulate 
through any 2D plane (coronal, sagittal, axial or oblique) and examine for image quality. 
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Figure 2-6 In vivo imaging of a neonatal patient. Axial (a), sagittal (b), and coronal 
(c) views of the cerebral ventricles of patient 1. Cube view (d) with segmented 
outline of the ventricular system (e) and the ventricle surface made from the 
segmentation (f). Calculated ventricle volume was 35.2 cm3. 
 
Table 2-3 summarizes the 3D US ventricle volume measurements along with the 
coefficient of variation (COV) of the three different IVH patients as segmented by 3 
different observers multiple times. The COV was < 5% for all patients and all observers 
indicating relatively low measurement variance. The ICC between the measurements 
made by the three different observers was found to be a high 0.97.  A two-way repeated 
measures ANOVA failed to find a statistical significant differences (p-values >>0.05) 
between the volumes segmented between the three observers (Table 2-3). 
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Table 2-3 Inter-intra observer measurements from neonatal images. Manual 
segmentations of the total ventricle volume (± standard deviation) of three IVH 
patients done by three different observers. Segmentations were performed five 
separate times per observer. Performed repeated measures ANOVA found no 
significant differences between the volume measurements made for the different 
observers (p>0.05). 
Patient Observer Volume  
(cm3) 
COV 
 (%) 
p-value (α=0.05) 
1 1 35.7 ± 2.2 6.2  
 2 35.1 ± 0.83 2.4  
 3 34.9 ± 0.62 1.8  
 total 35.2 ± 1.41 4.0 0.60 
     
2 1 11.1 ± 0.70 6.3  
 2 10.7 ± 0.43 4.0  
 3 10.4 ± 0.41 3.9  
 total 10.7 ± 0.53 4.9 0.14 
     
3 1 9.60 ± 0.39 4.1  
 2 9.45 ± 0.42 4.5  
 3 9.17 ± 0.18 1.9  
 total 9.41 ± 0.35 3.7 0.19 
 
2.3.4 Inter- and Intra- Observer Variation and Minimal Detectable 
Difference 
Mean squared values as used to calculate intra- and inter-observer variation are shown in 
Table 2-4. The inter observer SEM was 0.24 and intra observer SEM was 0.243 as 
calculated from equations 2-1 and 2-2. The MDDintra was found to be 0.63 cm
3 and the 
MDDinter was 0.68 cm
3 both calculated from equation 2-3.  
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Table 2-4 Calculated minimum detectable difference. Calculated values for error 
terms from repeated measures ANOVA, and minimal detectable difference (MDD). 
Where MSE is the mean squared error, MSR is the mean squared rater (observer), 
MSS is the mean squared for subject (patient), and MSSR is the mean squared 
interaction in cm6. The standard error of measure (SEM) for intra- and inter- 
observer variability is calculated from equations 1 and 2 respectively is in cm3. 
MDD are calculated from equation 3 assuming a 95% confidence interval and are 
also in cm3. 
Calculated Term  Value 
MSS 3.17x103 
MSR 0.0996 
MSSR 1.73 
MSE 0.451 
  
  
SEMintra 0.23 
SEMinter 0.24 
  
MDDintra 0.63 
MDDinter 0.68 
 
2.4 DISCUSSION 
We have shown that our 3D US system can measure ventricle volumes through a fontanelle 
in neonates accurately. We were able to show that ventricular volumes could be measured 
precisely between different observers with mean COV ranging between 1.8 and 6.3% and 
ICC of 0.97. IVH patient’s ventricles tend to be larger than normal, for example, patients 
in our study had mean ventricle volumes between 9.0-36.0 cm3 while patients with average 
sized ventricles at the same gestational age would have ventricle volumes between 0.5-2.0 
cm3.11 As was reported in Brann et. al. 1991, patients with ventriculomegaly have daily 
increases in ventricle volume in excess of 1 cm3/day. This is larger than the MDD 
calculated for our system (MDDintra = 0.63), indicating that our 3D US system can be used 
in a study focusing on monitoring IVH patients’ ventricular volumes change both in 
response to treatment and as a result of spontaneous recovery. 
We have extended the phantom development reported by Gatto et al. who developed an 
US cranial phantom with a fontanelle. While we also used 3D rapid prototyping technology 
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to manufacture the skull, the inclusion of ventricles that could be imaged in both US and 
MRI is important in the validation of the 3D US approach for monitoring patients with 
IVH. This type tungsten-agar phantom was developed previously for a CT and US 
compatible prostate phantom23 since embedded tungsten powder also increases the 
Hounsfield units of the agar. The quantity of the tungsten component of their phantom was 
much lower than in our phantom to avoid significant artifact in CT. We have shown, 
however, that this type of tungsten-agar phantom could also be used to validate systems 
for imaging pathologies commonly scanned in both US and MRI. As agar does not require 
time-consuming freeze/thaw cycles as would a PVA based phantom, the development of 
phantoms simulating changes in IVH can be done much faster and more economically. 
Tungsten powder does not diffuse through agar like gadolinium based contrast agents, 
which makes it more reliable as a contrast agent when volumes need to be validated with 
MRI and 3D US. It does seem plausible to create a triple modality phantom in the future 
using agar and tungsten, however, tungsten concentrations must be sufficiently low so as 
not to cause significant artifacts in the CT and MR images, but high enough to create 
contrast.  
Much like the findings of Abdul-Khaliq et al., we found mechanically moving a 2D 
transducer to generate a 3D US image is feasible in a clinical setting; however, their 
patients were already sedated due to other procedures, and therefore patient motion was 
not present in their images. Additionally, the scanner described in8 rotated a 2D probe 180 
degrees around a central axis, which may have caused the 2D probe to image the skull at 
some portions on the scan, causing shadowing. Our scanner tilts the US transducer through 
a maximum of 72 degrees with the transducer face held along the long axis of the 
fontanelle. This approach allows good contact with the fontanelle during the entire scan, 
and the ability to acquire full ventricle volumes in a shorter time than a 180 degree rotation 
approach. The free-hand system with position sensors described by Kampmann et al. is 
smaller than our system, and had volume measurements in phantoms with a COV ranging 
from 3.6-10%. This was comparable to values we found in our phantoms (COV of 4.1% 
for the phantom with a volume corresponding closest to the ones measured in Kampmann 
et al.) However, due to the more complicated reconstruction of a 3D US image from 
position sensor encoded 2D slices, this was done offline after scans were complete in their 
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study. In this study, only well after the procedure was completed could users verify whether 
or not the full ventricle volume was acquired, and so not all patients scanned were 
included.15 We were able to overcome this limitation, as the reconstruction of our 3D US 
images is performed at the bedside, much like the more expensive commercially available 
systems. The user can view the reconstruction of the 3D US image as it is being acquired 
and can examine the complete 3D US image immediately after the scan, and can conclude 
whether or not another image is required.  Thus, the user can limit scan time and ensure 
that high quality images of the full ventricular system are obtained prior to leaving the 
patient’s bedside.  
The main limitation of our 3D US system is the current requirement for manual 
segmentation of the ventricles for patients who have abnormal US scans. Bleeding in IVH 
creates a hyperechoic region around the relatively hypoechoic region of the CSF filled 
ventricles making simple threshold or boundary based segmentation algorithms not useful 
in this patient population (see Figure 2-7).  Though we have shown manual segmentation 
to be accurate and precise, it is time consuming and would not be feasible for routine 
clinical use. Automated segmentation of 3D US images has been previously performed 
successfully in other organ systems (bladder, and fetus) and has been made into 
commercially available product BladderScan® (Verathon, Bothell, WA). In addition, 
automated segmentation of the CSF and blood in the ventricles could be successfully 
segmented using raw US (RF) acoustic signal, but most clinical 2D US systems do not 
allow raw data capture in real time, or at all. We therefore acquired our images using a 
video frame grabber, which could potentially be another limitation to this system. The 
development of a stable automated or semi-automated segmentation algorithm for the 
cerebral ventricles, could make the 3D US scanning approach much more feasible 
clinically once segmentation times are reduced to a more acceptable sub-minute per patient.  
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Figure 2-7 Ultrasound image of a preterm neonate with IVH including the 
boundaries of the ventricle and hemorrhage. a) Parasagittal image of the left lateral 
ventricle in an infant with grade IV IVH at 7 days of life. b) The same image with 
approximate boundary of the ventricle. Notice the ambiguous boundary of the 
posterior horn (dashed arrow) as well as the hyper-echoic region from IVH that is 
similar in intensity to some surrounding brain tissue (white arrow). 
As other authors8,11 have discussed, fontanelle size is also a limiting factor in the quality 
of images.  As the patients get older and the fontanelle shrinks, images will reduce in 
quality as the skull starts to cause shadowing on the edges of the image frame, by 
effectively reflecting most of the US signal before it can image the brain.  This would cause 
the boundary of the posterior horns to become almost imperceptible. Neonates with 
inherently small fontanelle will pose a challenge for acquiring high quality 3D US images. 
Nevertheless, 3D US examinations require less scanning time than conventional US 
examinations, and can provide information for the full volume of the ventricular system. 
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Chapter 3  
This chapter will discuss the in vivo validation experiments used to validate the three-
dimensional ultrasound system in a clinical setting.  
The contents of this chapter were previously published in the journal Physics in Medicine 
and Biology: J. Kishimoto, A. Fenster, D.S.C. Lee, S. de Ribaupierre. In Vivo Validation 
of a 3D Ultrasound System for Imaging the Lateral Ventricles of Neonates. Ultrasound in 
Medicine and Biology 42(4) (2016) 971-79. doi: 10.1016/j.ultrasmedbio.2015.11.010. 
Permission to reproduce this article was granted by the Elsevier and is provided in 
Appendix A.2. 
3 In Vivo Validation of a 3D Ultrasound System for 
Imaging the Lateral Ventricles of Neonates 
3.1 INTRODUCTION 
As the survival of very low birth weight (VLBW) infants (birth weight less than 1500g) 
has increased over time, so has the necessity for better neonatal monitoring in order for 
clinicians to manage physiological stability and to screen for pathological conditions. The 
VLBW infant is most at risk for intraventricular hemorrhage (IVH), as a result of 
bleeding from the immature vascular structure of the germinal matrix located near the 
medial aspect of the cerebral ventricles. Across Canada, IVH occurs in 20-30% of 
VLBW infants1 and 25% of these may develop the secondary complication of post-
hemorrhagic ventricle dilatation (PHVD) as a result of interruption/blockage of the flow 
of cerebral spinal fluid (CSF).2 The development of PHVD has been linked to higher 
mortality and poor neurodevelopmental outcome later in life, thought to be caused by 
injury to the periventricular white matter.3 In general, there are three clinical courses of 
PHVD: 40% of patients spontaneously resolve, 10% progress rapidly, and 50% progress 
persistently but slowly.2 Infants who have rapidly progressing PHVD and some with 
persistent, slowly progressing PHVD will require interventions, including serial lumbar 
punctures or ventricle taps (VT), ventricular drainage, or shunting of the CSF to relieve 
the elevated intracranial pressure (ICP) in order to alleviate symptoms, and prevent 
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further brain damage.4 At our center, ventricle taps are used as an initial form of 
intervention. 
Since a large percentage of PHVD spontaneously resolve without intervention, current 
clinical management is to follow VLBW neonates with serial head ultrasound (US) and 
head circumference (HC) measurements to assess for ventricular dilatation, and to 
monitor for signs of raised ICP (tense, bulging fontanels, apnea and bradycardia). 
However, the timing of intervention remains imprecise as the clinical signs of increased 
ICP are nonspecific in the preterm infant and could be due to other co-morbidities. 
Further, 2D US cannot provide accurate quantitative measurements of irregular volumes, 
such as the cerebral ventricles. Brann et al. (1990) have found that the amount of CSF 
removed during serial lumbar punctures or ventricular drainage is significantly correlated 
(r2=0.84) with changes in ventricular volume (VV) as calculated from 2D US taken 
before and after intervention.5 Though this was very promising work, their approach 
never translated into clinical practice. To the best of our knowledge, no work has been 
done to date comparing 3D US ventricle volumes with volume of CSF removed in serial 
ventricle taps (VTs). 
Previous work with 3D US has been attempted in neonates.6-10 While this imaging 
technique was shown to be feasible, its clinical utility has not been established. A 
systematic bias has been found towards lower volumes in US-based measurements 
compared to gold standard MRI measurements when evaluating different organ 
systems.11,12 Nevertheless, Gilmore and Gerig (2001) have found good agreement 
between 3D US measurements of VV and MRI measurements when evaluating neonates 
with mild ventricular dilatation at term equivalent age.7 However, the study had limited 
variation in VV (10-18 cm3) and had a very small size of 7 patients. It is important to 
determine if the previous findings are applicable to PHVD patients who can have VV 
upwards of 100 cm3.  
A hand-held mechanical 3D US scanner system has been previously developed and 
validated on phantoms and a small set of patient images.13 This system can be coupled to 
any clinical 2D US machine with an appropriate transducer used for imaging the neonatal 
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brain. This system is akin to the mechanical “tilting” scanner system for 3D US imaging 
as described in Fenster et al.14 but constructed to suit a neonatal cerebral scan in the 
confines of an incubator.  
The 3D system used in this in vivo study is described briefly, and its validity in 
measuring ventricle volumes in neonates with non-resolving PHVD is compared to the 
gold standard MRI VV to further validate the image acquisition and volume 
determination using manual segmentations of the ventricles. Further validation is 
performed by comparing volume measurements from 3D US images obtained before and 
after VT with the reported volume of CSF that was removed from the tap.  
3.2 MATERIALS & METHODS  
As part of a larger, ongoing, observational study on the potential for new technologies 
(near infrared spectroscopy, 3D US, and functional MRI) to allow for better monitoring 
of patients with PHVD, patients were enrolled after informed parental consent once a 
positive diagnosis of IVH was made on routine clinical head US. Protocols used in this 
study were approved by the Research Ethics Board of Western University. Generally, 
enrollment was within two weeks after birth for patients between 25-34 weeks gestational 
age (GA), with pre-term birth considered to be any neonate born earlier than 37 weeks 
GA.  
3.2.1 3D US image acquisition and segmentation 
Images were acquired using a Philips HDI 5000 US machine with a C8-5 transducer set 
to Pediatric Cerebral scan. 3D US imaging was performed after placing the US transducer 
in a motorized housing that tilted the transducer about the axis at the probe tip (Figure 3-
1).15 In-house software reconstructed the 2D ultrasound frames into a 3D US image as 
images were received into the computer.14 Each 2D US frame was acquired every 0.3 
degrees at 25 frames/s over a scan angle of 60-72 degrees, making total image acquisition 
between 8-9.6 seconds.  Due to patient motion images of both lateral ventricles were 
obtained in 1-8 attempts, for a total bedside scan time of 2-15 minutes. Images were 
manually segmented in parallel sagittal slices of the 3D US image, 1 mm apart between 
adjacent slices, with manual adjustments to the lateral margins of the contours done in the 
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coronal plane to ensure that the full ventricle was segmented. A trained observer (JK) 
segmented all the images, and boundaries were verified by a clinical collaborator (SdR). 
Each image required between 20-45 minutes to segment. 
 
Figure 3-1– Mechanical 3D US transducer housing with transducer in place. This 
entire housing/transducer set up done through incubator port holes in order to 
mimic scan with minimal disruption to patient.  
3.2.2 MR Imaging of Patients 
Patients were imaged without sedation with a 1.5T Signa HDxt MRI scanner (General 
Electric Health Care, Milwaukee, WI) upon reaching term equivalent age (GA >37 
weeks), and limited oxygen dependency inside a MedVac blanket used to reduce patient 
movement (CFI Medical Solutions Inc, Fenton, MI). MRI and 3D US images were 
acquired within 3 days of each other if the ventricle size had been clinically stable, but 
for those with prior interventions and/or if the patient was suspected of having 
progressive PHVD, images were acquired on the same day. 3D T1-weighted MR images 
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of the brain were acquired in the axial plane (TR = 9.29 ms, TE = 4.20 ms, scan time ~ 9 
minutes) and these were manually segmented by the same observer who performed the 
3D US segmentation in parallel sagittal slices using the same in-house software and 
settings as was used for 3D US images. The observer was not blinded to the patient IDs, 
but were blinded to TVV for any of the segmentations until all segmentations were 
completed. 
3.2.3 Interventional Ventricle Tap Validations 
Ventricle taps (VT) are procedures in which a small needle is inserted through the 
fontanel of a patient into one of the lateral ventricles in order to drain excess CSF. The 
clinical team was blinded to the 3D US images and VV until after patient discharge, and 
as such, all taps were performed based on clinical 2D US scans, and signs and symptoms 
of increased ICP such as apnea, bradycardia and a full, tense fontanel. Once the decision 
to perform a VT, enrolled subjects were imaged using the 3D US system 15-60 minutes 
prior to the intervention, and 15-60 minutes afterward. Reported CSF removed during the 
tap was measured in specialized vials as the CSF was being removed by the neurosurgeon 
consult and recorded and stored until after images had been segmented to avoid bias. The 
difference between pre-tap and post-tap ventricle volume as measured using the 3D US 
images was calculated and compared to CSF removed during the procedure. Patients with 
grade IV IVH who had developed porencephalic cysts (Figure 3-2) were not included in 
the analysis when CSF was removed from the ipsilateral side of the cyst, as the CSF 
would have primarily been removed from the cyst and not the ventricles; however, the 
reported pre-post ventricle volumes were reported. Ventricles were segmented such that 
the hemorrhage and choroid plexus was included within the volume, but the grade IV 
hemorrhage and resultant porencephalic cysts were not included. 
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Figure 3-2 2D ultrasound images of a neonatal patient with a grade IV IVH. a) 
shows a grade IV hemorrhage (arrow in a) on the 7th day of life using a linear 
transducer, and b) shows an image of the same patient from a curvilinear 
transducer with the developed porencephalic cyst (arrow in b) on the 27th day of 
life.   
3.2.4 Statistical Methods  
Pearson correlation, as well as Bland-Altman plot to determine the bias between MRI and 
3D US, were performed using GraphPad Prism (GraphPad Software, San Diego, Calif). 
Additionally, Pearson correlation and Bland-Altman plot were performed between pre-
post VT difference in VV and the recorded volume of CSF removed. The slope of the 
regression was tested against the unity line (y=x) via t-test with α = 0.05. 
3.3 RESULTS 
3.3.1 3D US volume validation against MRI 
Twenty patients were used to analyze the relationship between 3D US and MRI VV. Two 
patients were not used as one had insufficient quality MRI (significant motion artifact) 
and one had insufficient quality 3D US (too much motion throughout scans). Images 
were usually acquired within one day (N=15) and all patients with prior interventions 
and/or suspected progressive PHVD were scanned on the same day. Three additional 
patients who were not scanned within 1 day had a history of mild/moderate IVH, had no 
prior interventions for PHVD, and were considered to clinically have had stabilized 
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ventricle size. The descriptions of the included 18 patients who were studied with 3D US 
and MRI are described in Table 3-1 with example MRI and 3D US images of a patient 
with grade IV(left), II (right) IVH are shown in Figure 3-3.  
 
Table 3-1 Characteristics of patients who had magnetic resonance imaging and 3D 
ultrasound (US) images at term equivalent age (37-40 weeks gestational age).  The 
intraventricular hemorrhage (IVH) grade was based on the severity scale by Papile 
23. ** Interventions included were ventricle tap, ventricle drain, shunt, or any 
combination. 
 Mean ± Stdev range 
Gestational Age (weeks)  26 ± 1.3 23 6/7-35 4/7 
Birth Weight (g) 1200 ± 572 640-2430 
Weight at MRI (g) 
 
3036 ± 863 
 
1250-5275 
 
 N (total=18) % 
IVH   
   Grade I 2  11% 
   Grade II 5  28% 
   Grade III 5  28% 
   Grade IV 6  33% 
   
Required Interventions** (%) 8  44% 
 
Figure 3-3 Para-sagittal slices of the right lateral ventricle with coronal anterior 
horn cut though a) 3D US and b) T1-weighted 3D MRI image of a neonate. This 
patient had grade IV IVH in the left ventricle and grade II IVH in the right 
ventricle. The VV measure from MRI was 157.7 cm3and from 3D US was 147.7 cm3. 
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Figure 3-4a shows the plot of the correlation between 3D US and MRI based VV and a 
very high correlation between the two modalities is present (R2 = 0.99). The slope of the 
best-fit line was 0.87, which was significantly different than 1 (95% CI of 0.83-0.90).  
MRI VV was higher than 3D US for almost all patients. Bland-Altman plot indicates a 
bias towards lower 3D US VV at larger VV (Figure 3-4b). 
 
Figure 3-4 Ventricle Volumes as measured through manual segmentation of 3D US 
and MR images. a) Linear regression line is shown in bold with 95% confidence 
intervals of the regression are shown as the dotted lines. b) Bland-Altman plot of the 
difference in 3D US compared against the mean in 3D US and MR ventricle 
volumes. 
3.3.2 Ventricle Tap Volume Validation  
Eight different IVH patients are described in Table 3-2 with their pre- and post-ventricle 
tap ventricle volume measurements shown in Figure 3-5. Of those 8 patients, 6 had 
multiple VTs (Table 3-2) during the course of the stay in the NICU, resulting in a total of 
25 VT studied. It was noted that during 5 of the studied procedures, CSF was taken from 
the ipsilateral side of in a patient who had developed unilateral porencephalic cysts, 
which left 20 taps to be included the regression analysis. 
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Table 3-2 Patient characteristics for those requiring ventricle taps. GA is gestational 
age indicating how premature the patient was (with 37-40 weeks being accepted as a 
term birth), and intraventricular hemorrhage (IVH) grade is based on the severity 
scale by Papile et al.23   
Patient Taps 
monitored 
age at first 
tap (days) 
GA at birth 
(weeks) 
Birth 
weight (g) 
IVH grade 
P007 1 27 27 920 IV(R)/III(L) 
P012 5 15 25 800 III(R)/III(L) 
P019 2 19 27 2/7 1080 III(R)/III(L) 
P041 5 16 25 3/7 910 III(R)/III(L) 
P043 4 16 27 3/7 1280 IV(R)/III(L) 
P052 1 16 30 2/7 1280 III(R)/III(L) 
P055 4 7 29 1210 IV(R)/III(L) 
P057 3 35 24 6/7 750 III(R)/IV(L) 
For all patients and all taps, the pre-tap ventricle volume was larger than the post-tap 
ventricle volume (Figure 3-5). Figure 3-6a shows a plot of the least squared fit of the 
difference between pre- and post-tap ventricle volumes as calculated from 3D US images 
against the reported volume of CSF removed. When CSF was taken from the 
contralateral ventricle of the grade IV IVH, or when the patient had hemorrhage 
contained within the ventricles, the calculated pre-post difference in VV is highly 
correlated with the reported amount of CSF removed (R2 = 0.92). A t-test comparing the 
pre-post tap volume difference with the CSF removed failed to show a statistically 
significant difference between the slope and 1 (slope 95% confidence interval 0.94 - 
1.26) and failed to show a statistically significant difference between the y-intercept and 
0 (y intercept 95% confidence interval -4.54 to 0.82). Bland-Altman plot found limited 
bias (0.32 ± 1.98) with only one point falling outside the 95% confidence interval and 
about the same number of points above and below the x-axis (Figure 3-6b). 
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Figure 3-5 Ventricle volumes from 3D US for neonates who required ventricle taps 
(VTs) for clinical reasons. Pre- (grey) and post- (black) VT and the ventricle 
volumes (cm3) segmented from each 3D ultrasound (US) image are graphed. As 
most patients in this study had multiple VTs, patient number followed by the serial 
tap number is indicated on the x-axis. 
 
Figure 3-6 Change in ventricle volume before and after ventricle tap compared to 
measured amount of CSF removed during the VT. a) Least squares fit (bold line) 
with 95% confidence intervals plotted as dotted lines. Difference between pre- and 
post-tap measurements is along the y-axis and the reported volume of CSF removed 
during intervention is along the x-axis. b) Bland-Altman plot of the difference in 
calculated change in ventricle volume compared to measured volume of CSF 
removed. 
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3.4 DISCUSSION 
We have shown that there is a systematic bias towards lowered VV using 3D US-based 
measurements as compared to MRI when the ventricle size becomes increasingly 
enlarged from PHVD (See Fig. 3-4). However, when comparing between 3D US images, 
such as before and after VT, the volume difference correlates significantly and matches 
well to the amount of CSF reported removed by the surgical team (See Fig. 3-6). The 
change in VV in neonatal patients is more clinically important than knowing the actual 
amount of fluid present in the system as it could inform clinicians how to optimize 
interventions, since there is no consensus on how much CSF to remove. While a reported 
study has shown that a minimum of 10 mL of fluid should be removed for every 1 kg of 
body weight,16 optimal amounts and upper limits have not been studied. Excess CSF 
removal can cause apnea and bradycardia after the intervention 17, but removal of too 
small amounts may not alleviate clinical signs and symptoms and may lead to excessive 
repeated interventions if there is no improvement in clinical status.  Thus, a more 
informed approach in how much CSF is being collected within the ventricles could lead 
to more optimized, personalized patient care. If necessary to compare to a previous MR 
image VV to 3D US VV, a simple calculation from the strong linear regression (Fig. 3-3) 
could be performed, although this requires further validation before routine use can be 
advised.  
In vivo neonatal VV validation during ventricle tap has only been previously used by 
Brann et al.  5 using their 2D US cylindrical coordinate method to estimate VV. While we 
found a very strong Pearson correlation coefficient of R2 = 0.92 comparing VV 
measurements before and after VT, Brann et al. found a correlation of R2 = 0.84.5 Brann 
et al’s cylindrical coordinate method relied on free-hand 2D US image slices acquisition 
that were exactly the same angular spacing apart from each other. While this is a 
reasonable assumption for a highly trained US technician, it is a potential source of error 
and variability and cannot be relied upon to provide accurate and reproducible volume 
measurements. 14 Discrepancy between their results and the improved results in our study 
can be partially accounted for by the fact that our study used a motorized system to 
acquire the images, which is less user dependent and more precise. 13  The technique 
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proposed by Brann et al. required a highly trained individual to draw manual contours on 
each 2D slice, which is both time and resource expensive and likely the reason that even 
though this technique was strongly predictive of interventional treatment necessity, it was 
never adopted as standard care.  
The validation of the 3D US system against MRI images of IVH patients with resolved 
ventricle dilatation as well as PHVD is an extension of previous research done on 
neonates. The previous paper outlined a small-scale study of 7 patients with slightly 
enlarged ventricles (Gilmore et al. 2001) and compared segmented 3D US ventricle 
volumes to those measured in MRI and found high agreement. It should be noted that 
patients in that study had a maximum ventricle volume of 18 mL, with most ventricles 
much less than 10 mL, while patients in our study had a much wider range from 8 mL to 
230 mL (in 3D US).  
While we have shown that there is a bias towards lower VV using 3D US-based 
measurement compared with MRI, this is systematic, and can be taken into account 
through calibration. We hypothesize that this bias is due to the acquisition of the images 
through the anterior fontanelle combined with characteristics of the neonatal brain at mid-
line, which is known to cause issues in visualization of some midline structures that are 
near the posterior fossa. 18,19 In the case of patients with severe PHVD, the posterior 
horns of the lateral ventricles themselves would be in this difficult-to-visualize area.  
We investigated the potential for boundary visualization discrepancies using a fiducial 
based rigid registration of 3D US to MRI in a few cases of PHVD. In 3D US, as most 
patients with PHVD had two separate images for left and right ventricle, four landmarks: 
a) the most anterior point of the anterior horn, b) midpoint of thalamus and choroid 
plexus intersection boundary, c) foramen of Monro, and d) middle of corpus callosum 
were manually chosen (See Fig. 3-7) from each ventricle resulting in eight landmarks for 
the two ventricles in each image. Eight corresponding initial landmarks were also 
manually chosen from the time-matched MRI. A rigid transformation was then calculated 
from those corresponding point pairs, which were used to roughly rigidly register the 3D 
US to the MR images. This rough registration was then manually adjusted following 
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alpha blending of the overlapped, registered image volumes. Once the images were 
manually adjusted to obtain a closer registration, the rigid registration was again 
performed using four points placed in a single slice outside of the ventricles in MRI with 
corresponding points found on the alpha-blended, registered MRI/US volume. This was 
iterated multiple times until a visual, qualitative ‘good’ registration was achieved.  
 
 
Figure 3-7 Examples of the described fiducial points used in the registration of 3D US 
to MRI. Fiducials presented on 3D US images from a patient who had PHVD 
following bilateral grade II IVH. a) the most anterior point of the anterior horn, b) 
midpoint of thalamus and choroid plexus intersection boundary, c) foramen of 
Monro, and d) middle of corpus callosum were manually chosen from each ventricle 
in a resulting in eight landmarks for the two ventricles. a) and b) are mid-ventricle in 
the sagittal plane while c) and d) are in the coronal plane at the level of the foramen 
of Monro. 
Registered images from three patients in the study can be found in Figure 3-8. Using 
these registered images, we showed that at the medial most part of the lateral ventricles 
(mid-line) boundaries are obscured when patients have highly enlarged ventricles  
(Figure 3-8 f,i).  Thus, a portion of the most medial part of each lateral ventricle was 
systematically missed in the manual 3D US segmentation, but was segmented in the MR 
image. In patients with mild PHVD, the lateral ventricles would have smaller portions 
missed or would have no lateral ventricle portions near mid-line (Figure 3-8c), likely 
closer to that of segmentation error, and as such, we saw no bias when the ventricles were 
smaller than 50 cm3 (Figure 3-3b). Additionally, the lateral edge of the ventricles were 
much harder to visualize in 3D US in comparison to MRI (Figure 3-8a,d,g); however, the 
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mid-ventricle images had fairly easy to visualize borders in both modalities (Figure 3-
8b,e,h). This hypothesized visualization-based bias will be investigated further in future 
studies, though is out of scope of this paper. 
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Figure 3-8 Registered 3D US and MR images sets of three IVH patients at the lateral edge of the lateral ventricle (left), mid-
ventricle (center) and mid-line of the brain (right) all in the sagittal plane. a) shows a patient with grade II IVH who did not 
require interventional therapy, b) shows a patient with bilateral grade II IVH who required a single ventricle tap and shunt 
while c) shows a patient with grade IV (right) and grade III (left) IVH who required multiple ventricle taps and a shunt.
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A limitation in the current study was the small number of neonates who required 
interventions (N=8). As the enrolment period of the study performed by Brann et al. was 
performed in the late 1980s when severe IVH, and PHVD was more common, they were 
able to recruit many more neonates who required interventions. While the MRI to US 
validation study had more patients than the study published by Gilmore and Gerig (N=7), 
the current study still had a relatively small sample size (N=18). Additionally, our MRI 
study could only be performed on preterm born neonates at term equivalent age. Future 
research investigating MRI and 3D US in low birth weight preterm neonatal patients 
which are incubator bound, or on extensive respiratory assistance would allow for a more 
complete validation of the system. Unfortunately, most centers, including our own, lack 
the equipment necessary to safely image incubator bound preterm neonates in an MRI 
facility, as that would require an MR compatible incubator and preterm head coil. While 
stable preterm neonates can be imaged with MR in other facilities, to perform MRI 
before and after a ventricle tap would almost certain be unattainable for most neonates 
who require a tap as they will have become unstable with spells of apnea and bradycardia 
making transfer to an imaging suite even more dangerous and time consuming. In 
addition, it is unrealistic to expect that all centers worldwide will ever be able to monitor 
IVH infants with repeated MRI, from a resources point of view (time and cost). 
Therefore, an US-based method will remain the method of choice for monitoring PHVD. 
That said, this validation study using the amount of tapped fluid is the also most feasible 
for extremely preterm neonates unable to be moved into an imaging suite, as the imaging 
study can be performed while the infant is in the incubator. 
The main limitation of implementing the 3D US system into clinical practice is the 
requirement for manual segmentation of the ventricles. As this can take up to 45 minutes 
per patient and seems to be not feasible in a clinical setting, a semi-automated 
segmentation approach to segmentation has been developed in our laboratory to address 
this issue. 20 The segmentation algorithm specifically for neonatal cerebral 3D US images 
has been shown to reduce segmentations times to 2-5 minutes, which is much more 
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reasonable to use as a tool to follow PHVD patients. We are currently integrating the 
segmentation software into our 3D US system so that it can be used in a prospective 
study of patients with PHVD. 
There are a few potential clinical applications for our 3D US system other than to 
monitor IVH patients’ progression. Infantile hydrocephalus can also occur following 
meningitis, other infections, or from congenital malformations. These patients would be 
good candidates to monitor before and after surgery with this non-invasive imaging tool, 
which could be done during routine follow up. Additionally, patients who have been 
diagnosed with ventricle dilatation in utero could be followed on antenatal exams using 
this technology. As many of these patients with in utero ventricle dilatation end up 
having some mental health and cognitive problems in later life,21,22 ventricle volume 
measurements might be able to indicate the severity of the defects to expect, which could 
inform parents as to what they should be expecting from their child and inform follow-up 
care. 
Our 3D US system was validated with patients ranging from <1000g, confined to 
incubators to >5000g and stable enough to be on room air and a crib. As there was such a 
variation in patient size and general stability, we believe that we have captured the 
majority of what we could be reasonably expected to see in future studies of preterm 
neonates.  
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Chapter 4  
This chapter will discuss the comparison of ultrasound measurements of the cerebral 
ventricles in neonates using clinical two-dimensional ultrasound as well as the validated 
three-dimensional ultrasound system. 
The contents of this chapter were previously published in the journal Physics in Medicine 
and Biology: J. Kishimoto, S. de Ribaupierre, F. Salehi, W. Romano, D.S.C. Lee, A. 
Fenster. Preterm neonatal lateral ventricle volume from three-dimensional ultrasound is 
not strongly correlated to 2D ultrasound measurements. J. Med. Imag. 3(4) (2016) 
046003. doi: 10.1117/1.JMI.3.4.046003. Permission to reproduce this article was 
granted by the Society of Photo-Optical Instrumentation Engineers (SPIE) and is 
provided in Appendix A.3. 
4 Preterm neonatal lateral ventricle volume from 3D 
ultrasound is not strongly correlated to 2D ultrasound 
measurements 
4.1 Introduction 
Post hemorrhagic ventricle dilatation (PHVD) is characterized by an enlargement of the 
cerebral ventricles and commonly occurs in preterm neonates with moderate to severe 
intraventricular hemorrhages (IVH), grades II-IV, as grade by the clinical standard 
system.1 PHVD can lead to lifelong neurological complications such as cerebral palsy as 
well as visuospatial disorders and lower developmental quotient.2,3 Trans-fontanel cranial 
ultrasound (US) is sensitive and specific for detection of PHVD, and is used clinically to 
diagnose and monitor this condition.4 However, 2D images cannot provide accurate 
volume measurements, and so ventricle volume (VV) is often estimated and monitored 
qualitatively. To address this, several quantitative measurements (ventricle index, anterior 
horn width, thalamo-occipital distance, 3rd ventricle width) have been derived for 2D US 
images.5 These measurements rely on linear widths of ventricles to estimate the changes 
in VV as the disease progresses. Such measurements have not been standardized across 
neonatal intensive care units (NICUs), and therefore there is a wide variation in the 
interpretation of 2D US-based measurements’ utility. This is further confounded by the 
user dependent nature of 2D ultrasound as the technician only records some image 
planes, and, furthermore, there has been no consensus on what should be measured by a 
radiologist to best illustrate VV.6  
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The ‘gold standard’ to quantify VV makes use of 3D MR images but can only be 
acquired once the patient is stable enough to be transferred to the imaging suite - often 
weeks after initial diagnosis and intervention for PHVD. Indeed, only a few studies 
directly comparing 2D US and MRI measurements of the ventricles have been done.7,8 
Specifically, Horsch et al found that the anterior horn width was strongly correlated with 
MRI VV (R2 = 0.88) when preterm born infants with varying ventricle size were imaged 
at term equivalent age.7  
In contrast to the ‘gold standard’ MRI-based measurements, 3D US images can be 
attained multiple times per week – early after birth - with limited adverse effects to the 
patient, as the imaging procedure is done within the incubator, and takes only a few 
minutes to complete.9 Additionally, serial 3D US is far less expensive than longitudinal 
monitoring with MRI.  
3D US imaging studies have been able to attain VV measurements from preterm neonates 
with both normal ventricles and those with mild ventricle dilatation throughout the course 
of stay in the NICU.10-14 Recently, a study found that 2D measurements can be made using 
a reconstructed 3D US image with reasonable inter-observer variability and with no 
significant differences from measurements made on 2D US images from the same day9 and 
another study has found excellent agreement for the diagnosis of different neonatal 
pathologies using 3D US images compared to 2D US obtained at the same time.15 
Additionally, when directly comparing VV made from 3D US images and MRI, high 
interclass correlations (ICC) were found (ICC = 0.92) in term born patients with mild 
ventricle dilation.10 We have previously found very high correlations between MRI and 3D 
US VV in preterm born infants with PHVD when imaged at term equivalent age (R2 = 
0.99).14  
However, in most centers, even in those with 3D US imaging capabilities, to guide 
treatment and therapy of patients with enlarged ventricles the only quantitative 
measurements of ventricle size routinely performed are 2D US measurements. While 
there are commercially available 3D US probes that perform well, the high cost may limit 
their use. We have previously developed and validated a low cost 3D US system.14,16 
Since this system acquires images using the same 2D US transducer used in clinical 
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scans, we are able to make direct comparisons to clinical images and the estimates of 
ventricle size from those images. 
In this paper, we compare 3D US VV to previously reported 2D US based measurements 
made on the same day. Additionally, we compare the change in 2D US measurements to 
changes in VV estimates from 3D US since serial changes in 2D US could determine 
whether treatment is performed on a neonate with symptoms of increased intracranial 
pressure stemming from PHVD.  
4.2 Methods 
4.2.1 Selection of subjects 
The research protocol was approved by the local human Research Ethics Board as part of 
a larger study investigating the development of patients with IVH. Patients with a 
positive diagnosis of IVH on an initial clinical head US exam were prospectively 
recruited following informed consent from their parents. Once enrolled, patients 
underwent serial US exams 1-2 times per week until discharge from the neonatal 
intensive care unit (NICU), or transfer to a secondary care center. Infants with congenital 
brain abnormalities were excluded from the study. Decisions on when to intervene in 
patients with severe PHVD were based on clinical assessment of the patient (neurological 
exam, palpation of the fontanelle, increase in head circumference measurements, 
monitoring for increased spells of apnea and bradycardia) and qualitative viewings of 2D 
US images. The care team was blinded to 3D US images and measurements.  
4.2.2 Ultrasound Imaging 
Patients were imaged by a trained clinical ultrasound technician who performed a 2D 
head US exam prior to a 3D US scan. 
4.2.2.1 2D US  
Imaging was performed at the bedside in the NICU using a HDI 5000 US system 
(Philips, Bothel WA) and a C8-5 curved array 5-8 MHz broadband transducer (Philips, 
Bothel WA). 2D US exams were performed using a standard technique, acquiring images 
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in coronal and sagittal planes through the anterior fontanelle, with a few screen captures 
chosen by the technician over the relevant landmarks as per the standardized exam.17 The 
2D US exams required approximately 10-15 minutes.  As the neonates’ heads grow 
during the study (both due to normal development and PHVD), depth settings were 
adjusted accordingly to capture the ventricle system. As such, images were acquired 
between 7.1 cm and 9.9 cm in depth and 2D US images were 640 x 476 pixels from 
0.0200 x 0.0200 mm per pixel for 7.1 cm depth to 0.0266 x 0.0266 mm per pixel for 9.9 
cm depth. 
4.2.2.2 3D US images 
3D US images were acquired using a 3D US motorized attachment developed in our 
laboratory, which housed the US transducer (Fig 4-1a). Technical details of the 3D US 
system were previously described.16,18,19 The 3D US images were acquired by locating 
the midline in the sagittal plane, then firmly holding the motor encasement to allow the 
device to mechanically tilt the transducer about the axis at the probe tip along parasagittal 
slices, while the technician’s hand remained as still as possible.  
 
Figure 4-1 Motorized 3D ultrasound system and image. a) The mechanical ‘tilting’ 
3D US transducer device being held in position next to a preterm sized mannequin. 
This is approximately the position used for neonates scanned while intubated or 
while on CPAP during a 3D US acquisition. b) A representative ‘cube’ view cut 
through three orthogonal planes of a 3D US image of a patient with PHVD 
75 
 
 
This image can be viewed through any reconstructed plane (i.e., sagittal, axial, coronal, 
or oblique) using a multi-planar reformatted 3D visualizer (See Fig. 4-1b) at the bedside 
to determine that the full ventricle volume was acquired with limited motion from either 
the patient or the technician during the scan.20 An example of motion artifact that would 
require additional scans can be seen in Figure 4-2a, whereas Figure 4-2b shows the same 
patient’s ‘acceptable’ 3D US image from the same scanning session. Imaging 
specifications are as such that 2D US images were acquired with an angular spacing of 
0.3 degrees at 25 frames/s over a scan angle of 60-72 degrees, making total 3D image 
acquisition between 8-9.6 seconds. 3D US images ranged from 300x300x300 to 
400x400x400 pixels with voxel sizes ranging from 0.2x0.2x0.2 mm for 7.1 cm depth to 
0.24x0.24x0.24 mm for 9.9 cm depth. The same depth settings were used in 2D and 3D 
images on the same day for the same patient. Under ideal circumstances a single sweep of 
the mechanical tilting device is able to capture the entire ventricular system in 3D US.  
Generally, an acceptable image (Fig. 4-2b) was acquired in 2-3 sweeps of the device, 
taking between 2-10 minutes for the entire 3D US examination. Some patients with 
extremely dilated ventricles required acquisition of two separate 3D US images to capture 
the entire ventricular system, one of the right lateral ventricle, and one of the left.  
 
Figure 4-2 Reconstructed coronal slice of 3D US images of a preterm patient with 
ventriculomegaly following a bilateral grade II IVH. a) arrows showing motion 
‘shifts’ that disrupt the smooth ventricle boundary (left side of image) as well as the 
skull reflection (right side of image) in comparison to b) which has much less motion 
and would be considered an acceptable image. 
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4.2.3 Image analysis and ventricle segmentation 
4.2.3.1 2D US 
Two observers (FS and WR) analyzed the 2D US images and reported the ventricle index 
(VI) and anterior horn width (AHW) for the left and right lateral ventricles as well as the 
third ventricle width (3rd) and the largest thalamo-occipital distance (TOD). Reporting a 
single TOD was the standard at our institution, and was used as there was often large 
differences between the left and right side, with one much larger than the other.21 
Therefore, to attain the best correlation possible, we used the largest TOD, as we believed 
this would be a better representative of both ventricle volume and change in the ventricle 
volume. Measurements are described in detail in Davies et al.5 and examples are shown 
in Figure 4-3. The differences (∆) obtained between consecutive time points (i.e., 
between scans 2 and 3 and scans 3 and 4 but not between 2 and 4) were calculated for all 
2D US based measurements. 
 
Figure 4-3 2D US images of a preterm patient with ventriculomegaly following a 
grade II bilateral IVH. a) coronal plane at the level of the foramina of Monro 
indicating LI, AHW and 3rd ventricle width, and b) parasagittal plane indicating 
TOD.  
4.2.3.2 3D US 
Ventricle volume (VV) was obtained by manually segmenting the ventricles from the 3D 
US images by a single trained observer (JK) and verified by an experienced clinician 
(SdR). Due to the high volume of images to be segmented (N=255), each image was only 
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segmented once in order to mitigate user-fatigue which can cause an increase in variance 
of segmentation.22 The segmentation was performed on parallel sagittal slices on the 
reconstructed 3D image. The manually segmented boundaries included the 
intraventricular blood clot as well as the choroid plexus, but not porencephalic cysts if 
they were present. Slice spacing was set at 0.5 or 1 mm depending on the amount of 
ventricular dilatation. Patients with smaller ventricles (that could be captured in a single 
image) required smaller slice spacing (0.5mm) due to the highly irregular shape, as well 
as the thinness of the anterior and temporal horns. Patients with severe PHVD who 
required two 3D US images to fully capture the ventricles (one image for right and one 
for the left lateral ventricle) had slice spacing set at 1 mm as the ventricles were much 
less irregular in shape and the segmentation of these patients required the most time and 
most contours to segment for determination of VV. For these patients, each of the left and 
right lateral ventricle volumes were segmented from separate images and added together. 
Each image set required an average of 20 minutes to segment, with 30-70 contours 
segmented per 3D US image set. Figure 4-4 shows 3D US segmented image and volume 
rendered ventricle surface for a patient with mild ventricle dilatation as well as a patient 
with PHVD. The difference in 3D US ventricle volumes (∆VV) between successive time 
points were calculated and recorded. 
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Figure 4-4 3D US images and segmented ventricle surfaces. a) 3D US image through 
the anterior fontanelle of a patient with bilateral grade II IVH. a) depicts the 
segmented region within the 3D US image, b) is the ventricle model generated from 
the segmented boundaries in a, and c) depicts a 3D US ventricle model generated 
from 2 3D US images of a patient with PHH following a bilateral grade III IVH. 
Volume was measured to be b) 20.2 cm3 and c) 45.7 cm3. 
4.2.4 Observer Agreement in reported 2D US measurements  
As there were two observers (FS and WR) for the 2D US images, a small subset of the 
images was measured by both observers to determine measurement agreement. Seventeen 
images were analyzed, and they were all from different neonates with varying severities 
of IVH and ventricle dilatation. VI and AHW for the left and right lateral ventricles as 
well as the 3rd and the largest TOD were reported by the two observers.  
4.2.5 2D US measurements made on 3D US images 
In order to further validate our 3D US system, VI, AHW, and TOD were measured on 
approximately the same plane on the 3D US images as would be used for 2D US. 3rd was 
excluded as images were taken too close to mid-line to visualize this structure in most 
‘acceptable’ 3D US images. A single observer (F.S.) performed measurements on both 
the 3D US images and time matched 2D US images. Twenty-eight image sets from 
different neonates with varying severities of IVH and ventricle dilatation were analyzed 
for this study.  
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4.2.6 Statistical Analysis 
Linear regression (R2) were performed using GraphPad Prism 6 (GraphPad Software, San 
Diego, CA). A regression of R2>0.7 was considered strong, 0.7-0.5 moderate, and <0.5 
weak. Observer agreement between the two observers on the same 2D US images was 
performed through absolute agreement, two-way random intraclass correlation (ICC) 
using SPSS v.20 (IBM Corp, Armonk, NY). Absolute agreement, two-way random ICC 
was additionally performed to determine agreement between 2D US images made on 
both 2D and 3D US for the same observer. 
4.3 Results 
4.3.1 Patient Characteristics 
Forty-two neonates were enrolled into the study following an initial diagnosis of IVH and 
subsequent ventricle dilatation between April 2012 and February 2015. The median age 
of enrollment was 9 days of life (range 4-30 days). Patient characteristics are summarized 
in Table 4-1. A total of 265 image sets (2D and 3D US images acquired on the same day) 
were collected for this study. 255 2D/3D US exams provided all the required US 
measurements, with 8 image sets missing 3rd measurement and 2 missing TOD. Scans 
were performed between 25 and 42 2/7 weeks corrected GA with the median GA at 
imaging being 30 3/7 weeks (Figure 4-5).  
 
 
 
 
 
 
Table 4-1 Clinical characteristics of the study population. Interventions include 
ventricle taps, external ventricle drains and VP-shunts. Direct Comparison indicates 
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all patients used to study VV to 2D ultrasound measurements of the ventricles, while 
Changes is the patients who had more than one imaging session and therefore 
changes in VV as well as 2D ultrasound measurements of the ventricles between 
imaging sessions could be calculated and correlated. 
 Direct comparisons (N = 42) 
(N = 42) 
Changes (N = 35) 
Gestational Age  
(weeks ± SD) 
27.6 ± 3.0 27.3 ± 3.1 
Birth Weight (g ± SD) 1105 ± 450 1062 ± 480 
Sex (M:F) 30:12 25:9 
Patent Ductus Arteriosus (%) 30 (68%) 24 (71%) 
Antenatal Steroids (%) 24 (37%) 20 (57%) 
   
IVH   
   Grade I 7 (11%) 4 (11%) 
   Grade II 17 (58%) 16 (46%) 
   Grade III 10 (21%) 9 (26%) 
   Grade IV 8 (11%) 6 (17%) 
Required Intervention   
   Yes  10 (16%) 9 (26%) 
   No  32 (84%) 26 (74%) 
 
Figure 4-5 - The number of 2D/3D US image sets. Patients were separated by given 
corrected gestational age (GA) as reported on the chart on the day of the scan. 
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To compare changes between images, patients required at least two 3D/2D US image 
sets, and 7 patients were discharged to a secondary care center or home after only a single 
imaging session leaving 35 to be used in the change study, with their 248 images for a 
total of 213 comparison points with a median of 6.5 days in between scans (range 3-46 
days). These change scans were over the same GA range as the direct comparisons (25-
42 2/7 weeks). Of the 35 patients who had >1 imaging session the median number of 
images per patient was 7 (range 2-14).  
Ventricle volumes ranged from 2.7 cm3 (GA at scan 25 weeks) to 96.2 cm3 (GA at scan 
was 26 5/7 weeks) where the overall median was 10.3 cm3 for patients ranging in GA 
from 25 - 42 2/7 weeks. In comparison, normal preterm neonates without IVH between 
25 - 40 weeks GA would have ventricle volumes in the range of 0.4 - 2 cm3.11  
4.3.2 Observer Agreement 
There was a high ICC (> 0.95) between the two observers for all 2D ultrasound 
measurements and can be seen in Table 4-2. 
 
Table 4-2 Inter-observer agreement. Intraclass correlation (ICC) of the ventricle 
index (VI) and anterior horn width (AHW) for the left and right lateral ventricles as 
well as the third ventricle width (3rd) and the largest thalamo-occipital distance 
(TOD). 95% confidence intervals (95% CI) are within []. 
 VIR VIL AHWR AHWL 3rd TOD 
ICC 
[95% CI] 
0.98 
[0.99-0.91] 
0.99 
[0.99-0.98] 
0.97 
[0.99-0.92] 
0.99 
[0.99-0.98] 
0.95 
[0.98-0.86] 
0.96 
[0.98-0.89] 
4.3.3 2D US measurements on 3D US images 
There was a high ICC (>0.70) between measurements made by a single observer on both 
2D and 3D US images for VI, AHW and TOD which is presented in Table 4-3.  
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Table 4-3 - Intra-observer agreement though intra-class correlation (ICC) between 
2D and 3D US images. ICC of the ventricle index (VI) and anterior horn width 
(AHW) for the left and right lateral ventricles as well as the third ventricle width 
(3rd) and the largest thalamo-occipital distance (TOD). 95% confidence intervals 
(95% CI) are within []. 
 VIR VIL AHWR AHWL TOD 
ICC 
[95% CI] 
0.70 
[0.91-0.50] 
0.70 
[0.90-0.54] 
0.85 
[0.93-0.70] 
0.87 
[0.93-0.73] 
0.77 
[0.89-0.56] 
4.3.4 Ventricle Volumes compared to 2D US parameters 
Linear regressions were performed between 3D US VV and the corresponding 2D US 
based measurements recorded at the same time. Figure 4-6 shows the linear regressions 
(bolded line) and 95% confidence intervals (thin lines) of VV as measured using 3D US 
images against the corresponding 2D US based measurements (VI, AHW, 3rd and TOD). 
While there were trends towards increasing 2D US measurements with increased VV, the 
Pearson correlation coefficients were between 0.69 and 0.36. For the left lateral ventricle 
measurements, there was a single patient (open circles) who tended to have high 2D US 
measurements in the coronal plane (LI, AHW), but relatively low VV (Figure 4-6 b,d). 
This appeared to be due to a very large porencephalic cyst on the left side that was 
communicating with the ventricular system and was erroneously included in the coronal 
measurements. This patient was removed from the analysis, the correlation for LIL and 
AHWL became 0.65 and 0.69 respectively, and the linear regression line on Figure 4-6 
reflects this patient being removed from analysis. 
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Figure 4-6 Correlation graphs for ultrasound measurements. Ventricle index (VI) a) right (R) and b) left (L), Anterior Horn 
Width (AHW) c) right (R) and d) left (L), e) third ventricle width (3rd) and f) thalamo-occipital distance (TOD) measurements 
against VV from 3D US. Linear regression is indicated by the bolded line along with 95% confidence interval (thin lines). A 
single patient was excluded from regression analysis for VIL and AHWL (b,d) as the measurements included a left side 
porencephalic cyst and are represented as the cluster of points well above the linear regression 
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4.3.5 Changes in Ventricle Volumes compared to changes 2D US 
parameters 
We investigated the differences in 2D and 3D measurements between successive imaging 
sessions as an indication of how ventricular size changes post-IVH. Since there can be 
substantial differences in rates of change from one patient to the next, and due to the various 
number of imaging points per patient, linear regression between adjacent time points was used 
instead of multilevel modeling, or ANOVA. We believed that linear regression on the difference 
of measurements at two time points would be fairly representative of what would happen on a 
day to day use of measurements when comparisons are made to the previous scans. Figure 4-7 
shows the linear regressions (bolded line) and 95% confidence intervals (thin lines) of ∆VV as 
measured using 3D US images against the corresponding change in 2D US based measurements. 
The Pearson correlation coefficients found between ∆VV estimated using 3D US and the 
measured change in 2D US parameters were between 0.13 and 0.02.  
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Figure 4-7 Correlation graphs for change in ultrasound. Change in ventricle index a) right and b) left, Anterior Horn Width c) 
right and d) left, e) third ventricle width and f) thalamo-occipital distance measurements (∆LI, ∆AHW, ∆3rd, and ∆TOD 
respectively) against the change in ventricle volume (∆VV) from 3D US.  Linear regression is indicated by the bolded line along 
with 95% confidence interval (thin lines).   
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4.4 Discussion 
 
As expected, there was a trend towards increasing 2D US-based measurements with increased 
VV (Fig. 4-6), though there was no 2D US measurement that ‘best’ correlated with 3D US VV. 
Additionally, due to the longitudinal nature of this study, we were able to show that changes in 
serial 2D US measurements are weakly correlated to changes in VV and indeed, there was not an 
obvious trend. This is possible due to the variability in 2D US-based measurements. Previously 
reported standard deviations of measurements ranged from 2 mm for the AHW9 to 2.5 mm for 
the VI and 4 mm for the TOD,8 whereas the mean absolute change between imaging sessions 
was 1.4 mm for AHW, 1.2 mm for VI, and 2.7 mm for TOD – less than measurement variability. 
In comparison, we have previously found intra-user variance (standard error of measure, SEM) 
to be 0.23cm3 for intra-user and 0.24cm3 for inter-user through a study of 3D US ventricle 
segmentation using three different observers.16 An additional study found variability in 3D US as 
measured through standard deviation to be an average of 0.95 cm3 (range 0.31-2.03 cm3) for 
preterm patients born less than 32 weeks GA with ventricles that ranged in size from 5-34cm3.2  
Given that a single observer, who was one previously used in the prior published work,16,23 was 
used in the present study for 3D US VV, the mean absolute change in VV of 4.1 cm3 was much 
higher than the intra-user variability reported in either previous study.  
Attempting to estimate change in an irregular 3D volume, such as the lateral ventricles, with a 
linear measurement obtained from 2D US has obvious limitations other than high measurement 
error as well. This could explain why, to our knowledge, no previous papers have found rates of 
change in 2D US parameters that predict which patients will go on to develop PHVD, and why 
there is a reliance on qualitative viewings of 2D US scans to determine if an intervention is 
required.  
A previous study9 has shown  that the 2D US measurements of the VI and AHW can be made on 
3D US images with reasonable reproducibility and accuracy. While they looked specifically at 
the AHW and VI, we additionally found reasonable agreement with the TOD between 2D and 
3D US. We found the agreement (measured through ICC) is lower when comparing between 2D 
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US and 3D US than between users for the same 2D US images and we believe this could be 
because the measurements were not able to be made on exactly the same planes. While we are 
able to reproduce oblique planes using our 3D US system, the plane selection is still a potential 
source of error in this study. Further research into how to best select and present para-sagittal and 
para-coronal planes from 3D US images is necessary to make robust 2D US measurements as 
well as indicate other planes of interest such as those with cysts or other abnormalities. This is 
likely necessary to support translation of 3D US imaging into the clinical setting. 
In contrast to what had previously been shown using MRI VV and 2D US images by Horsch et 
al.,7 we did not find strong correlations between 3D US VV and linear measurements. This could 
partially be due to a higher variance in volume measurement made on 3D US in comparison to 
MR images as the boundaries are less clear in US images.14 In Horsch et al.’s MRI based VV 
study they were only able to make one comparison at a single time point per patient at term 
equivalent age, and only 4 of 28 patients analyzed had ventricle dilatation. As most of the 
patients in that study would have clustered near the lower ‘normal’ end of VV, the 4 with 
ventricle dilatation would have driven the linear regression and strengthened the correlation in 
that study, especially with such a relatively low sample size. In comparison, in the present study, 
we had patients with ventricle sizes along the continuum of both normal (2.7 cm3) to very large 
(96.2 cm3) and included a total of 255 image sets from 42 patients.  
An additional strength of the present study is that we were able to make 3D US-based VV 
measurements prior to term equivalent age in every preterm neonate studied with varying 
severities of ventricle dilatation throughout the course of their stay in the NICU as opposed to 
only when stable enough to be transferred to an MRI suite. This is in keeping with when 
neonates would be monitored most closely to detect IVH as well as to monitor for PHVD and to 
determine potential initial interventional therapy. A previous study examining normal preterm 
patients’ VV from 3D US found that small increases in VV occurred in the preterm period (from 
medians of 0.25 cm3 at 25 weeks GA to a median of 0.56 cm3 at 37 weeks GA).11 However, the 
main limitation in comparing those values to ones reported in our study is that the previous paper 
excluded the choroid plexus in their segmentation, and would make for smaller than actual VV.  
To our knowledge, that is the only study on normal VV from 3D US in neonates. In comparison, 
a review paper noted that over the course of GA 24-42 weeks, the VI was the only measurement 
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that increased with GA, whereas AHW and TOD remained fairly constant, with the exception of 
a single paper, which the review paper’s authors’ noted as having a remarkably small standard 
deviation and did not agree with their experience or other published works.8 In a follow up 
paper,23 this group developed new reference values for VI, AHW and TOD for patients without 
US abnormalities born at varying GA (25-42 weeks) and found that increased GA was related to 
increased VI and TOD, but not AHW. However, studying neonates born <30 weeks GA and 
comparing VI, AHW and TOD near birth to that at term equivalent age (GA 37-40 weeks), the 
authors found increases over time for all ultrasound measurements.23 
Recent studies6,24 have advised using the >97th percentile of 2D US measurements as the ‘action 
line’ for when interventional therapies should begin. While this may provide guidance as to 
when the first intervention should occur, often patients with severe PHVD will remain over the 
97th percentile even after intervention.  Thus, subsequent interventions can no longer be guided 
by 2D US measurements. The change in 3D US-based VV as opposed to 2D US-based 
measurements might be a better indicator as to when subsequent interventions are required and 
would provide another metric to those already proposed. Although outside the scope of this 
study, a future study should be performed using 3D US VV to determine thresholds for 
interventional therapy while the patient is in the NICU and during follow up to determine 
whether or not a neonate requires shunting, or whether or not the shunt has failed, as there are 
also no consensus imaging guidelines for that intervention. 
The main limitation in our study from a translational standpoint is that the methodology involves 
manual segmentation of the images off-line and does not provide timely data for routine patient 
care. For 3D US to become a viable method for determining the VV at the bedside, an automated 
or semi-automated approach must be developed.  This was beyond the scope of this pilot study. 
Neonates with PHVD pose a particularly challenging segmentation problem as the ventricles 
change fairly significantly in shape as well as echogenicity over time. For example, the ventricles 
become rounder over time, and the bleed, initially hyperechoic, slowly breaks down over time 
and becomes indistinguishable from the hypoechoic CSF (Fig. 4-8) The change in echogenicity 
over time makes simple thresholding or local optimization based methods like active contour or 
level set methods not useful for this application, while the dramatic change in shape makes atlas 
based approaches challenging. Given the inherent variability and prohibitively long segmentation 
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times in manual segmentation, our lab has developed a semi-automated approach based on 
convex optimization with some encouraging preliminary results25 and we have integrated this 
new software into our acquisition software, and are currently piloting this new protocol in a 
small sample of patients. The semi-automated segmentation algorithm has been validated 
through a multi-observer study and compared to multi-user manual segmentation.26 The 
segmentation time was reduced to approximately 2 minutes in comparison to an average of 20 
minutes for manual segmentation. In Chen et al., a new framework for future validation of both 
manual and algorithm based ventricle segmentation was presented and gave us knowledge on 
areas of local segmentation variability that were not easily seen using global metrics such as VV 
agreement, or Dice Coefficient. In particular, the temporal and posterior horns have the largest 
segmentation variability in both manual and semi-automated algorithm segmentation,26 and this 
information can be used to generate better segmentations in the future. Additionally, an offline, 
atlas initialized automated segmentation method27 was recently developed, though has yet to be 
integrated into our protocols.  
 
Figure 4-8 - The progression of PHVD in a patient with grade III/IV IVH in 3D US images. 
All images show a parasagittal view of the right ventricle. a) At 8 days of life, the ventricle 
is nearly completely filled with blood and is hyperechoic in comparison to surrounding 
brain. b) at 25 days of life the bleed is beginning to break down and appears nearly the 
same echogenicy as surrounding brain. c) at 64 days of life the bleed is still breaking down, 
however, most of it cannot be distinguished from hypoechoic CSF. Ventricle volumes were 
measured to be 11.4, 62.0, and 83.7 cm3 respectively. 
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Another limitation to direct translation to other centers, is the use of a non-commercial system. 
As our 3D US has been validated both using phantom14 and patient images,16 we would 
anticipate that there should not be a discrepancy between the VV attained from our system in 
comparison to a commercial system; however, we were not able to definitively prove this as our 
center does not have an appropriate commercial 3D US transducer for this type of imaging. The 
HDI 5000 US system used in this study is the most easily assessable unit within the NICU at our 
center and there is no 3D US transducer within the frequency range for neonatal head ultrasound. 
However, the semi-automated segmentation software we have developed would be able to 
accommodate 3D US images from commercial systems, so there is potential for a future study to 
use this software along with a commercial 3D US transducer. Any patient/technician motion 
(Fig. 2a) identified through our 3D US system, could be addressed by a commercial system 2D 
array transducer as the whole 3D US volume is performed in real time (in 33 ms) instead of over 
8s. While beyond the scope of this study, detecting and analyzing motion artifacts during 
acquisition that both can and cannot be detected upon visual inspection would be interesting 
future work to both understand how this can be adjusted for and how it impacts volume 
measurements from 3D US. 
If 3D US based measurements of VV are a more accurate and precise measurement of ventricle 
size than 2D based measurements, and they have moderate-weak correlation to 2D US 
measurements, this suggests that 2D US measurements alone might not be enough to determine 
the progression of PHVD. This is further shown given the weak correlations between changes in 
serial 2D US to changes in VV for neonatal patients. This could help explain why there is no 
consensus image based standard on when PHVD is occurring at a rate that merits intervention. 
Previous studies9,15 have shown the time per exam is reduced when acquiring a 3D scan instead 
of 2D imaging sets, and the diagnostic accuracy is maintained. Therefore, a 3D US approach 
would preserve the ability to obtain the clinical standard set of measurements, while potentially 
enhancing the ability to determine whether or not a new clinical standard could be developed 
using 3D US-based VV estimates. We have presented further evidence that 3D cranial US has 
potential as valuable tool; however, a future study with a larger cohort would be necessary before 
guidelines for intervention could be suggested for the clinical management of PHVD.
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Chapter 5  
This chapter will discuss the ability of three-dimensional ultrasound based ventricle 
volume measurements of the cerebral ventricles of preterm neonates to predict whether a 
neonate will receive a ventricle tap.  
The contents of this chapter have been submitted to the journal Scientific Reports in 
January 2017: J. Kishimoto, A. Fenster, D.S.C. Lee, S. de Ribaupierre. Quantitative 3D 
head ultrasound measurements of ventricle volume to determine thresholds for preterm 
neonates requiring interventional therapies following PHVD. 
5 Quantitative 3D head ultrasound measurements of 
ventricle volume to determine thresholds for preterm 
neonates requiring interventional therapies following 
post hemorrhagic ventricle dilatation: A single center 
study 
5.1 Introduction 
Despite advances in neonatal care and improved evidence-based perinatal management 
guidelines, preterm neonates are still at a high risk of morbidity. Intraventricular 
hemorrhage (IVH), bleeding inside the cerebral ventricles, has been decreasing in 
prevalence yet remains as a common morbidity among preterm born neonates.1 The risk 
of long-term disabilities such as cerebral palsy and cognitive impairment increases 
significantly with the occurrence of post-hemorrhagic hydrocephalus (PHH), the 
abnormal enlargement of the ventricles, which typically occurs in 25-28% of IVH 
patients with severe bleeds (Grade III and IV by the Papile scale2).3 Generally, PHH is 
thought to be caused by the blood clots and inflammatory reactions from blood 
breakdown products causing obstruction of the flow of CSF which normally flows from 
the ventricles where CSF is generated to the subarachnoid space where it is reabsorbed 
into the blood stream.  
While the definitive treatment for PHH is the placement of a ventriculoperitoneal shunt 
(tubing between the ventricles and the abdomen), placement of the shunt is often delayed 
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by several weeks in order to allow for the blood clot to resolve, the CSF proteins to 
decrease (below 1000mg/dL) and the weight of the infant to increase (at minimum above 
800g-1kg). However, during this delay in treatment, the increase in ventricle size, also 
known as post-hemorrhagic ventricle dilatation (PHVD), can cause dangerously 
increased intracranial pressure (ICP), which can limit blood flow to the brain. Any 
ischemia or decreased blood flow during this critical period can be detrimental to the 
developing brain and can lead to impairment later in life. Due to this risk, neonates who 
have rapidly progressing PHVD and some with persistent, slowly progressing PHVD will 
require temporary interventions to relieve the elevated ICP. These interventions include 
lumbar/ventricle puncture, external ventricle drainage, ventricular access devices 
(reservoirs), and ventriculosubgaleal shunts. There is no consensus of evidence as to 
which of these methods are the best for temporary CSF diversion.4,5 
Currently, clinical experience, as well as daily head circumference and transfontanelle 
brain ultrasound (US), are used to determine when neonates receive temporary 
interventions to removed built up CSF.6 However, it has been shown that head 
circumference does not accurately correlate with increases in clinical US measurements 
(Evan’s ratio)7 or with ventricular volume.8 Additionally, clinical signs of increased ICP 
(apnea, bradycardia) are nonspecific in the preterm infant and could be due to other co-
morbidities. Early detection of interventional necessity could potentially lead to better 
management of the condition, while early detection of resolution could provide comfort 
to the clinician and parents that intervention is unlikely to be necessary. Additionally, 
since many cases of PHVD resolve after a temporizing CSF diversion procedure and do 
not then require a shunt, we aimed to characterize an ultrasound-based metric to 
determine the resolution of PHVD versus continual, progressive ventricle dilatation 
leading to PHH, which may receive additional interventions. 
Previous work with transfontanelle brain 3D US has been attempted in neonates.9-13 
While this imaging technique was shown to be feasible, gives similar measurements14 
and diagnosis12,15 as 2D US, its clinical utility above and beyond 2D has not been 
established.  Recent studies have had success acquiring 3D US images of neonatal 
ventricles using commercial systems;9,10,12,14,15 however, these transducers are not part of 
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standard-of-care and must be bought separately. The expense of these systems may limit 
their use, especially in the developing world. A system that could be used in conjunction 
with a conventional clinical 2D transducer to generate full 3D images would allow 
centers without a 3D US capable machine to confidently acquire 3D ventricle volumes. 
As hydrocephalus is far from only an issue in the developed world with 6000 cases per 
year diagnosed in East Africa,16 we developed a relatively low-cost 3D US system that 
can be modified to generate 3D US images from virtually any conventional 2D US 
system.17 From these 3D images, we measure the volume of the infants’ ventricles. This 
system has been validated both using test phantom ventricles of known volume17 and in 
vivo against the volume of CSF withdrawn during a tap as well as against MRI.18   
In this paper, we present for the first time a preliminary study used to examine whether a 
3D US-based ventricle volume and ventricle volume change measurements allow us to 
prognosticate which infants with PHVD will receive a temporary intervention and who 
will have a spontaneous resolution of PHVD.  
5.2 Methods 
As part of a larger study, between April 2012 and May 2016, after an initial diagnosis of 
IVH1 was made during standard screening head ultrasound exam, preterm neonatal 
patients were enrolled with informed parental consent. 3D US images and all 
experimental protocol were acquired in accordance with a protocol approved by the 
Research Ethics Board at the University of Western Ontario. Imaging was performed 
twice per week with 3-4 days between imaging sessions.  
Interventions were performed based on clinical judgement, with the clinician using the 
head circumference growth over time, the increase in ventricular dilatation on the 2D US, 
as well as sometimes, but not necessarily, clinical signs and symptoms of increased 
intracranial pressure such as apnea, bradycardia, and a full, tense fontanelle. Interventions 
were not based on 3D US images collected during the study, as the clinical team was 
blinded to all 3D US images during the course of the stay in the neonatal intensive care 
unit (NICU). The initial intervention at our center is a ventricular tap (VT) since it can be 
done at the bedside and doesn’t require to go to the operating room (whereas the 
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Ommaya catheter insertion would); but if taps are thought to be needed frequently, then 
an external ventricle drain is usually inserted. For the purpose of this study, only patients 
born <32 weeks gestational age (GA) were included in the analysis.  
5.2.1 3D US image acquisition 
Images were acquired using a Philips HDI 5000 US machine with a C8-5 transducer. 3D 
US imaging was performed after placing the ultrasound transducer in a hand-held 
motorized housing that tilted the transducer about the axis at the probe tip for 8-9 sec.2  
During image acquisition, 2D US images were collected on a laptop computer as the 
motor tilted the transducer over 9.6 sec and in-house software reconstructed the 3D US 
image in real time as images were received into the computer.3 Technical details can be 
found in Kishimoto et al. (2013).17 This system has been validated both for geometric 
fidelity and volume measurements.17 
5.2.2 3D US image segmentation 
The lateral ventricles were manually segmented in parallel sagittal slices with 1 mm gaps 
between adjacent slices. A trained observer (JK) segmented all the images and a 
paediatric neurosurgeon (SdR) verified the boundaries after the patient had left the NICU. 
Each image required between 20-45 minutes to segment. The 3D US imaging system and 
ventricle segmentation have been previously validated using phantom and patient 
images.2 An example of segmented ventricles from a patient with PHVD following IVH, 
is shown in Figure 5-1. 
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Figure 5-1 3D US images of a pre-term neonate with PHVD over the first three 
weeks of life. This patient required multiple VT to treat the rapid increase in 
ventricle size.  a) week one, b) week two, and c) week three. Ventricles have been 
segmented as indicated by the red outline. 
5.2.3 Determining which neonates with PHVD receive an initial 
ventricle tap 
We performed the analysis between patients who did and did not receive interventional 
therapies for PHVD. The maximum ventricle volume (VV) for each scan was recorded 
during the first month of life for each patient as well as whether or not they eventually 
received a VT.  
5.2.3.1 Volume measurement as a predictive marker 
The ventricle volume for age ranges <7, 8-11, 12-15, 16-19, 20-22, 23-27 days of life was 
calculated and recorded for each patient. Volume measurements were not always 
attainable for every patient at each time point, as some enrolled late, or were too unstable 
to be scanned that day. Given the study population leaned towards extremely preterm 
neonates with at minimum an IVH and often with other morbidities related to 
prematurity, instability following minimal handling (such as during a head US) was more 
common in this population than it would be for most NICU patients. For some patients, 
two measurements were made within the time periods (i.e., days 8 and 11) and both were 
used as independent points.  
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5.2.3.2 Maximum rate of change of ventricle volume 
We calculated the maximum rate of change of ventricle volume between 2 scans, and 
analyzed it for the first week (day <8), second week (day 8-14) and third week (day 15-
21) of life.  The neonatal ‘week of life’ was categorized depending on the week of the 
second scan (ie: if scans were obtained on days 3 and 7 of life, this would be considered 
‘first week of life’ but if scans were obtained on days 6 and 10 of life, this would be 
‘second week of life’). 
5.2.4 Determining which neonates with PHVD will receive follow-
up interventions 
Since most patients with PHVD who have an initial VT will go on to have multiple VTs 
during the course of the stay in the NICU, we investigated whether or not imaging based 
measurements could detect the requirement for further treatments. Thus, we analyzed 
ventricle volume as well as ventricle volume change using the images obtained closest to 
the initial VT but not on the day of, and within the week after the VT.  
5.2.5 Data Analysis 
Receiver operator curves (ROC) were generated between patients who did and did not 
receive interventions using 3D US based ventricle volumes. In the second study in 
patients who had previous interventions, ROC analysis was performed using 3D US-
based ventricle volumes, between patients who did not receive further interventions, and 
those that received at least one additional intervention. For each parameter (volume and 
volume change), optimal threshold for intervention was estimated through the highest 
product of sensitivity and specificity. Additionally, the area under the ROC curve (AUC), 
sensitivity and specificity were calculated. Assuming a Bonferroni correction, two sided 
t-tests were performed between all previously described compared groups of patients 
with an α=0.05. All analyses were performed using GraphPad Prism 6 (GraphPad 
Software, San Diego, CA). 
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5.3 Results 
5.3.1 Patient Characteristics 
Thirty-eight neonates were enrolled prior to the second week of life (before most patients 
with PHVD would receive an intervention) and were used to determine thresholds in this 
study. Of those, 14 patients received at least one VT. Mean age of enrolment was 9 days 
of life, and 12 patients were enrolled in the first week of life (7 did not receive 
interventions, 5 had at least a single VT).  Descriptions of the all study patients are shown 
in Table 5-1.  
Table 5-1 - Patient characteristics for those who did and did not receive 
interventional therapies 
 
Intervention (N = 14) No Intervention (N =24) 
Gestational Age  
(weeks ± SD) 
27.2 ± 2.3 27.3 ± 2.7 
Birth Weight (g ± SD) 1060 ± 300 1040 ± 490 
Sex  
(M/F) 
10/4 16/8 
IVH Grade3  
(I/II/III/IV) 
0/1/7/6 3/13/6/2 
5.3.2 Determining which neonates with PHVD require an initial 
ventricle tap. 
5.3.2.1 Volume measurements as predictive marker 
Table 5-2 shows the threshold in ventricle volume used to determine which patients did 
or did not receive a VT intervention for PHVD for a given patient’s age in days. 
Sensitivity and specificity for the threshold used as well as area under the ROC curve 
(AUC) is also given in Table 5-2. Figure 5-2 shows the VV in neonates with PHVD 
during the different time periods previously specified as well as the calculated threshold 
from ROC analysis.  In general, through the use of VV we found the thresholds that 
characterized patients that received interventional therapy with high sensitivity (100-
91.7%) and high specificity (100-92.9%) during the first three weeks of life (Table 5-2). 
The most ambiguity came during the second week of life (Table 5-2, 8-11 and 12-16 
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days) when a portion of the patients who did not receive interventions had transient 
increases in ventricle size, reflected in a small increase in mean volume from 7 to 8 cm3. 
After this time, those patients who did not receive interventions and who transiently saw 
small increases in VV had VV which decreased or stabilized with the average volume 
remaining at about 7 cm3. The patients who had interventions saw a continued increase in 
VV at every time interval and this can be seen in Fig. 5-2. The group differences between 
patients who did and did not receive interventions were reflected in the increase in the 
threshold between the two groups, as well as the increase in sensitivity and specificity 
after day 17 (Table 5-2). 
Table 5-2 - Optimal sensitivity and specificity using the maximum single 
measurement of 3D US-based VV, area under the ROC curve (AUC), and volume 
threshold obtained from ROC curve specificity/sensitivity maximum. The number 
of patients for each time interval is indicated as recruitment often happened after 
the first week of life, and not all patients were stable enough to image at every time 
interval. 
Age of 
Patient 
Interventional 
patients (N) 
No 
Interventions 
(N) 
Sensitivity 
(%) 
Specificity 
(%) 
AUC 
Threshold 
used (cm3) 
<7 
days 
7 8 100 100 1 > 9.4 
8-11 
days 
14 12 91.7 100 0.98 > 10.6 
12-16 
days 
14 22 100 92.9 0.99 > 20.3 
17-20 
days 
8 13 100 100 1 > 20.4 
21-27 
days 
5 17 100 100 1 > 20.9 
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Figure 5-2 Box and whisker plots of the ventricle volume of neonatal patients who 
received an interventional ventricle tap for clinical reasons (Intervention), 
compared to those who did not require intervention (No Intervention).  
Images obtained at a) 7 b) 8-11 c) 12-16 d) 17-20 and e) 21-27 days of life for patients 
born <32 weeks gestational age. Threshold from ROC analysis is marked as a dotted line. 
Sig. differences from t-test are indicated as * over the graph. 
5.3.2.2 Maximum rate of change of ventricle volume as a predictive 
marker 
Table 5-3 shows the threshold in the rate of change ventricle volume to determine, which 
patients did or did not receive a temporary intervention for PHH for different age ranges 
in days. Sensitivity and specificity for the threshold used as well as the area under the 
ROC curve (AUC) are also given in Table 5-3. Figure 5-3 shows the rate of change in 
ventricle volume in neonates with PHVD between those who did and did not receive 
interventions during the different age ranges previously specified. Additionally, the 
threshold calculated in ROC analysis is indicated in Fig. 5-3 for ease of comparison 
between time periods.  
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The rate of change in ventricle volume was highly sensitive for detecting which patients 
received interventions (100% sensitivity) during all age intervals monitored (Table 5-3). 
The ROC in VV additionally allowed for more specific thresholds (100% specificity) to 
be generated for patients who received interventional therapy in comparison to a single 
measurement of VV for all age ranges except for those of <11 days, which had a 
sensitivity of 75% (Table 5-3). From day 7 to 11, some patients who did not receive 
intervention had a transient period of ventricle dilatation that appeared to resolve by the 
second week of life when the rate of change stopped increasing or increased by a small 
amount (Figure 5-3). The threshold for 7 days of life had a very low N (5 patients total), 
which should be taken into consideration as this might not be representative of the total 
patient group studied (Table 5-3). 
Table 5-3 - Optimal sensitivity and specificity using the maximum rate of change in 
the first three weeks of life in 3D US VV is reported along with area under the curve 
(AUC) from ROC curve, and threshold is reported from ROC curve 
specificity/sensitivity maximum. The number of patients for each time point is 
indicated as recruitment often happened after the first week of life, or patients only 
had a single VV recorded during their time in the study.  
Age of 
Patient 
Interventional 
patients (N) 
No Interventions 
(N) 
Sensitivity 
(%) 
Specificity 
(%) 
AUC 
Threshold 
used 
(cm3/day) 
<7 days 2 3 100 100 1 > 0.25 
<11 days 8 9 100 75 0.82 > 1.35 
2 weeks 10 18 100 100 1 > 2.20 
3 weeks 10 19 100 100 1 > 2.20 
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Figure 5-3 - Box and whisker plot of the change in ventricle volume between 
consecutive imaging sessions for preterm neonates born <32 weeks gestational age 
who required an interventional ventricle tap for clinical reasons (Intervention), 
compared to those who did not require intervention (No Intervention). Scans taken 
at a) 1 week of life b) 11 days of life c) second week of life and d) third week of life. 
Threshold from ROC analysis is marked as a dotted line. Sig. differences from t-test 
are indicated as * over the graph. 
5.3.3 Determining which neonates with PHVD will receive follow-
up interventions 
For this study, we examined only the patients who already had a previous VT. Of the 11 
patients with a previous VT, 4 resolved clinically without further interventions during 
their NICU stay. Table 5-4 shows 3D US-based thresholds between patients who 
received at least one additional VT, and patients who had PHVD, which resolved after a 
single VT. Figure 5-4 shows the 3D US-based VV (left) as well as the change in VV 
In te r v e n t io n N o  In te r v e n t io n
0 .0
0 .5
1 .0
1 .5
2 .0
< 7  d a y s
C
h
a
n
g
e
 i
n
 V
V
 (
c
m
3
/d
a
y
)
a )
In te r v e n t io n N o  In te r v e n t io n
-2
0
2
4
6
8
1 0
1 1  d a y s
C
h
a
n
g
e
 i
n
 V
V
 (
c
m
3
/d
a
y
)
b )
105 
 
 
(right) between neonates who previously had VT who received repeated VT and those 
who had resolving PHVD. Ventricle volume appeared to remain high in 3D US images 
acquired after a first intervention, and there was no clear threshold between those patients 
who received further interventional management. (Figure 5-4, left). Indeed, there was no 
sig. difference between the average VV for patients who received additional VT (48.8 
±12.5 cm3 stdev) and patients who were undergoing resolution of PHVD (45.1 ± 16.1 
cm3 stdev). However, when the patient was monitored for an additional imaging session 
and the change of volume could be calculated, it was clear that patients who did not 
receive further VT had a decrease in ventricle size (Figure 5-4, right). The threshold for 
change in ventricle volume (<0.31 cm3/day) was able to characterize patients who were 
resolving vs those receiving further monitoring with a sensitivity and specificity of 100% 
(Table 5-4). 
Table 5-4 Optimal sensitivity and specificity using the maximum ventricle volume 
(VV) and maximum rate of change in ventricle volume (ΔVV) in the week following 
initial VT from 3D US is reported along with area under the curve (AUC) from 
ROC curve, and threshold is reported from ROC curve specificity/sensitivity 
maximum.  
Measurement Sensitivity (%) Specificity (%) AUC Threshold used 
VV 75 71.4 0.61 < 45.45 cm3 
ΔVV 100 100 1 <0.31 cm3/day 
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Figure 5-4 - Box and Whisker plot of the ventricle volume in the imaging session 
immediately after VT (left) as well as the change in ventricle volume in consecutive 
imaging session after VT (right) for patients who required either multiple 
interventions, or had resolving ventricle dilatation after a single intervention. 
Threshold from ROC analysis is marked as a dotted line.  Sig. differences from t-test 
are indicated as * over the graph. 
5.4 Discussion 
In our preliminary study, we presented the potential for 3D US-based measurements of 
ventricle volumes from neonatal brain images to characterize whether or not patients with 
PHVD will receive interventions. Specifically, neonates who go on to receive 
interventions have larger ventricle volumes, (mean 21 ± 14 cm3 for patients who received 
interventions, vs. 5.6 ± 2.1 cm3 for patients who did not receive interventions during the 
first week of life (Figure 5-1a). The patients who received interventions tend to have 
larger increases in VV change over time (Figure 5-2).  
3D US-based VV acutely remains very high in the week following an intervention 
regardless of whether or not the patient is undergoing resolution of PHVD (interventional 
patients had VV of 48.8 ±12.5 cm3 (mean±stdev) whereas patients undergoing resolution 
were 45.1 ± 16.1 cm3 (mean±stdev)). However, neonates who have PHVD that is 
resolving do show a change in VV (-1.9±1.3 cm3/day, mean±stdev) from one 3D imaging 
session to the next that is indicative of a reduction in VV or no change from previous 
image even in the week immediately after an intervention. This is in comparison to the 
R e p e a t  In te r v e n t io n R e s o lu t io n
0
2 0
4 0
6 0
8 0
V
V
 a
ft
e
r
 f
ir
s
t 
V
T
 (
c
m
3
)
107 
 
 
increasing change in VV shown in patients that receive additional VT (2.4±1.1 cm3/day, 
mean±stdev). Though calculating the change in VV requires multiple imaging sessions, 
this may prove to be a better indicator for when to schedule therapies to drain CSF than 
using VV alone. IVH patients receiving interventions, and certainly those receiving 
repeated VTs tend to have serial US images performed as part of clinical care. 
Furthermore, given the presented data, there is a high likelihood that even immediately 
after an initial VT even if the ventricles are stable or resolving, the VV could very well be 
above a threshold VV. This could be due to how much CSF can be drained at any given 
VT. Removing larger amounts of CSF occasionally results in infants transiently 
appearing ashen, and in some cases the drop in blood pressure, heart rate, and oxygen 
saturation is large enough that the patients require resuscitation after the procedure. 
Knowing how much the VV has increased following a tap might help better inform how 
much CSF to drain during subsequent interventions, in order to mediate adverse effects. 
Currently, it is not known how much CSF is optimal to drain and practices vary greatly 
between neurosurgeons; however, it is known that too little drained (<10 ml per kg of 
body weight) has no effect on ventricle size or ICP.19 
Previous mathematical estimates of VV based on 2D US images found that there was a 
significant difference between patients who received interventions and those who did 
not.20 This model received 2D US images spaced at regular angular intervals and a 
calculation involving solving an integral using cylindrical coordinates.21 While fairly 
simplistic to solve for those with a background in calculus and geometry, this is a non-
trivial level of knowledge to expect any given user to have. They found very good 
classification for patients who received treatment at 21 days of life using 30mL VV or 
greater as a threshold, whereas we found a lower threshold of 20.9 cm3 at 21-27 days 
(Table 5-2). Brann et al additionally found the change in VV was more predictive than 
VV alone with 100% sensitivity and specificity in both retrospective and prospective 
analysis,20 which concurs with the results of the present study. Admittedly, change in VV 
is a more challenging metric as it requires multiple 3D images. Additionally, it should be 
noted that although this previous work was performed in the late 1980s, these criteria 
never made it into clinical practice. Perhaps the relative difficulty in generating this 
measurement was the reasons this method did not translate into general clinical practice. 
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Perhaps there is less user error in the acquisition of a 3D US image than attempting to 
acquire 2D US images at equal angular spacing, and therefore, a 3D US approach is more 
realistic to translate into practice. 
Neonatal patients in the NICU are also at risk of having prenatal ventriculomegaly and 
this finding could be indicative of abnormalities such as neural tube defects or trisomy, 
which require follow up after birth. For these neonates with larger than normal ventricles, 
the rate of change in VV might be a better indicator of which patients have progressive 
VD and not just large ventricles which are stable in volume and are likely not to 
contribute to signs and symptoms of increases in ICP. Therefore, while our study did not 
include patients with prenatal ventriculomegaly, 3D US VV should be examined in a 
cohort of patients with this indication, as it could impact how these patients’ care is 
managed. 
The relative difficulty of generating VV through manual contouring a 3D US image 
might prove too difficult for translation into practice and this is a limitation of the current 
work. In light of this, work in our lab has been performed to speed up the segmentation of 
ventricles from the 3D US images. Both a semi-automated segmentation algorithm that 
can be used online at the bedside and an automated segmentation algorithm that can be 
run offline with no user input have been developed. 22,23 Further research is required to 
determine best practices in the implementation of these new methods; however, the semi-
automated segmentation has been integrated into our acquisition software and is ongoing 
a pilot study to test and improve upon the software. 
Additional limitations of this work include the use of VT as the initial intervention and 
not using 2D ultrasound linear measurements to determine interventional necessity. There 
is a wide variation between centers as far as what intervention is performed with lumbar 
puncture, ventricular taps, ventricular reservoirs, third ventriculostomy, subgaleal shunts 
and/or external ventricle drains all being used. Further confounding the use of image 
based metrics, 3D US might be easier or harder to obtain depending on the ease of access 
to the fontanelle after different types of treatments have been performed. Furthermore, 
the criteria for intervention in this study is based highly on clinical judgment with 
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multiple clinicians deciding on whether or not to tap; and not on quantitative 
measurements, which could hinder the reproducibility depending on the degree of clinical 
variation in practice. These limitations and questions of the validity of 3D US based VV 
in this patient population can only be elucidated in a larger study with more variation in 
clinical practice accounted for. 
As such, we have presented a potential clinical use for 3D US within the NICU. This type 
of imaging appears to be promising to be able to help generate management strategies for 
neonates at risk of PHVD and the subsequent potential brain damage from elevated ICP. 
A larger, multicenter study is required to generate guidelines as this will increase the 
patient pool and better account for differences in clinical practice that occur in different 
centers.  
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Chapter 6  
In this chapter, we discuss the potential for two-dimensional ultrasound based estimates 
of cerebral ventricle volumes to three-dimensional ultrasound estimates. In addition, the 
chapter discusses the differences between two-dimensional and three-dimensional 
ultrasound based ventricle volume estimates to predict interventions in neonates with 
post hemorrhagic ventricle dilatation. 
The contents of this chapter are in preparation to be submitted to the journal Acte 
Paediatrica in June 2017: J. Kishimoto, A. Fenster, D.S.C. Lee, S. de Ribaupierre. 
Estimating ventricle volume from lineal ultrasound measurements in neonates with post 
hemorrhagic ventricle dilatation: benefits and limitations. 
6 Estimating ventricle volume from lineal ultrasound 
measurements in neonates with post hemorrhagic 
ventricle dilatation: benefits and limitations 
6.1 Introduction 
While intraventricular hemorrhage (IVH), has been decreasing in prevalence in infants, 
this type of hemorrhage remains common among preterm born neonates.1 
Posthemorrhagic ventricle dilatation (PHVD) due to IVH often requires treatment and 
has a complicated management course with highly variable practices. 
The definitive treatment for severe, unresolved PHVD is the placement of a 
ventriculoperitoneal (VP) shunt, but its placement is often delayed several weeks to allow 
for the neonate to grow. VP shunt placement in these neonates, especially placement that 
requires revision surgery, is a well-known marker of poor outcomes.2 Currently, a clinical 
exam to test for signs and symptoms of increased intracranial pressure, as well as daily 
head circumference and transfontanelle brain ultrasound (US) are used in order to 
diagnose and manage PHVD.3 Several ultrasound-based measurements have been 
proposed to quantify ventricle dilatation, with the most commonly used being ventricle 
index, anterior horn width, and thalamo-occipital distance.3,4 
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Previous work with transfontanelle brain 3D US has been attempted in neonates.5-9 While 
this imaging technique gives similar measurements10 and diagnosis8,11 as 2D US, its 
clinical utility above and beyond 2D has not been established.  Recent studies have had 
success acquiring 3D US images of neonatal ventricles using commercial systems;5,6,8,10-
12 however, these transducers are not part of standard-of-care and must be purchased 
separately. Previously, we have developed a relatively low-cost 3D US system that can 
be modified to generate 3D US images from virtually any conventional 2D US system.13 
This system has been validated using test phantom ventricles of known volume13 and in 
vivo against the volume of CSF withdrawn during a tap as well as against MRI.14   
Previously, studies have been performed with small numbers of neonates to evaluate the 
relationship between ventricle volume (VV) and ventricle linear measurements. 
Comparison between MRI and ultrasound has found a strong correlation between linear 
measurements and ventricle volume (R2= 0.37-0.88); however, even stronger correlations 
were found in the same study when combining linear measurements (R2 = 0.94).15 3D US 
to 2D linear measurements have been investigated in two independent studies and were 
found to have correlations of 0.70-0.69 for anterior horn width, 0.65-0.62 for ventricle 
index and 0.72-0.44 for the thalamo-occipital distance.12,16 In one of the previously 
mentioned studies, an equation was proposed to accurately estimate ventricle volume 
using a significant multilevel mixed-effects linear regression model; however, this was 
developed using a small patient set (N=7).12  
In this paper, we test the equation proposed in Benavente-Fernandez et al.12 against an 
independent data set of 2D/3D US pairs, and in addition, we investigate the ability of 
other combinations of 2D US measurements to predict 3D US ventricle volume 
measurements. We also test the ability of the proposed equation calculated VV to detect 
whether a neonate received an intervention in a retrospective sample of 42 patient 
images. 
6.2 Methods 
After an initial diagnosis of IVH1 was made during a standard screening head ultrasound 
exam, preterm neonatal patients were enrolled with informed parental consent. As part of 
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a larger study investigating novel techniques (3D US, fMRI, and near infrared 
spectroscopy) 2D and 3D US images were acquired and all experimental protocols were 
performed in accordance with a protocol approved by the Research Ethics Board at the 
University of Western Ontario. The clinical team was blinded to all 3D US images during 
the course of the patients’ stay in the neonatal intensive care unit (NICU). The patients in 
this study were enrolled between April 2012 and February 2015. Imaging was performed 
1-2 times per week for the duration of the stay in the NICU until transfer to a secondary 
care center or discharge from the unit.  
6.2.1 Two-dimensional ultrasound 
Patients were imaged by a trained ultrasound technician using a standard 2D US 
technique, acquiring images in coronal and sagittal planes through the anterior fontanelle, 
with a few screen captures chosen by the technician over the relevant landmarks as per the 
standardized exam.17  Imaging was performed at the bedside in the NICU using an HDI 
5000 US system (Philips, Bothel WA) and a C8-5 curved array 5-8 MHz broadband 
transducer (Philips, Bothel WA). The 2D US exams required approximately 10-15 minutes.   
6.2.2 Two-dimensional ultrasound analysis 
The ventricle index (VI) and anterior horn width (AHW) for the left and right lateral 
ventricles and the thalamo-occipital distance (TOD) were recorded for all 2D US exams 
in the study. Measurements have been previously described in Davies et al.4 While two 
different radiologists made measurements in this study, these observers have previously 
shown agreement with intraclass correlation on neonatal head US measurements (ICC = 
0.96-0.99 for VI, AHW and TOD).18 
Given the improved correlations previously found by combining multiple linear 
measurements in both Horsch15 and Benavente-Fernandez12, we combined linear 
measurements as described in Table 1. The equation provided by Benavente-Fernandez to 
generate VV estimates from these linear 2D US measurements is:  
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Equation 6-1  
𝑉𝑉 =  −11.02 + 0.668 × 𝑉𝐼 + 0.817 × 𝐴𝐻𝑊 + 0.256 × 𝑇𝑂𝐷                
where linear measurements are in mm, VV is in cm3 and this is for a single lateral 
ventricle.12 
Table 6-1 - Abbreviations for combined linear 2D US measurements 
Abbreviation Combination of measurements 
VI*AHW the product of the ventricle index and the ipsilateral anterior horn width  
VI*TOD 
the product of the ventricle index and the ipsilateral thalamo-occipital 
distance 
AHW*TOD 
the product of the anterior horn width and the ipsilateral thalamo-occipital 
distance 
VI*AHW*TOD 
the product of the ventricle index, anterior horn width, and the thalamo-
occipital distance 
 
6.2.3 Three-dimensional ultrasound image acquisition 
3D US imaging was performed after placing the ultrasound transducer in a hand-held motorized 
housing that tilted the transducer about the axis at the probe tip for 8-10 sec.2 Motorized transducer 
housing and the clinical transducer is shown in Figure 6-1. 
116 
 
 
 
Figure 6-1 - Clinical 2D US transducer within the hand-held motorized transducer 
housing simulating a scan of a preterm sized mannequin. 
During image acquisition, 2D US images were acquired on a laptop computer as the 
motor tilted the transducer over 9.6 sec, and in-house software reconstructed the 3D US 
image in real-time as images were received into the computer.3,19 The total image 
acquisition lasted between 3-10 minutes and was highly dependent on patient motion. 
Technical details can be found in Kishimoto et al. (2013).13 This system has been 
validated both for geometric fidelity and volume measurements accuracy.13 
6.2.4 Three-dimensional ultrasound image segmentation 
The lateral ventricles were manually segmented offline by a trained observer in parallel 
sagittal slices with 1 mm gaps between adjacent slices. Each 3D ultrasound image 
required between 20-45 minutes to segment both lateral ventricles (10-25 minutes per 
ventricle) and the time depended on image quality and ventricle size. The 3D ultrasound 
imaging system and ventricle segmentation have been previously validated using 
phantom and patient images.2 An example of segmented ventricles from a patient with 
PHVD following IVH is shown in Figure 6-2.  
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Figure 6-2 - 3D US images of a pre-term neonate with PHVD. Manually segmented 
contour (left) and segmented surface on 3D ultrasound image cut through oblique 
planes (right). 
6.2.5 Data Analysis 
For the purpose of this paper, ventricle volume (VV) will describe a single lateral 
ventricle, and total ventricle volume (TVV) will describe the sum of the left and right 
lateral ventricles. The rate of change in TVV (ΔTVV) was recorded between each 
imaging time point for 3D US and equation based TVV and will be measured in cm3/day. 
The subscript eq will denote VV made from the equation, while the subscript 3DUS will 
denote VV from 3D US images. 
All analyses were performed using GraphPad Prism 6 (GraphPad Software, San Diego, 
CA). Statistical analysis was performed using SPSS v.20 (IBM, Armonk, NY). 
Correlations for regressions were performed between each combination of 2D US 
parameter and VVeq. Linear regression was used to test the proposed hypothesis that 2D 
US will be strongly correlated with 3D US VV.  A regression of R2>0.7 was considered 
strong. The significance of the regression was determined for an α  < 0.05. In addition to 
a Pearson correlation, a Bland-Altman plot was generated for VVeq and VV3DUS. 
Receiver operator curves (ROC) were generated between patients who did and did not 
require interventions using the TVVeq. In this study, for patients who had previous 
interventions, ROC analysis was performed using the TVVeq and ΔTVVeq between 
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patients who did not require further interventions, and those who required at least one 
additional intervention. For each parameter (TVVeq and ΔTVVeq) optimal threshold for 
intervention was estimated using the highest product of sensitivity and specificity. 
Additionally, the area under the ROC curve (AUC), sensitivity and specificity were 
calculated. Using a Bonferroni correction, two-sided t-tests were performed between all 
previously described compared groups of patients with an uncorrected α=0.05.  
6.3 Results 
6.3.1 Patient Characteristics 
Forty-two neonates with previously diagnosed IVH were enrolled in the study following 
informed parental consent.  Descriptions of all study patients are shown in Table 6-2. A 
total of 265 image sets (2D and 3D US images acquired on the same day) were collected 
for this study. All required US measurements were available providing 263 2D/3D US 
exams, with 2 missing TOD due to poor image quality. Enrolled patients had serial US 
exams performed between 25 and 42 2/7 weeks corrected gestational age with the median 
gestational age at imaging of 30 3/7 weeks. 
Table 6-2- Patient characteristics for neonates diagnosed with IVH and enrolled into 
the study 
Patient Characteristic 
N = 42 
Gestational age at birth  
(weeks ± SD) 
27.6 ± 3.0 
Birth weight (g ± SD) 1105 ± 450 
Sex (M/F) 30/12 
Patent ductus arteriosus (%) 30 (68%) 
antenatal steroids (%) 24 (37%) 
IVH Grade3  
(I/II/III/IV) 
7/17/10/8 
6.3.2 Ventricle Size Measurements from 2D and 3D ultrasound 
For ease of comparison to previous papers12, VV will be discussed in this section. VV is 
compared to 2D US measurements made on the same ventricle (ie.  right VI and right 
lateral ventricle VV are compared and left VI and left lateral ventricle VV are compared). 
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The median VI was 11.7 mm (range 5.5 - 39.1), the median AHW was 4.7 mm (range 1.1 
- 35.4), and the median TOD was 21.4 mm (range 8.3 - 44.9). Ventricle volume (VV3DUS) 
ranged between 1.1 - 55.3 cm3 with a median of 4.6 cm3. In general, the left lateral 
ventricles were larger than the right lateral ventricles with the average left VV3DUS of 8.9 
± 9.9 cm3 and the average right VV3DUS of 7.7 ± 7.9 cm
3. Moderate correlations were 
found between lateral VV3DUS and 2D US linear measurements as can be seen in Fig. 6-3 
(R2 = 0.43-0.67). Similar regressions were found between left and right sided 
measurements, so the reported regressions are the amalgamation of right and left 
ventricle measurements. 
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Figure 6-3 - Linear regression for 3D US generated VV and 2D US measurements 
when comparing ipsilateral 2D US measurements to left or right lateral ventricle 
volumes taken from 3D US.   
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6.3.3 Combining 2D US measurements to predict 3D US ventricle 
volume 
Combined 2D US linear measurements described in Table 6-1 had strong-moderate 
correlations with VV3DUS (R2=0.68-0.72) and are shown in Fig. 6-4. These correlations 
were all higher than using a single linear measurement, but were comparable to the 
highest performing single measurement, AHW (Fig. 6-3).   
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Figure 6-4 - Linear regression for 3D US generated VV and combined 2D US 
measurements when comparing ipsilateral 2D US measurements to left or right 
lateral ventricle volumes taken from 3D US. 
6.3.4 Equation based VV estimates compared to 3D US VV 
Strong correlations were found between the VVeq and VV3DUS (Fig. 6-5a) with R
2 = 0.71-
0.74. There was some bias detected for larger values of VV, where the VVeq was more 
likely to be outside the 95% CI (Fig. 6-5b).   
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Figure 6-5 - Equation-based VV compared to 3D US based VV. a) Linear 
regressions comparing 2D US equation based lateral VV to 3D US lateral VV. b) 
Bland-Altman plot comparing equation based VV and 3D US based VV (dashed 
lines are the 95% confidence intervals). 
6.3.5 Determining whether PHVD received interventions – 
retrospective study using equation-based ventricle volumes 
Previous papers have examined this patient population and used thresholds for 
intervention based on total ventricle volume (TVV) (sum of left and right lateral 
ventricles), so for ease of comparison, the results in this section will be given in TVV.20,21 
Previously, we had shown that TVV from 3D US was predictive of both whether a 
neonate received an initial intervention and whether or not follow-up intervention was 
received with very high sensitivity and specificity.21 Of the 42 neonates in the study, 7 
had documented interventions. 
6.3.5.1 Initial intervention requirement 
For initial intervention, we examined the TVV of neonates with PHVD at the maximum 
TVVeq during the first three weeks of life. Patients who received interventions had higher 
TVVeq than those who did not receive interventions with no overlap in TVVeq between 
the groups (Fig. 6-6a). There was a high sensitivity and specificity of 100% (Fig. 6-6a,b) 
using a threshold of 27.6 cm3 to determine whether the patient was one who had received 
an intervention or not. The maximum ΔTVVeq over this time period was slightly less 
specific (91.7%), but as sensitive (100%) when using a threshold of 2.14 cm3/day (Fig. 6-
6c,d). 
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Figure 6-6 a) Box and whisker plot, and b) ROC curve describing equation based 
TVV to predict whether an initial intervention was received by a neonate with 
PHVD. c) Box and whisker plot, and d) ROC curve describing the equation-based 
rate of change in TVV to predict whether an initial intervention was received by a 
neonate with PHVD. 
6.3.5.2 Serial Interventions received 
Since we had previously observed that TVV3DUS measurements were able to predict 
whether a neonate received serial interventions,21 we investigated the utility of the TVVeq 
to do the same. 
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Figure 6-7 – a) Box and whisker plot, and b) ROC curve describing equation based 
TVV to predict whether a repeat intervention was received by a neonate with 
PHVD. c) Box and whisker plot, and d) ROC curve describing the equation-based 
rate of change in TVV to predict whether a repeat intervention was received by a 
neonate with PHVD. 
We used the TVVeq to predict interventional necessity in patients who previously had at 
least one VT and found that this measurement was not very sensitive, but had high 
specificity (50% sensitivity and 100% specificity) if a high enough threshold was used 
(Threshold 50.5 cm3, Figure 6-7a). We also used the ΔTVVeq to predict whether repeat 
interventions were received and also found that it was not very sensitive or specific (75% 
sensitivity and 60% specificity) (Threshold 1.2 cm3/day, Figure 6-7c). 
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6.4 Discussion 
We analyzed 263 2D/3D US image sets from 42 neonates with PHVD and found 
moderate to strong correlations between 2D US linear measurements and VV3DUS. These 
correlations increased slightly when multiple 2D US measurements were included, which 
has been previously shown in 3D US12 and MRI15.  
The novelty of this study was the use of TVVeq
12 to predict whether or not a neonate with 
PHVD would receive an interventional VT. Using TVVeq, we were able to 
retrospectively predict with very high sensitivity and specificity (100%), which patient 
would receive an initial intervention, which was similar to previously reported values we 
found using estimates of TVV3DUS and a method of acquiring TVV estimates from 
regularly spaced 2D US (cylindrical coordinate method).16,20 Furthermore, we used the 
TVVeq to predict whether neonates with PHVD who previously had at least one 
intervention would receive additional interventions. Deciding when to perform additional 
interventions when ventricle size is already large is challenging, as even immediately 
post-intervention, the size of the ventricles can be above the threshold to intervene (such 
as when the VI 97+4mm mark is used).3 We found that the TVVeq was not very sensitive, 
but could be fairly specific if a high enough threshold was used (50% sensitivity and 
100% specificity for a threshold 50.5 cm3, Fig 6-7). In comparison, TVV3DUS had 75% 
sensitivity and 71.4% specificity using 20.9 cm3 as a threshold.21 Comparisons between 
these three studies’ thresholds can be found in Table 6-3.  
Table 6-3 - Equation based thresholds, sensitivity, and specificity compared to 
previous literature for initial intervention and repeated interventions based on 
estimated ventricle volumes. Equation 6-1 (eq)12, CC – cylindrical coordinates20, 3D 
US based. CC TVV did not report specificity. 
Intervention  Method Threshold Sensitivity (%) Specificity (%) 
Initial TVVeq 27.6 cm
3 100 100 
 CC TVV 30 mL 90  
 TVV3DUS 20.9 cm
3 100 100 
     
Serial TVVeq 50.5 cm
3 50 100 
 TVV3DUS 45.5 cm
3 75 71 
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We also used the ΔTVVeq to predict initial and serial interventional necessity. While in 
general, in all studies ΔTVV was comparable or slightly worse than using TVV to 
differentiate between neonates who received at least one intervention and those who 
never had an intervention, previously we had found ΔTVV3DUS to be more predictive of 
serial interventions than TVV3DUS.
21 We found that ΔTVVeq was not very sensitive or 
specific to identify patients who received serial interventions and those who had 
resolution after a single intervention (75% sensitivity and 60% specificity, threshold 
1.2cm3/day, Fig. 6-7). Comparisons between the three studies measures of ΔTVV for 
initial and serial interventions can be found in Table 6-4. 
Table 6-4 - equation based thresholds, sensitivity and specificity compared to 
previous literature for initial interventions and repeated intervention based on rate 
of change in ventricle volume. Equation 6-1 (eq)12, CC – cylindrical coordinates20, 
3D US based. 
Intervention  Method Threshold Sensitivity (%) Specificity (%) 
Initial TVVeq 2.14 cm
3/day 100 91.7 
 CC TVV 0.55 mL/day 98  
 TVV3DUS 2.2 cm
3/day 100 100 
     
Serial TVVeq 1.2 cm
3/day 75 50 
 TVV3DUS 0.3 cm
3/day 100 100 
Given the variability in linear measurements performed on 2D US, TVVeq, as a product 
of 2D US measurements would have even higher variability than any one 2D US 
measurement. Perhaps these results are not surprising in that context. For example, in 
some patients who are undergoing ventricle dilatation, the TVVeq will show a decline in 
TVVeq from one day to the next where this is not seen in TVV3DUS, or vice versa (See 
Fig. 6-8). 
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Figure 6-8 - Equation based (blue) and 3D US based TVV estimates in two patients 
who eventually required surgical intervention for PHVD. Both patients had 
bilateral grade III IVH and received multiple VT during their stay in the NICU. 
While not performed in this study, determining how the inter- and intra-reader variability 
of 2D US measurements effects the TVVeq variability is necessary to determine how 
much confidence a clinician can have in this type of measurement. The variance in VVeq 
can be calculated analytically if the variance (var) and co-variance (covar) of the three 2D 
US measurements is known: 
Equation 6-2:  
𝑉𝑎𝑟𝑉𝑉𝑒𝑞 =  𝑣𝑎𝑟𝑉𝐼  +  𝑣𝑎𝑟𝐴𝐻𝑊 +  𝑣𝑎𝑟𝑇𝑂𝐷 +  2(𝑐𝑜𝑣𝑎𝑟𝑉𝐼,𝐴𝐻𝑊 + 𝑐𝑜𝑣𝑎𝑟𝑉𝐼,𝑇𝑂𝐷 + 𝑐𝑜𝑣𝑎𝑟𝐴𝐻𝑊,𝑇𝑂𝐷) 
However, previously published studies of variance4,22,23 in 2D US linear measurements 
have not published the covariance between the measurements, and this is required to 
determine the variance in VVeq as it is known that the 2D US variables are not 
independent of one another (they are linearly correlated, as was described in Benavente-
Fernandez et al.12). Our single center study only had two observers making one 
measurement per patient (vs repeated measurements), and as such is very limited in what 
kind of variance we can report. A study with more representation from different 
observers would be required to report the inter-observer variance in VVeq. In order to 
calculate intra-observer variance of VVeq, a single observer would need to make multiple 
measurements on the same patient imaging sets (e.g. measure 20 patients 5 times each 
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with days in between each measurement), which was not performed in this study. Ideally, 
multiple observers would be involved to be able to delineate between inter- and intra-
observer variance. We do not have enough expert observers (radiologists) involved in this 
project to accomplish this, which is a limitation of the current work. 
Additional limitations of the present study include being a single center study with a 
small sample of intervention patients, although this study does reinforce results found in 
another completely independent single center study.12 However, the work on using TVV 
to assist with management of interventional therapies for patients with PHVD will need 
to be repeated in a multi-center study before recommendations can be made to use TVV 
in clinical practice.  
Another limitation of the study is the use of manual segmentations to generate VV3DUS as 
these are very time consuming and can only be performed by a relatively skilled 
technician or clinician. While we have developed and validated semi-automated24 and 
automated25 techniques for segmenting neonatal ventricle volumes, this is just beginning 
to be implemented into the image acquisition system at our center and is not yet 
commercially available.  
We have presented a potential clinical use for both 2D US and 3D US-based VV within 
the NICU while independently validating results from a previous study. In addition to the 
validation study, TVVeq seems to be able to predict initial intervention in neonates with 
PHVD, and TVV3DUS seems to be able to predict both initial and repeated interventions. 
This type of imaging appears to be promising to be able to help generate management 
strategies for neonates at risk of PHVD and the subsequent potential brain damage from 
elevated ICP. A larger, multicenter study is required to generate guidelines as this will 
increase the patient pool and better account for differences in clinical practice that occur 
in different centers.  
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Chapter 7  
The final chapter of this thesis reexamines the research objectives and provides a 
summary of findings for Chapters 2-6. The chapter addresses the limitations of the study, 
and potential solutions. Additionally, this chapter will illustrate some of the potential 
future directions for this work. 
7 Conclusions and Future Directions 
7.1 Overview of Rationale and Research Questions 
Clinical 2D ultrasound remains a very important part of the diagnosis and management of 
IVH and resulting PHVD. While ultrasound is very good at detecting IVH and PHVD, 
there are ongoing questions regarding the type of treatment that is most effective and 
when to perform interventions. As such, clinical 2D US cannot differentiate between 
neonates with PHVD who will receive interventions versus those that will undergo 
spontaneous resolution of PHVD. 
Accordingly, the overarching objective of this thesis was to develop a 3D US system to 
detect when a neonate will require interventional procedures and surgery with greater 
confidence than currently used clinical US techniques. Five objectives were focused on: 
1) the development and in vitro validation of the 3D US system to measure the volume of 
the ventricles in neonates along with intra- and inter- observer variability measurements 
using patient images (CHAPTER 2); 2) the in vivo validation of ventricle volume 
measurements from this 3D US system (CHAPTER 3); 3) the comparison of 3D US 
based ventricle volumes to 2D US measurements of the lateral ventricles (CHAPTER 4); 
4) using retrospective 3D US based ventricle measurements of ventricle volume to 
predict interventional requirement and resolution (CHAPTER 5); comparing 2D US 
based estimates of ventricle volume to 3D US VV and using 2D US based estimates of 
ventricle volumes predict interventional requirement and resolution (CHAPTER 6). 
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7.2 Summary and Conclusions 
In Chapter 2, we described the development and in vitro validation of a 3D US system 
using neonatal head phantom experiments. The system was found to be geometrically 
accurate in all three orthogonal directions based on comparison to known manufactured 
distances of 10 mm with no statistically significant difference found (p>>0.5, α=0.05). 
Additionally, the 3D US-based volume measurement of a ventricle-like phantom (50 cm3 
and 290 cm3) was compared to MRI and water displacement, and results failed to show a 
statistically significant difference when compared to the other two modalities using 
ANOVA (p>> 0.3, α=0.05).  
The minimum detectable difference (MDD) is a measure of how much ventricle volume 
must change in order to statistically determine whether a change as occurred above the 
level of measurement variance. An intra- and inter- observer study in three neonates 
found MDD to be 0.63 cm3, much less than the previously determined 2 cm3/day increase 
in VV seen in patients with PHVD who received interventions.1 This validation study 
indicated that 3D US-based VV could be usable in a clinical setting to monitor patients 
with PHVD.  
In Chapter 3, we validated the 3D US system further in in vivo experiments with 18 
patients. The comparison between CSF drained by a ventricle tap and the difference in 
measured ventricle volume before and after the tap was strongly correlated (R2 = 0.92). 
The comparison between 3D US and MRI showed very high correlation (R2 = 0.99); 
however, 3D US ventricle volumes appeared to be lower than MRI. This latter finding 
was followed up by investigating whether certain regions of the ventricles were 
systematically not being segmented in US using a manual, point-=based 3D US to MRI 
registration. Our results showed that the mid-line ventricle structures in patients with 
severe ventricle dilatation are not visualized in 3D US, though further investigation is 
required. These findings suggest that direct MRI to 3D US ventricle volume comparison 
should not be made without accounting for image based bias, however, US to US 
ventricle volumes comparisons appear to be valid.  
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In Chapter 4, we compared 3D US ventricle volumes to linear measurements made using 
2D US as previously described in other clinical papers2-4 in 42 patients with IVH. Our 
results showed that there was a trend towards larger 2D US measurements reflecting 
larger 3D US VV (R2 = 0.69-0.44). However, when examining changes in measurements 
from successive imaging sessions from the same patient, there was no strong correlation 
between changes in linear 2D measurements and changes in VV (R2 = 0.13-0.02). 2D US 
measurements might not be accurately reflecting a change in ventricle size due to 
measurement error, plane selection error, and even that the ventricles are not expanding 
in the area being measured. These results are important, as PHVD is a progressive disease 
and serial US sessions are often acquired, with changes in qualitative and quantitative 
estimates of ventricle size impacting patient management. If the currently used imaging 
metrics are not sufficiently accurate to detect changes in ventricle size from day to day, 
then this would explain the lack of adoption of image-based thresholds for intervention. 
In Chapter 5 we describe the results of a retrospective pilot study attempting to determine 
3D US volume-based threshold for interventional ventricle tap in 38 neonates with IVH. 
3D US VV was able to characterize patients who required at least one intervention with 
very high sensitivity and specificity (>90%). The change in VV was able to allow 
determination between whether a follow-up to intervention was required, or if the patient 
had at least intermittent resolution of PHVD with very high sensitivity and specificity, in 
fact, no patient in the study was misclassified using a threshold of 0.31 cm3/day. These 
results are sufficient to suggest that a larger study is indicated to develop image-based 
guidelines for these patients. 
In Chapter 6 we were able to independently verify a previously reported method to 
estimate ventricle volume using 2D US measurements.5 We found strong correlations 
(R2=0.74) between 2D US estimates of VV compared to 3D US VV. In addition to this, 
we used 2D US estimates of VV to predict whether a neonate with PHVD will receive an 
intervention, as this had not been performed in the previous study by Benavente-
Fernandez et al.5 Equation based VV was able to predict whether a neonate received an 
initial intervention using a threshold of 27.6 cm3 with very high sensitivity and specificity 
(100%). The equation generated TVV estimates were not able to predict that additional 
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interventions would be received by neonates who had previously had one intervention as 
the highest sensitivity was 50% and required a very high threshold (50.5cm3).  
In summary, we have developed and validated a 3D US system for imaging the brains of 
preterm neonates, compared the system to currently used clinical measures of ventricle 
size, and performed a small clinical pilot study with promising results.  
7.3 Limitations 
In this section, some of the limitations of the studies presented in Chapters 2-6 are 
discussed. While the study specific limitations are presented in the discussion section of 
the respective Chapters, we will detail more general limitations common to Chapters 2-6 
in this section. 
7.3.1 General Limitations 
The major limitation with this 3D US system is that it is still a fairly large peripheral 
addition to a 2D US unit. While large strides have been made to make the system have a 
smaller footprint, there is definitely room for improvement, for instance, by mounting it 
onto the 2D US system so that it is easier to maneuver in a tightly packed NICU 
environment.  
Another limitation is the amount of brain that can be interrogated in a single scan. Since 
our maximum scan angle is 70 degrees, in patients with severe PHVD, the entire ventricle 
system cannot be captured in a single scan (Fig. 7-1). This limits segmentation 
algorithms, as atlas based initialization takes much longer when the ventricles could be in 
multiple images. Additionally, in a small number of extremely severe cases of PHVD, a 
70-degree scan was insufficient to scan even a single lateral ventricle. 
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Figure 7-1 – 3D US images of a neonate with PHVD. This patient had ventricles 
enlarged enough that a single scan could not fully encompass the entire ventricle 
system, but each lateral ventricle could be imaged separately. a) right lateral 
ventricle b) left lateral ventricle with some overlapping regions within the middle 
portion of the brain/ventricle system. 
The majority of the 3D US segmentations were made by a single trained user at a single 
center institute. The validity of this technique can only be fully realized if these results 
are confirmed by additional users at multiple centers.  
In addition to this, some patients were not imaged due to handling concerns by the 
parents or nurses. While it would have been feasible to perform the imaging if necessary 
for a clinical reason, as the 3D US was only being performed for research purposes, there 
were a few patients with complicated medical courses in the NICU who were not 
represented in this data set. While the ‘skipped’ patients’ PHVD was not particularly 
severe, and none of the ‘skipped’ patients had interventional VT or VP-shunts, this could 
potentially cause some bias in this sample.  
7.4 Future Directions 
7.4.1 Prospective Prediction of VT using 3D US thresholds 
The next step that will be occurring is a prospective study performed using thresholds 
proposed in this thesis. At our center, enrolled neonates with PHVD will be monitored 
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using the developed 3D US system and VV will be measured using semi-automated 
segmented contours of the ventricles. Clinicians will be unblinded to the 3D US data and 
will make decisions based on current clinical practice with the addition of the 3D US data 
and thresholds.  
7.4.2 Multi-center study using 3D US for interventions 
3D US VV must be used in a multi-center study in order to gather a large enough sample 
size and obtain a variation of clinical practice in managing PHVD. As 3D US is 
becoming a far more accessible modality, we expect that this study could be performed in 
the near future.  
7.4.3 Image Stitching 
For the patients with severe PHVD, a single imaging volume is insufficient to capture the 
ventricles. As such, multiple 3D US images are acquired to fully capture the ventricles 
and surrounding brain regions of interest. Stitching these images into a large ‘panoramic’ 
3D image will allow better visualization of the ventricles over time as well as allow for 
the creation of stitched images taken from different fontanelles. For example, images 
acquired from the posterior fontanelle allow for better visualization of the posterior horns 
and the cerebellum, which is currently not imaged with this system due to the poor 
visualization of the majority of the ventricle system. If the anterior fontanelle view could 
be combined with the posterior horn view, the images could allow for easier diagnosis of 
a wider variety of brain abnormalities.  
We have developed a landmark-based registration similar to that used in the discussion 
section of Chapter 3 and are working towards generating an automated stitching program 
based on image-based registration of the midline overlap of images acquired through the 
anterior fontanelle. 
7.4.4 Diagnosing VP-Shunt failure and requirement 
Infantile hydrocephalus is a highly variable disease with numerous causes outside of 
IVH. These causes can be congenital, such as from spina bifida, or from genetic 
abnormalities, but also can be acquired after meningitis.6 Infantile hydrocephalus from all 
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causes occurs in about 1.1 in 1000 infants.7 For many of these patients, neurosurgical 
insertion of a VP shunt that constantly drains CSF into the abdomen is used to prevent 
further brain damage and alleviate symptoms of increased intracranial pressure (apnea, 
bradycardia). Despite the widespread clinical use of VP shunts, 31% of shunts will fail 
within the first year and require revision surgery.8 Often shunt failure only becomes 
apparent when clinical symptoms occur, such as when an infant is overly irritable, 
lethargic, nauseous, ataxic, and has failure to thrive. Especially in infants who are not 
able to communicate with their caregivers that they have a headache, these symptoms are 
not specific to VP-shunt failure. 
3D US can be performed in a neurosurgical clinic both before VP shunt insertion and at 
follow-up for much less than the cost of other 3D medical images, and in fractions of the 
time in order to measure changes in the ventricle volume. Given that the fontanelle does 
not close until 18 months of age, our 3D US system would provide non-invasive images 
of the ventricles at the time when acute shunt failure is likely. Given that patients with 
working shunts should undergo decreased CSF accumulation, we hypothesize that 
ventricle volumes measured by 3D head US will detect acute shunt failure as continued 
or sudden increases in ventricle volume at follow-up. Additionally, the 3D US images 
might be able to detect subdural hemorrhage/hematoma, which is a condition that can 
occur due to over-drainage of CSF. Other than the hemorrhage, over-drainage can lead to 
slit-ventricle syndrome, which can be a chronic cause of migraines in these patients. We 
have performed 3D US in the neurosurgical follow-up clinic up in 5 patients with 
hydrocephalus to assess shunt function and found that this intervention seems entirely 
feasible to study, though to date we have not seen acute shunt failure. 
Some infants with hydrocephalus will not have shunts implanted until clinical symptoms 
appear after some skull sutures have closed. These infants present with enlarged 
ventricles during the peri-neonatal period. We hypothesize that infants with progressive 
increases in ventricle volume during the peri-neonatal period will go on to require shunts 
once all skull sutures have closed, while those with decreases or stabilization in ventricle 
size will not require further interventions. Assessing these at-risk patients during normal 
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follow-up appointments should provide good indicators towards which of these patients 
will require VP-shunts later in life. 
7.4.5 Using imaging to as a priori information for near infrared 
spectroscopy 
Although not in the body of this thesis, near infrared spectroscopy (NIRS) measurements 
were taken on some of the same days as 3D US imaging was performed. Generally, NIRS 
measurements are associated with oxygenation measurements due to the difference in 
NIRS signal from oxy- and deoxy-hemoglobin (Fig. 7-2).  
 
Figure 7-2 Differing near infrared absorption spectra of oxygenated hemoglobin 
(HbO) and deoxygenated hemoglobin (Hb) 
However, due to the multi-modality nature of the study, we were able to detect ‘ventricle 
contamination’ of the NIRS signal in patients with IVH.9 Specifically, we showed 
qualitatively that there was noticeable signal contamination stemming from what 
appeared to be decrease in brain mantle thickness due to compression from PHVD (Fig. 
7-3). It was proposed that this contamination is from the ventricles where blood 
breakdown products appear to be similar to deoxy-hemoglobin, as well as from decrease 
photon scatter in CSF in comparison to tissues.  
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Figure 7-3 Smaller cortical mantel thickness after PHVD as seen on a coronal 
ultrasound image. 
Neonates and infants with PHVD would likely be the patients that benefit the most from 
neuromonitoring during the neonatal period in order to better manage their condition 
through therapies and surgeries aimed at alleviating elevated ICP. Since most NIRS 
systems and algorithms assume homogenous tissue as the region being interrogated by 
the light, and these patients appear to violate those assumptions, a better model is 
required to produce accurate and reproducible NIRS measurements in patients with 
PHVD.  A two-layered model, including a top layer for ‘tissue’ and a bottom layer for 
‘CSF’ could solve this issue. 3D ultrasound would allow for a model of the brain to be 
generated and to determine how thick the top layer should be. As such, this imaging data 
could provide the necessary a priori information to develop a two-layer model of the 
brain/ventricles and could assist in analyzing NIRS signal from neonates with PHVD in 
order to more accurately monitor brain oxygenation despite variations in brain thickness 
over time. 
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Currently, a study is being performed using Monte Carlo simulations on a two-layered 
model with various tissue thicknesses to determine if this previously acquired NIRS/3D 
US data can be analyzed more appropriately.10 
7.5 Significance and Impact 
Management of PHVD is a complex process with outcomes often not known for years 
until the patient reaches school age. Current monitoring is based on clinical exams and 
2D US images, and while able to diagnose the disease, these methods are not specific 
enough to generate threshold-based guidelines for treatment past an initial intervention.  
This thesis illustrates the potential for 3D US-based ventricle volumes to be used to 
generate a more specific criterion for interventions and allow for more precise 
monitoring. The potential for improved outcomes for these children based on better 
evidence and more clinician confidence could result in less delayed treatments. While 
still unknown, this thesis will allow for a better definition of ‘early’ treatment (i.e., when 
the ventricle’s rate of dilatation is over a certain threshold), and could directly lead to a 
rigorous study on whether or not earlier treatment can lead to better outcomes.  
7.6 References 
1. Brann, B.S.t., Qualls, C., Papile, L., Wells, L. & Werner, S. Measurement of 
progressive cerebral ventriculomegaly in infants after grades III and IV 
intraventricular hemorrhages. The Journal of pediatrics 117, 615-621 (1990). 
2. Levene, M.I. Measurement of the growth of the lateral ventricles in preterm 
infants with real-time ultrasound. Archives of disease in childhood 56, 900-904 
(1981). 
3. Davies, M.W., Swaminathan, M., Chuang, S.L. & Betheras, F.R. Reference 
ranges for the linear dimensions of the intracranial ventricles in preterm neonates. 
Archives of disease in childhood. Fetal and neonatal edition 82, F218-223 (2000). 
4. McLean, G., et al. Measurement of the lateral ventricles in the neonatal head: 
comparison of 2-D and 3-D techniques. Ultrasound in medicine & biology 38, 
2051-2057 (2012). 
5. Benavente-Fernandez, I., Lubian-Gutierrez, M., Jimenez-Gomez, G., Lechuga-
Sancho, A.M. & Lubian-Lopez, S.P. Ultrasound lineal measurements predict 
ventricular volume in posthaemorrhagic ventricular dilatation in preterm infants. 
Acta paediatrica (Oslo, Norway : 1992) 106, 211-217 (2017). 
6. Tully, H.M. & Dobyns, W.B. Infantile hydrocephalus: a review of epidemiology, 
classification and causes. European journal of medical genetics 57, 359-368 
(2014). 
142 
 
 
7. Munch, T.N., et al. Familial aggregation of congenital hydrocephalus in a 
nationwide cohort. Brain : a journal of neurology 135, 2409-2415 (2012). 
8. Stein, S.C. & Guo, W. Have we made progress in preventing shunt failure? A 
critical analysis. Journal of Neurosurgery: Pediatrics 1, 40-47 (2008). 
9. Kishimoto, J., et al. Evidence of ventricular contamination of the optical signal in 
preterm neonates with post hemorrhagic ventricle dilation. Vol. 9319 931908-
931908-931909 (2015). 
10. McLachlan, P., et al. Development of a NIRS method to quantify cerebral 
perfusion and oxidative metabolism in preterm infants with post-hemorrhagic 
ventricle dilation (Conference Presentation). Vol. 10054 100540S-100540S-
100541 (2017). 
 
 
143 
 
 
APPENDIX 
Appendix A – Permission for Reproduction of Scientific 
Articles 
Appendix A-1 – Permission to use scientific article in Chapter 2 
 
 
 
 
144 
 
 
Appendix A-2 - Permission to use scientific article in Chapter 3 
 
4/28/2017 Mail —jkishimo@uwo.ca 
145 
 
 
Appendix A-3 - Permission to use scientific article in Chapter 4 
 
 
146 
 
 
Appendix B - Health Science Research Ethics Board 
Approval Notice 
Appendix B4- Research Ethics Board Approval Notice 
 
147 
 
 
Curriculum Vitae 
EDUCATION 
 
Sept 2011- Doctor of Philosophy 
summer 2017 Department of Medical Biophysics 
 The University of Western Ontario, London, Ontario, Canada 
Thesis: Three-dimensional ultrasound for the management of post-
hemorrhagic ventricle dilatation 
Supervisors: Dr. Sandrine de Ribaupierre and Dr. Aaron Fenster 
 
Sept 2007- Bachelor of Medical Science 
April 2011 Honours Specialization Medical Biophysics (Medical Science 
Concentration) 
 The University of Western Ontario, London, Ontario, Canada 
 Thesis: The development of a bi-axial dynamic strain platform for live cell 
microscopy  
Supervisors: Dr. David Holdsworth and Dr. S. Jeffery Dixon 
 
RESEARCH POSITIONS 
 
Sept 2011- Graduate Research Assistant, Doctoral 
Summer 2017 Department of Medical Biophysics 
 The University of Western Ontario, London, Ontario, Canada 
Supervisors: Dr. Sandrine de Ribaupierre and Dr. Aaron Fenster 
Project: New technologies in the management of post hemorrhagic 
hydrocephalus 
 
May 2011- Summer Research Student 
Aug 2011 Robarts Research Institute, London, Canada 
  Supervisors: Dr. David Holdsworth and Dr. S. Jeffery Dixon 
Project: Vibration and high speed microscopy to study 
mechanotransduction in osteoblasts 
 
Sept 2010- Forth Year Undergraduate Honours Thesis Student 
April 2011 Robarts Research Institute, London, Canada 
  Supervisors: Dr. David Holdsworth and Dr. S. Jeffery Dixon 
  Project: Development of a bi-axial strain platform for live cell microscopy 
  
RESEARCH SPECIFIC SCHOLARSHIPS AND AWARDS 
 
A. Scholarships 
2015-2016 Ontario Graduate Scholarships  
148 
 
 
• A merit based scholarship (based on academic standing) that encourages 
excellence in graduate studies and is available to students in all disciplines 
$15,000 
2014  Internal Research Fund Studentship  
• Awarded to a student supervised by a member of London Health Sciences 
center or St. Joseph’s hospital in a medical science related field. Awarded 
based on research achievement and proposal design to support stipend 
$15,000 
2016-2011 Western Graduate Research Scholarship  
• Awarded for entering and maintaining an overall average of 80% during 
graduate studies to support tuition $1,500-$2,900 per term 
2011  Summer Research Studentship - CIHR JuMP (Joint Motion Program) 
• Awarded to a summer research student involved in musculoskeletal research 
for stipend support $5000 
2008  Evelyn Moxley Bursary 
• For achieving over 80% cumulative average in undergraduate studies in 
addition to financial need $500 
2007-2010  Queen Elizabeth II Aiming for the Top Scholarship  
• For achieving over 80% cumulative average in undergraduate studies  
$2,885 per year 
2007  Elgin St. Thomas Medical Scholarship  
• Awarded to a single outstanding high school student within Elgin county 
entering into a medical related undergrad program $1,000 
 
B.  Awards 
2016   Cum Laude Abstract – Imaging Network Ontario.  
 
2014  CIHR Travel Award to Canadian Student Health Research Forum.  
Winnipeg, MB. $833 
 
2014 First place, Oral Presentations – Clinical. Paediatric Research Day, 
London, ON. $200 
 
2014  Alfred Jay Award for Translational Research. A.C. Burton Day – 
Medical Biophysics. $1500 
 
2014  First place, Poster Competition - Imaging Network Ontario. $300 
 
2014 Second place, Platform competition. Oral Presentation. London Health 
Research Day $600 
 
149 
 
 
2013 CHRI Translational Research Award. Oral Presentation. Paediatric 
Research Day. $500 
 
2013 Cum Laude Poster Presentation. SPIE Medical Imaging 2013. 
Ultrasonic Imaging, Tomography, and Therapy Session. Orlando, FL, 
USA.  
 
SCIENTIFIC REVIEWER 
Journal of Medical Imaging 2015, 2016 
 
PUBLICATIONS AND PRESENTATIONS 
 
A. Referred Journal Manuscripts (9 Published, 2 In Review) 
In review 
1. J. Kishimoto, A. Fenster, D.S.C. Lee, S. de Ribaupierre. Quantitative 3D head ultrasound 
measurements of ventricle volume to determine thresholds for preterm neonates requiring 
interventional therapies following PHVD. (Scientific Reports) 
2. P. McLachlan, J. Kishimoto, M. Diop, D. Milej, S. de Ribaupierre, D.S.C. Lee, K. St. 
Lawrence. Investigating the Effects of Cerebrospinal Fluid Removal on Cerebral Blood Flow 
and Oxidative Metabolism in Infants with Post-Hemorrhagic Ventricular Dilatation (Pediatric 
Research) 
Published 
1. W. Qiu, Y. Chen, J. Kishimoto, S. de Ribaupierre, B. Chiu, A. Fenster, J. Yuan. 
Longitudinal Analysis of Pre-term Neonatal Cerebral Ventricles from 3D Ultrasound Images 
Using Spatial-Temporal Deformable Registration. IEEE Trans. Med. Imaging. 36(4):1016-
1026 
2. J. Kishimoto, S. de Ribaupierre, F. Salehi, W. Romano, D.S.C. Lee, A. Fenster. Preterm 
neonatal lateral ventricle volume from 3D ultrasound is not strongly correlated to 2D 
ultrasound measurements. J. Med. Imag. 3(4) (2016) 046003 
3. W. Qiu, Y. Chen, J. Kishimoto, S. de Ribaupierre, B. Chiu, A. Fenster, J. Yuan. Automatic 
Segmentation Approach to Extracting the Neonatal Cerebral Ventricles from 3D Ultrasound 
Images. Medical Image Analysis 35 (2016) 181-191 
4. J. Kishimoto, A. Fenster, D.S.C. Lee, S. de Ribaupierre. In Vivo Validation of a 3D 
Ultrasound System for Imaging the Lateral Ventricles of Neonates. Ultrasound in Medicine 
and Biology 42(4) (2016) 971-79. 
5. Y. Chen, W. Qiu, J. Kishimoto, Y. Gao, R. Chan, S. Ribaupierre, A. Fenster, B. Chiu. A 
framework for quantification and visualization of segmentation accuracy and variability in 
3D lateral ventricle ultrasound images of preterm neonates. Medical Physics 42(11) (2015) 
6387-405. 
150 
 
 
6. M. Diop, J. Kishimoto, V. Toronov, D. S. C. Lee, K. St. Lawrence. Development of a 
combined broadband near-infrared and diffusion correlation system for monitoring cerebral 
blood flow and oxidative metabolism in preterm infants. Biomedical Optics Express. 6(10) 
(2015) 3907-3918 
7. W. Qiu, J. Yuan, M. Rajchl, J Kishimoto, Y. Chen, S. de Ribaupierre, B. Chui, A. Fenster 
3D MR Ventricle Segmentation in Pre-Term Infants with Post-Hemorrhagic Ventricle 
Dilatation (PHVD) Using Multi-Phase Geodesic Level-Sets. NeuroImage 118 (2015) 13–25. 
8. W. Qiu, J. Yuan, J Kishimoto, J. McLeod, Y. Chen, S. de Ribaupierre, A. Fenster. User-
Guided Segmentation of Preterm Neonate Ventricular System from 3D Ultrasound Images 
Using Convex Optimization Ultrasound in Medicine and Biology. 41(2) (2015) 542–556. 
9. J. Kishimoto, S. de Ribaupierre, R. Mehta, K. St. Lawrence, D.S.C. Lee, A. Fenster. 3D 
ultrasound system to investigate intraventricular hemorrhage in preterm neonates. Phys. Med. 
Biol. 58 (2013) 7513-7526.  
 
B. Published Refereed Conference Papers (15) 
 
1. J. Kishimoto, A. Fenster, F. Salehi, W. Romano, D.S.C Lee, S. de Ribaupierre. Quantitative 
head ultrasound measurements to determine thresholds for preterm neonates requiring 
interventional therapies following intraventricular hemorrhage.  SPIE Medical Imaging 2016. 
February 27 – March 3 2016, San Diego, CA (Oral Presentation) 
2. W. Qiu, J. Yuan, J. Kishimoto, Y. Chen, M. Rajchl, E. Ukwatta, S. de Ribaupierre, A. 
Fenster. Automatic 3D US Ventricle Segmentation in Pre-term Neonates Using Multi-Phase 
Geodesic Level-Sets with Shape Prior. MICCAI 2015. October 5-9 2015, Munich, Germany 
(Poster Presentation) 
3. W. Qiu, J. Yuan, J. Kishimoto, M. Rajchl, E. Ukwatta, S. de Ribaupierre, A. Fenster. 
Longitudinal Analysis of Pre-Term Neonatal Ventricle in Ultrasound Images Based on 
Convex Optimization. MICCAI 2015. October 5-9 2015, Munich, Germany (Oral 
Presentation) 
4. J. Kishimoto, A. Fenster D.S.C. Lee, S de Ribaupierre. Characterization of neonatal patients 
with intraventricular hemorrhage using 3D ultrasound cerebral ventricle volumes. SPIE – 
Medical Imaging 2015. February 21-26 2015. Orlando, FL. (Oral Presentation) 
5. W. Qiu, J. Yuan, J. Kishimoto, Y. Chen, S. de Ribaupierre, A. Fenster. 3D MR Ventricle 
Segmentation in Pre-term Infants with Post-Hemorrhagic Hydrocephalus. SPIE – Medical 
Imaging 2015. February 21-26 2015. Orlando, FL. (Oral Presentation) 
6. Y. Chen, J. Kishimoto, B. Chiu, W. Qiu, S. de Ribaupierre, A. Fenster. Quantification of 
Cerebral Ventricle Volume Change of Preterm Neonates Using 3D Ultrasound Images.  SPIE 
– Medical Imaging 2015. February 21-26 2015. Orlando, FL. (Oral Presentation) 
7. J. Kishimoto, M. Diop, P. McLachlan, S. de Ribaupierre, D.S.C. Lee, K. St Lawrence. 
Evidence of ventricular contamination of the optical signal in preterm neonates with post 
hemorrhagic ventricle dilation.  SPIE – Photonics West 2015. February 7-12 2015. San 
Francisco, CA. (Oral Presentation) 
8. W. Qiu, J. Yuan, M. Rajchl, J. Kishimoto, E. Ukwatta, S. de Ribaupierre, A. Fenster. 
Cerebral Ventricle Segmentation from 3D Pre-term IVH Neonate MR Images Using Atlas-
Based Convex Optimization. Computer-Assisted and Robotic Endoscopy Workshop, 
MICCAI, Sept 14-19 2014 Boston, MA. (Workshop) 
9. W. Qiu, J. Yuan, J Kishimoto, S de Ribaupierre, E. Ukwatta, A. Fenster. Semi-automatic 
Segmentation of Pre-term Neonate Ventricle System From 3D Ultrasound Images. IEEE 
151 
 
 
International Symposium on Biomedical Imaging (ISBI), Apr 28-May 2, 2014. Beijing, 
China (Poster Presentation) 
10. J. Kishimoto, J. T. Elliot, P. McLachlan, M. Diop, S. de Ribaupierre, D.S.C. Lee, K. St. 
Lawrence. Monitoring Cerebral Blood Flow in Preterm Infants with Post-Hemorrhagic 
Hydrocephalus. The Optics Society – Biomedical Optics. April 26-30 2014. Miami, FL. US 
(Poster Presentation) 
11. J Kishimoto, Fenster, A, Chen, N, D.S.C. Lee, S de Ribaupierre. In Vivo Validation of a 3D 
Ultrasound System for Imaging the Lateral Ventricles of Neonates. Proceedings of SPIE 
Volume 9036 Feb 15-21 2014. San Diego, California. (Oral Presentation.) 
12. W. Qiu, J. Yuan, J Kishimoto, E. Ukwatta, A. Fenster. Lateral Ventricle Segmentation of 3D 
Pre-term Neonates US Using Convex Optimization. MICCAI 2013. Sept 21-26 2013. 
Nagoya, Japan (Poster Presentation) 
13. M. Diop, J. Kishimoto, D. S. C. Lee, T-Y. Lee, K. St. Lawrence. Cerebral Blood Flow 
Monitoring in Preterm Infants by Diffuse Correlation Spectroscopy The Optics Society – 
Biomedical Optics. April 26-30 2014. Miami, FL. US (Poster Presentation) 
14. J Kishimoto, D.S.C. Lee, K. St. Lawrence, A. Fenster, S de Ribaupierre. Development of a 
3D Ultrasound System to Investigate Post- Hemorrhagic Hydrocephalus in Pre-term 
Neonates. SPIE Medical Imaging. Proceedings of SPIE Volume 8675. Feb 9-14 2013, 
Orlando Florida, US. (Poster Presentation) 
15. D.W. Holdsworth, H. Nikolov, J. Au, K Beaucage, J Kishimoto, S.J.Dixon. Simultaneous 
vibration and high-speed microscopy to study mechanotransduction in living cells. SPIE 
Medical Imaging. Proceedings of SPIE Volume 8317. Feb 4-9 2012, San Diego, California. 
(Oral Presentation) 
 
C. Peer Reviewed Oral Presentations (10) 
 
1. J Kishimoto, A Fenster, F. Salehi, W. Romano, D.S.C Lee, S. de Ribaupierre. Cranial 
ultrasound in 2D and 3D to guide treatment in preterm neonates with post-hemorrhagic 
ventricular dilatation. Paediatric Surgery Day. February 6 2017, London, ON 
2. P. McLachlan, J. Kishimoto, S. de Ribaupierre, D.S.C. Lee, M. Diop, K. St. Lawrence. 
Development of a NIRS method to quantify cerebral perfusion and oxidative metabolism in 
preterm neonates with post hemorrhagic ventricle dilation. SPIE Photonics West 2017. 
January 28 – February 2 2017, San Francisco, CA 
3. J. Kishimoto, W. Romano, D.S.C. Lee, A. Fenster, S. de Ribaupierre.  To tap or not to tap: A 
comparison of cerebral 3D ultrasound to 2D ultrasound in extremely preterm neonates with 
post-hemorrhagic ventricle dilation to predict the necessity of interventional ventricular tap. 
World Congress on Medical Imaging. June 7-12 2015, Toronto, ON. 
4. J Kishimoto, A. Fenster, D.S.C. Lee, S de Ribaupierre. Development of an image based 
classification method for the interventional treatment of preterm neonates with 
intraventricular hemorrhage using 3D ultrasound. Imaging Network Ontario. March 30 - 31, 
2015. London, ON.  
5. J. Kishimoto, D.S.C. Lee, W. Romano, A. Fenster, S. de Ribaupierre.  Improved 
Characterization of Post Hemorrhagic Ventriculomegaly using 3D head Ultrasound. 
Paediatric Research Day. May 21 2014. London, ON.  
6. J Kishimoto, A. Fenster, N. Chen, D.S.C. Lee, S de Ribaupierre. In Vivo Validation of a 3D 
Ultrasound System for Imaging the Lateral Ventricles of Neonates. Imaging Network 
Ontario. March 24 - 25, 2014. Toronto, ON.  
152 
 
 
7. J Kishimoto, A. Fenster, N. Chen, D.S.C. Lee, S de Ribaupierre. Development of a 3D 
ultrasound system for the measurement of ventricle dilation in preterm patients: In Vivo 
Validation Studies. London Health Research Day. March 18th 2014. London, ON 
8. J. Kishimoto, W. Romano, A. Fenster, D.S.C. Lee, S. de Ribaupierre.  Comparison of 
clinical US measurements of the ventricles to 3D US ventricle volumes in IVH 
patients. RSNA. Chicago, IL. Dec 1-6 2013  
9. J. Kishimoto, S. de Ribaupierre, W. Romano, K. St. Lawrence, M. Diop, S. Levin, V. Han, 
A. Fenster, D. S. Lee. 3-D volumetric assessment of cerebral ventricles and quantitative 
cerebral blood flow in the management of posthemorrhagic hydrocephalus in preterm infants. 
Canadian Pediatric Society. Edmonton, AB. June 19-22, 2013.  
10. J Kishimoto, D.S.C. Lee, M. Diop., A. Fenster, K. St. Lawrence, Romano, W., S. Levin, V. 
Han, S de Ribaupierre. Bedside monitoring of post-hemorrhagic hydrocephalus:  3D US to 
measure ventricular volumes and NIRS to track changes in cerebral blood flow. Pediatrics 
Research Day. London, ON., May 29 2013. 
 
D. Peer Reviewed Poster Presentations (24) 
 
1. A. Harris, J. Kishimoto, L. Gardi, S de Ribaupierre, D.S.C. Lee, A. Fenster. Automatic 
Image Registration and Stitching in 3D Ultrasound for Monitoring of Neonatal Post-
Hemorrhagic Ventricle Dilation. Imaging Network Ontario. March 15 - 16, 2017. London, 
ON.  
2. J. Kishimoto, A. Fenster, D.S.C. Lee, S de Ribaupierre. Three dimensional head ultrasound 
for the detection of shunt failure in infants with hydrocephalus: pilot study. Imaging Network 
Ontario. March 15 - 16, 2017. London, ON.  
3. J. Kishimoto, A. Fenster, F. Salehi, W. Romano, D.S.C Lee, S. de Ribaupierre. Quantitative 
3D and 2D head ultrasound to determine thresholds for intervention in preterm neonates with 
post hemorrhagic ventricle dilation.  Canadian Pediatric Society. June 22-25 2016, 
Charlottetown, PEI 
4. J. Kishimoto, A. Fenster, F. Salehi, W. Romano, D.S.C Lee, S. de Ribaupierre. Quantitative 
3D and 2D Ultrasound to Guide Treatment in Neonates With Post-Hemorrhagic Ventricle 
Dilatation: Pilot Study Results.  Pediatric Academic Societies. April 30-May 3 2016, 
Baltimore, MD 
5. J. Kishimoto, A. Fenster, F. Salehi, W. Romano, D.S.C Lee, M Bhaduri, S. de Ribaupierre. 
3D ultrasound to guide IVH treatment in neonates. ARRS 2016. April 17-22 2016. Los 
Angeles, CA 
6. J. Kishimoto, A. Fenster, F. Salehi, W. Romano, D.S.C Lee, S. de Ribaupierre. Cranial 
ultrasound in 2D and 3D to guide treatment in preterm neonates with posthemorrhagic 
ventricular dilatation.  Imaging Network Ontario. March 30 & 31 2016, Toronto, ON 
7. J. Kishimoto, S. de Ribaupierre, J.T. Elliot, D.S.C. Lee, M. Diop, K. St. Lawrence. Preterm 
neonates with post hemorrhagic ventricle dilation show improvements in cerebral perfusion 
after ventricle tap: a near infrared spectroscopy study. London Health Research Day. March 
29 2016. London, ON 
8. M. Diop, J. Kishimoto, V. Toronov, D.S.C. Lee, K. St. Lawrence. Using a hybrid optical 
system to detect the uncoupling of cerebral blood flow and cerebral oxidative metabolism in 
preterm infants undergoing treatment for patent ductus arteriosus International Symposium 
on Cerebral Blood Flow, Metabolism and Function. June 27-30 2015, Vancouver, BC 
153 
 
 
9. J. Kishimoto, K. St. Lawrence, M. Diop, V.K.M. Han , D.S.C. Lee, S. de Ribaupierre. 
Limitations of Cerebral Monitoring with Near Infrared Spectroscopy in Neonates with Post 
Hemorrhagic Ventricular Dilatation. Pediatric Academic Society. April 25-28 2015. San 
Diego, CA 
10. P. McLachlan, J. Kishimoto, K. St. Lawrence, M. Diop, V.K.M. Han , D.S.C. Lee, S. de 
Ribaupierre. Pitfalls of Cerebral Oxygenation Monitoring in the Presence of Ventricular 
Dilatation. Pediatric Academic Society. April 25-28 2015. San Diego, CA 
11. J. Kishimoto, M. Diop,  K. St. Lawrence, V.K.M. Han , D.S.C. Lee. Validation of a Non-
Invasive Optical Method, Diffuse Correlation Spectroscopy (DCS), for Measuring Cerebral 
Blood Flow in Preterm Neonates with PDA undergoing Indomethacin Treatment. Pediatric 
Academic Society. April 25-28 2015. San Diego, CA 
12. J. Kishimoto, W. Romano, D.S.C. Lee, A. Fenster, S. de Ribaupierre. To tap or not to tap: A 
comparison of 3D ultrasound to 2D ultrasound in extremely preterm neonates with post-
hemorrhagic ventricle dilation to predict the necessity of interventional ventricular tap. 
London Health Research Day. April 1 2015. London, ON 
13. J. Kishimoto, M. Diop, P. McLachlan, S. de Ribaupierre, D.S.C. Lee, K. St Lawrence. 
Clinical Evidence of Ventricular Contamination in a NIRS Study of Post-Hemorrhagic 
Hydrocephalus in Preterm Infants. fNIRS 2014. October 10-12. Montreal, QU. 
14. J. Kishimoto, D.S.C. Lee, W. Romano, A. Fenster, S. de Ribaupierre.  Improved 
Characterization of Post Hemorrhagic Ventriculomegaly using 3D head Ultrasound. Pediatric 
Academic Society. May 3-6 2014. Vancouver, BC, Canada.  
15. P. McLachlan, J. Kishimoto, J. T. Elliot, M. Diop, S. de Ribaupierre, D.C. Lee, K. St. 
Lawrence. Path length correction using Monte Carlo modelling for near-infrared 
spectroscopy measurements of cerebral blood flow in preterm infants with intraventricular 
hemorrhage. London Health Research Day. March 18th 2014. London, ON 
16. J. Kishimoto, S. de Ribaupierre, K. St. Lawrence, M. Diop, A. Fenster, D. S. C. Lee. The 
role of 3D US and Near Infrared Spectroscopy in Monitoring Post-Hemorrhagic 
Ventriculomegaly in Preterm Neonates. Canadian Perinatal Research Meeting in Banff, Feb. 
12-15 2014 
17. J. Kishimoto, S. de Ribaupierre, K. St. Lawrence, M. Diop, A. Fenster, D. S. C. Lee. 
Improving the Management of Hydrocephalus by Monitoring Ventricle Volume with 3-D 
Ultrasound and Cerebral Blood Flow by Near-Infrared Spectroscopy. International 
Conference on Brain Monitoring and Neuroprotection in the Newborn. Florida, US. January 
16-18 2014. 
18. J Kishimoto, N. Chen, D.S.C. Lee, A. Fenster, S de Ribaupierre. Quantification of neonatal 
cerebral ventricular volume using 3D US before and after ventricular tap in patients with post 
hemorrhagic hydrocephalus. London Imaging Discovery Conference. London Health 
Sciences Centre, London, ON. June 13 2013. 
19. J Kishimoto, G. Jawa, D.S.C. Lee, K. St. Lawrence, S de Ribaupierre., A. Fenster 
Development of a 3D Ultrasound System to Investigate Post-Hemorrhagic Hydrocephalus in 
Pre-term Neonates. London Health Research Day. London, ON March 19 2013. 
20. J Kishimoto, D.S.C. Lee, K. St. Lawrence, A. Fenster, S de Ribaupierre., The role of 3D US 
and Near Infrared Spectroscopy to Investigate Post-Hemorrhagic Ventriculomegaly in Pre-
term Neonates. Imaging Network Ontario Symposium. Feb 4-5 2013, Toronto, ON  
21. S de Ribaupierre, J Kishimoto, G. Jawa, K. St. Lawrence, A. Fenster D.S.C. Lee. Alternative 
ways for hydrocephalus monitoring in IVH infants. International Society for Pediatric 
Neurosurgery: 40th Annual Meeting. Sydney, Australia. September 9-13 2012.  
154 
 
 
22. J Kishimoto, G. Jawa, D.S.C. Lee, W. Romano, K. St. Lawrence, A. Fenster, S de 
Ribaupierre Development of a 3D Ultrasound System to Investigate Post-Hemorrhagic 
Hydrocephalus in Pre-term Neonates. London Imaging Discovery Conference. London 
Health Sciences Centre, London, ON. June 27 2012.  
23. J. Kishimoto, K. Beaucage, H. Nikolov, S.J. Dixon, D.W. Holdsworth.., Development of a 
bi-axial strain platform for live-cell microscopy CIHR Joint Motion Training Program in 
Musculoskeletal Health Research and Leadership: Summer Research Symposium. University 
of Western Ontario, London, ON. Aug 4 2011.  
24. J. Kishimoto, K. Beaucage, H. Nikolov, S.J. Dixon, D.W. Holdsworth. Development of a bi-
axial radial strain platform for high speed live-cell microscopy CIHR Joint Motion Training 
Program in Musculoskeletal Health Research and Leadership: Annual Retreat. University of 
Western Ontario. London, ON.  May 13 & 14, 2011.  
 
E. Invited Talks and Presentations (4) 
 
1. In Vivo Validation of a 3D Ultrasound System for Measuring the Cerebral Ventricle 
Volume in Preterm Neonates. Canadian Student Health Research Forum, Winnepeg, MB, 
June 10-12 2014 (Poster) 
2. Assessment of ventricle dilation in preterm infants following intraventricular 
hemorrhage: Comparison of 2D and 3D cranial ultrasound. Mini-Symposium on Imaging 
of Mothers, Fetuses, Infants and Children, Western University London, ON May 20th 2014 
3. The role of 3D Ultrasound in the Monitoring of Post Hemorrhagic Hydrocephalus: Mind 
and Brain Institute, Western University, London ON. Nov 9 2012. 
4. The role of 3D Ultrasound in the Monitoring of Ventriculomegaly following IVH: 
Research Rounds. Victoria Hospital, London, ON. Oct 22 2012. 
 
POST GRADUATE EDUCATION DEVELOPMENT 
 
Sept 2014- Graduate Student Supervisor  
April 2017 Andrew Harris, BSc, PhD Student, Medical Biophysics 
  PhD Student (Sept 2017-present) 
Project: Automated image registrtion and stitching of 3D ultrasound 
images 
 
Duncan Riviere, Medical Physics Undergraduate Student 
Volunteer Researcher (Sept 2016-April 2017) 
Project: Further development of a semi-automated segmentation algorthm 
for 3D ultrasoud images of neonatal cerebral ventricles 
 
Peter McLachlan, BMSc, Master’s Candidate, Medical Biophysics 
Master’s Student (Sept 2014-May 2017) 
4th year thesis student (Sept 2013-April 2014) 
Project: Investigating potential improvements in cerebral blood flow and 
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